"","title","geo_accession","status","submission_date","last_update_date","type","channel_count","source_name_ch1","organism_ch1","characteristics_ch1","characteristics_ch1.1","characteristics_ch1.2","treatment_protocol_ch1","molecule_ch1","extract_protocol_ch1","label_ch1","label_protocol_ch1","taxid_ch1","hyb_protocol","scan_protocol","description","description.1","data_processing","platform_id","contact_name","contact_email","contact_phone","contact_department","contact_institute","contact_address","contact_city","contact_state","contact_zip/postal_code","contact_country","contact_web_link","supplementary_file","data_row_count","relation"
"GSM537330","patient 006, cancer, LCM [OPG study]","GSM537330","Public on Feb 28 2011","Apr 26 2010","Feb 28 2011","RNA","1","surgically resected material","Homo sapiens","metastasis: metastatic recurrence","stage: 2b","tissue: cancer, LCM","Tumor tissue was extracted using laser-capture microdissection.","total RNA","Total RNA was extracted from tissue specimens using RNeasy kit (Qiagen, Hilden, Germany). Integrity of obtained RNA was assessed using Agilent 2100 BioAnalyzer (Agilent Technologies, Palo Alto, CA). All samples had RNA Integrity Number (RIN) greater than 5.0. Contaminant DNA was removed by digestion with RNase-free DNase (Qiagen).","biotin","cRNA was prepared using two-cycle target labeling and control reagents kit (Affymetrix, Santa Clara, CA).","9606","Hybridization and signal detection of HG-U133 Plus 2.0 arrays (Affymetrix) was performed following the manufacturer's instruction using the Affymetrix Fluidics Station 450.","GeneChips were scanned using Affymetrix GeneChip Scanner 3000.","Gene expression profile of surgically resected material","C006","The data was normalized by robust multichip analysis (RMA) using R/Bioconductor (affy package).","GPL570","Kaoru,,Mogushi","mogushi@bioinfo.tmd.ac.jp","+81-3-5803-4758","Information Center for Medical Sciences","Tokyo Medical and Dental University","1-5-45 Yushima","Bunkyo-ku","Tokyo","113-8510","Japan","http://bioinfo.tmd.ac.jp/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM537nnn/GSM537330/GSM537330_chip_array_C06T.CEL.gz","54675",""
"GSM537331","patient 100, cancer, LCM [OPG study]","GSM537331","Public on Feb 28 2011","Apr 26 2010","Feb 28 2011","RNA","1","surgically resected material","Homo sapiens","metastasis: none","stage: 3b","tissue: cancer, LCM","Tumor tissue was extracted using laser-capture microdissection.","total RNA","Total RNA was extracted from tissue specimens using RNeasy kit (Qiagen, Hilden, Germany). Integrity of obtained RNA was assessed using Agilent 2100 BioAnalyzer (Agilent Technologies, Palo Alto, CA). All samples had RNA Integrity Number (RIN) greater than 5.0. Contaminant DNA was removed by digestion with RNase-free DNase (Qiagen).","biotin","cRNA was prepared using two-cycle target labeling and control reagents kit (Affymetrix, Santa Clara, CA).","9606","Hybridization and signal detection of HG-U133 Plus 2.0 arrays (Affymetrix) was performed following the manufacturer's instruction using the Affymetrix Fluidics Station 450.","GeneChips were scanned using Affymetrix GeneChip Scanner 3000.","Gene expression profile of surgically resected material","C100","The data was normalized by robust multichip analysis (RMA) using R/Bioconductor (affy package).","GPL570","Kaoru,,Mogushi","mogushi@bioinfo.tmd.ac.jp","+81-3-5803-4758","Information Center for Medical Sciences","Tokyo Medical and Dental University","1-5-45 Yushima","Bunkyo-ku","Tokyo","113-8510","Japan","http://bioinfo.tmd.ac.jp/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM537nnn/GSM537331/GSM537331_chip_array_C100T.CEL.gz","54675","Reanalysis of: GSM452552"
"GSM537332","patient 101, cancer, LCM [OPG study]","GSM537332","Public on Feb 28 2011","Apr 26 2010","Feb 28 2011","RNA","1","surgically resected material","Homo sapiens","metastasis: none","stage: 3b","tissue: cancer, LCM","Tumor tissue was extracted using laser-capture microdissection.","total RNA","Total RNA was extracted from tissue specimens using RNeasy kit (Qiagen, Hilden, Germany). Integrity of obtained RNA was assessed using Agilent 2100 BioAnalyzer (Agilent Technologies, Palo Alto, CA). All samples had RNA Integrity Number (RIN) greater than 5.0. Contaminant DNA was removed by digestion with RNase-free DNase (Qiagen).","biotin","cRNA was prepared using two-cycle target labeling and control reagents kit (Affymetrix, Santa Clara, CA).","9606","Hybridization and signal detection of HG-U133 Plus 2.0 arrays (Affymetrix) was performed following the manufacturer's instruction using the Affymetrix Fluidics Station 450.","GeneChips were scanned using Affymetrix GeneChip Scanner 3000.","Gene expression profile of surgically resected material","C101","The data was normalized by robust multichip analysis (RMA) using R/Bioconductor (affy package).","GPL570","Kaoru,,Mogushi","mogushi@bioinfo.tmd.ac.jp","+81-3-5803-4758","Information Center for Medical Sciences","Tokyo Medical and Dental University","1-5-45 Yushima","Bunkyo-ku","Tokyo","113-8510","Japan","http://bioinfo.tmd.ac.jp/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM537nnn/GSM537332/GSM537332_chip_array_C101T.CEL.gz","54675","Reanalysis of: GSM452553"
"GSM537333","patient 102, cancer, LCM [OPG study]","GSM537333","Public on Feb 28 2011","Apr 26 2010","Feb 28 2011","RNA","1","surgically resected material","Homo sapiens","metastasis: none","stage: 2b","tissue: cancer, LCM","Tumor tissue was extracted using laser-capture microdissection.","total RNA","Total RNA was extracted from tissue specimens using RNeasy kit (Qiagen, Hilden, Germany). Integrity of obtained RNA was assessed using Agilent 2100 BioAnalyzer (Agilent Technologies, Palo Alto, CA). All samples had RNA Integrity Number (RIN) greater than 5.0. Contaminant DNA was removed by digestion with RNase-free DNase (Qiagen).","biotin","cRNA was prepared using two-cycle target labeling and control reagents kit (Affymetrix, Santa Clara, CA).","9606","Hybridization and signal detection of HG-U133 Plus 2.0 arrays (Affymetrix) was performed following the manufacturer's instruction using the Affymetrix Fluidics Station 450.","GeneChips were scanned using Affymetrix GeneChip Scanner 3000.","Gene expression profile of surgically resected material","C102","The data was normalized by robust multichip analysis (RMA) using R/Bioconductor (affy package).","GPL570","Kaoru,,Mogushi","mogushi@bioinfo.tmd.ac.jp","+81-3-5803-4758","Information Center for Medical Sciences","Tokyo Medical and Dental University","1-5-45 Yushima","Bunkyo-ku","Tokyo","113-8510","Japan","http://bioinfo.tmd.ac.jp/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM537nnn/GSM537333/GSM537333_chip_array_C102T.CEL.gz","54675","Reanalysis of: GSM452554"
"GSM537334","patient 103, cancer, LCM [OPG study]","GSM537334","Public on Feb 28 2011","Apr 26 2010","Feb 28 2011","RNA","1","surgically resected material","Homo sapiens","metastasis: none","stage: 3b","tissue: cancer, LCM","Tumor tissue was extracted using laser-capture microdissection.","total RNA","Total RNA was extracted from tissue specimens using RNeasy kit (Qiagen, Hilden, Germany). Integrity of obtained RNA was assessed using Agilent 2100 BioAnalyzer (Agilent Technologies, Palo Alto, CA). All samples had RNA Integrity Number (RIN) greater than 5.0. Contaminant DNA was removed by digestion with RNase-free DNase (Qiagen).","biotin","cRNA was prepared using two-cycle target labeling and control reagents kit (Affymetrix, Santa Clara, CA).","9606","Hybridization and signal detection of HG-U133 Plus 2.0 arrays (Affymetrix) was performed following the manufacturer's instruction using the Affymetrix Fluidics Station 450.","GeneChips were scanned using Affymetrix GeneChip Scanner 3000.","Gene expression profile of surgically resected material","C103","The data was normalized by robust multichip analysis (RMA) using R/Bioconductor (affy package).","GPL570","Kaoru,,Mogushi","mogushi@bioinfo.tmd.ac.jp","+81-3-5803-4758","Information Center for Medical Sciences","Tokyo Medical and Dental University","1-5-45 Yushima","Bunkyo-ku","Tokyo","113-8510","Japan","http://bioinfo.tmd.ac.jp/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM537nnn/GSM537334/GSM537334_chip_array_C103T.CEL.gz","54675","Reanalysis of: GSM452555"
"GSM537335","patient 104, cancer, LCM [OPG study]","GSM537335","Public on Feb 28 2011","Apr 26 2010","Feb 28 2011","RNA","1","surgically resected material","Homo sapiens","metastasis: metastasis","stage: 4","tissue: cancer, LCM","Tumor tissue was extracted using laser-capture microdissection.","total RNA","Total RNA was extracted from tissue specimens using RNeasy kit (Qiagen, Hilden, Germany). Integrity of obtained RNA was assessed using Agilent 2100 BioAnalyzer (Agilent Technologies, Palo Alto, CA). All samples had RNA Integrity Number (RIN) greater than 5.0. Contaminant DNA was removed by digestion with RNase-free DNase (Qiagen).","biotin","cRNA was prepared using two-cycle target labeling and control reagents kit (Affymetrix, Santa Clara, CA).","9606","Hybridization and signal detection of HG-U133 Plus 2.0 arrays (Affymetrix) was performed following the manufacturer's instruction using the Affymetrix Fluidics Station 450.","GeneChips were scanned using Affymetrix GeneChip Scanner 3000.","Gene expression profile of surgically resected material","C104","The data was normalized by robust multichip analysis (RMA) using R/Bioconductor (affy package).","GPL570","Kaoru,,Mogushi","mogushi@bioinfo.tmd.ac.jp","+81-3-5803-4758","Information Center for Medical Sciences","Tokyo Medical and Dental University","1-5-45 Yushima","Bunkyo-ku","Tokyo","113-8510","Japan","http://bioinfo.tmd.ac.jp/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM537nnn/GSM537335/GSM537335_chip_array_C104T.CEL.gz","54675","Reanalysis of: GSM452556"
"GSM537336","patient 107, cancer, LCM [OPG study]","GSM537336","Public on Feb 28 2011","Apr 26 2010","Feb 28 2011","RNA","1","surgically resected material","Homo sapiens","metastasis: none","stage: 2a","tissue: cancer, LCM","Tumor tissue was extracted using laser-capture microdissection.","total RNA","Total RNA was extracted from tissue specimens using RNeasy kit (Qiagen, Hilden, Germany). Integrity of obtained RNA was assessed using Agilent 2100 BioAnalyzer (Agilent Technologies, Palo Alto, CA). All samples had RNA Integrity Number (RIN) greater than 5.0. Contaminant DNA was removed by digestion with RNase-free DNase (Qiagen).","biotin","cRNA was prepared using two-cycle target labeling and control reagents kit (Affymetrix, Santa Clara, CA).","9606","Hybridization and signal detection of HG-U133 Plus 2.0 arrays (Affymetrix) was performed following the manufacturer's instruction using the Affymetrix Fluidics Station 450.","GeneChips were scanned using Affymetrix GeneChip Scanner 3000.","Gene expression profile of surgically resected material","C107","The data was normalized by robust multichip analysis (RMA) using R/Bioconductor (affy package).","GPL570","Kaoru,,Mogushi","mogushi@bioinfo.tmd.ac.jp","+81-3-5803-4758","Information Center for Medical Sciences","Tokyo Medical and Dental University","1-5-45 Yushima","Bunkyo-ku","Tokyo","113-8510","Japan","http://bioinfo.tmd.ac.jp/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM537nnn/GSM537336/GSM537336_chip_array_C107T.CEL.gz","54675","Reanalysis of: GSM452557"
"GSM537337","patient 108, cancer, LCM [OPG study]","GSM537337","Public on Feb 28 2011","Apr 26 2010","Feb 28 2011","RNA","1","surgically resected material","Homo sapiens","metastasis: none","stage: 2a","tissue: cancer, LCM","Tumor tissue was extracted using laser-capture microdissection.","total RNA","Total RNA was extracted from tissue specimens using RNeasy kit (Qiagen, Hilden, Germany). Integrity of obtained RNA was assessed using Agilent 2100 BioAnalyzer (Agilent Technologies, Palo Alto, CA). All samples had RNA Integrity Number (RIN) greater than 5.0. Contaminant DNA was removed by digestion with RNase-free DNase (Qiagen).","biotin","cRNA was prepared using two-cycle target labeling and control reagents kit (Affymetrix, Santa Clara, CA).","9606","Hybridization and signal detection of HG-U133 Plus 2.0 arrays (Affymetrix) was performed following the manufacturer's instruction using the Affymetrix Fluidics Station 450.","GeneChips were scanned using Affymetrix GeneChip Scanner 3000.","Gene expression profile of surgically resected material","C108","The data was normalized by robust multichip analysis (RMA) using R/Bioconductor (affy package).","GPL570","Kaoru,,Mogushi","mogushi@bioinfo.tmd.ac.jp","+81-3-5803-4758","Information Center for Medical Sciences","Tokyo Medical and Dental University","1-5-45 Yushima","Bunkyo-ku","Tokyo","113-8510","Japan","http://bioinfo.tmd.ac.jp/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM537nnn/GSM537337/GSM537337_chip_array_C108T.CEL.gz","54675",""
"GSM537338","patient 110, cancer, LCM [OPG study]","GSM537338","Public on Feb 28 2011","Apr 26 2010","Feb 28 2011","RNA","1","surgically resected material","Homo sapiens","metastasis: none","stage: 3b","tissue: cancer, LCM","Tumor tissue was extracted using laser-capture microdissection.","total RNA","Total RNA was extracted from tissue specimens using RNeasy kit (Qiagen, Hilden, Germany). Integrity of obtained RNA was assessed using Agilent 2100 BioAnalyzer (Agilent Technologies, Palo Alto, CA). All samples had RNA Integrity Number (RIN) greater than 5.0. Contaminant DNA was removed by digestion with RNase-free DNase (Qiagen).","biotin","cRNA was prepared using two-cycle target labeling and control reagents kit (Affymetrix, Santa Clara, CA).","9606","Hybridization and signal detection of HG-U133 Plus 2.0 arrays (Affymetrix) was performed following the manufacturer's instruction using the Affymetrix Fluidics Station 450.","GeneChips were scanned using Affymetrix GeneChip Scanner 3000.","Gene expression profile of surgically resected material","C110","The data was normalized by robust multichip analysis (RMA) using R/Bioconductor (affy package).","GPL570","Kaoru,,Mogushi","mogushi@bioinfo.tmd.ac.jp","+81-3-5803-4758","Information Center for Medical Sciences","Tokyo Medical and Dental University","1-5-45 Yushima","Bunkyo-ku","Tokyo","113-8510","Japan","http://bioinfo.tmd.ac.jp/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM537nnn/GSM537338/GSM537338_chip_array_C110T.CEL.gz","54675",""
"GSM537339","patient 111, cancer, LCM [OPG study]","GSM537339","Public on Feb 28 2011","Apr 26 2010","Feb 28 2011","RNA","1","surgically resected material","Homo sapiens","metastasis: metastasis","stage: 4","tissue: cancer, LCM","Tumor tissue was extracted using laser-capture microdissection.","total RNA","Total RNA was extracted from tissue specimens using RNeasy kit (Qiagen, Hilden, Germany). Integrity of obtained RNA was assessed using Agilent 2100 BioAnalyzer (Agilent Technologies, Palo Alto, CA). All samples had RNA Integrity Number (RIN) greater than 5.0. Contaminant DNA was removed by digestion with RNase-free DNase (Qiagen).","biotin","cRNA was prepared using two-cycle target labeling and control reagents kit (Affymetrix, Santa Clara, CA).","9606","Hybridization and signal detection of HG-U133 Plus 2.0 arrays (Affymetrix) was performed following the manufacturer's instruction using the Affymetrix Fluidics Station 450.","GeneChips were scanned using Affymetrix GeneChip Scanner 3000.","Gene expression profile of surgically resected material","C111","The data was normalized by robust multichip analysis (RMA) using R/Bioconductor (affy package).","GPL570","Kaoru,,Mogushi","mogushi@bioinfo.tmd.ac.jp","+81-3-5803-4758","Information Center for Medical Sciences","Tokyo Medical and Dental University","1-5-45 Yushima","Bunkyo-ku","Tokyo","113-8510","Japan","http://bioinfo.tmd.ac.jp/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM537nnn/GSM537339/GSM537339_chip_array_C111T.CEL.gz","54675","Reanalysis of: GSM452558"
"GSM537340","patient 113, cancer, LCM [OPG study]","GSM537340","Public on Feb 28 2011","Apr 26 2010","Feb 28 2011","RNA","1","surgically resected material","Homo sapiens","metastasis: metastasis","stage: 4","tissue: cancer, LCM","Tumor tissue was extracted using laser-capture microdissection.","total RNA","Total RNA was extracted from tissue specimens using RNeasy kit (Qiagen, Hilden, Germany). Integrity of obtained RNA was assessed using Agilent 2100 BioAnalyzer (Agilent Technologies, Palo Alto, CA). All samples had RNA Integrity Number (RIN) greater than 5.0. Contaminant DNA was removed by digestion with RNase-free DNase (Qiagen).","biotin","cRNA was prepared using two-cycle target labeling and control reagents kit (Affymetrix, Santa Clara, CA).","9606","Hybridization and signal detection of HG-U133 Plus 2.0 arrays (Affymetrix) was performed following the manufacturer's instruction using the Affymetrix Fluidics Station 450.","GeneChips were scanned using Affymetrix GeneChip Scanner 3000.","Gene expression profile of surgically resected material","C113","The data was normalized by robust multichip analysis (RMA) using R/Bioconductor (affy package).","GPL570","Kaoru,,Mogushi","mogushi@bioinfo.tmd.ac.jp","+81-3-5803-4758","Information Center for Medical Sciences","Tokyo Medical and Dental University","1-5-45 Yushima","Bunkyo-ku","Tokyo","113-8510","Japan","http://bioinfo.tmd.ac.jp/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM537nnn/GSM537340/GSM537340_chip_array_C113T.CEL.gz","54675","Reanalysis of: GSM452559"
"GSM537341","patient 115, cancer, LCM [OPG study]","GSM537341","Public on Feb 28 2011","Apr 26 2010","Feb 28 2011","RNA","1","surgically resected material","Homo sapiens","metastasis: none","stage: 1","tissue: cancer, LCM","Tumor tissue was extracted using laser-capture microdissection.","total RNA","Total RNA was extracted from tissue specimens using RNeasy kit (Qiagen, Hilden, Germany). Integrity of obtained RNA was assessed using Agilent 2100 BioAnalyzer (Agilent Technologies, Palo Alto, CA). All samples had RNA Integrity Number (RIN) greater than 5.0. Contaminant DNA was removed by digestion with RNase-free DNase (Qiagen).","biotin","cRNA was prepared using two-cycle target labeling and control reagents kit (Affymetrix, Santa Clara, CA).","9606","Hybridization and signal detection of HG-U133 Plus 2.0 arrays (Affymetrix) was performed following the manufacturer's instruction using the Affymetrix Fluidics Station 450.","GeneChips were scanned using Affymetrix GeneChip Scanner 3000.","Gene expression profile of surgically resected material","C115","The data was normalized by robust multichip analysis (RMA) using R/Bioconductor (affy package).","GPL570","Kaoru,,Mogushi","mogushi@bioinfo.tmd.ac.jp","+81-3-5803-4758","Information Center for Medical Sciences","Tokyo Medical and Dental University","1-5-45 Yushima","Bunkyo-ku","Tokyo","113-8510","Japan","http://bioinfo.tmd.ac.jp/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM537nnn/GSM537341/GSM537341_chip_array_C115T.CEL.gz","54675","Reanalysis of: GSM452560"
"GSM537342","patient 116, cancer, LCM [OPG study]","GSM537342","Public on Feb 28 2011","Apr 26 2010","Feb 28 2011","RNA","1","surgically resected material","Homo sapiens","metastasis: none","stage: 2b","tissue: cancer, LCM","Tumor tissue was extracted using laser-capture microdissection.","total RNA","Total RNA was extracted from tissue specimens using RNeasy kit (Qiagen, Hilden, Germany). Integrity of obtained RNA was assessed using Agilent 2100 BioAnalyzer (Agilent Technologies, Palo Alto, CA). All samples had RNA Integrity Number (RIN) greater than 5.0. Contaminant DNA was removed by digestion with RNase-free DNase (Qiagen).","biotin","cRNA was prepared using two-cycle target labeling and control reagents kit (Affymetrix, Santa Clara, CA).","9606","Hybridization and signal detection of HG-U133 Plus 2.0 arrays (Affymetrix) was performed following the manufacturer's instruction using the Affymetrix Fluidics Station 450.","GeneChips were scanned using Affymetrix GeneChip Scanner 3000.","Gene expression profile of surgically resected material","C116","The data was normalized by robust multichip analysis (RMA) using R/Bioconductor (affy package).","GPL570","Kaoru,,Mogushi","mogushi@bioinfo.tmd.ac.jp","+81-3-5803-4758","Information Center for Medical Sciences","Tokyo Medical and Dental University","1-5-45 Yushima","Bunkyo-ku","Tokyo","113-8510","Japan","http://bioinfo.tmd.ac.jp/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM537nnn/GSM537342/GSM537342_chip_array_C116T.CEL.gz","54675","Reanalysis of: GSM452561"
"GSM537343","patient 117, cancer, LCM [OPG study]","GSM537343","Public on Feb 28 2011","Apr 26 2010","Feb 28 2011","RNA","1","surgically resected material","Homo sapiens","metastasis: metastatic recurrence","stage: 3b","tissue: cancer, LCM","Tumor tissue was extracted using laser-capture microdissection.","total RNA","Total RNA was extracted from tissue specimens using RNeasy kit (Qiagen, Hilden, Germany). Integrity of obtained RNA was assessed using Agilent 2100 BioAnalyzer (Agilent Technologies, Palo Alto, CA). All samples had RNA Integrity Number (RIN) greater than 5.0. Contaminant DNA was removed by digestion with RNase-free DNase (Qiagen).","biotin","cRNA was prepared using two-cycle target labeling and control reagents kit (Affymetrix, Santa Clara, CA).","9606","Hybridization and signal detection of HG-U133 Plus 2.0 arrays (Affymetrix) was performed following the manufacturer's instruction using the Affymetrix Fluidics Station 450.","GeneChips were scanned using Affymetrix GeneChip Scanner 3000.","Gene expression profile of surgically resected material","C117","The data was normalized by robust multichip analysis (RMA) using R/Bioconductor (affy package).","GPL570","Kaoru,,Mogushi","mogushi@bioinfo.tmd.ac.jp","+81-3-5803-4758","Information Center for Medical Sciences","Tokyo Medical and Dental University","1-5-45 Yushima","Bunkyo-ku","Tokyo","113-8510","Japan","http://bioinfo.tmd.ac.jp/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM537nnn/GSM537343/GSM537343_chip_array_C117T.CEL.gz","54675","Reanalysis of: GSM452562"
"GSM537344","patient 118, cancer, LCM [OPG study]","GSM537344","Public on Feb 28 2011","Apr 26 2010","Feb 28 2011","RNA","1","surgically resected material","Homo sapiens","metastasis: metastasis","stage: 4","tissue: cancer, LCM","Tumor tissue was extracted using laser-capture microdissection.","total RNA","Total RNA was extracted from tissue specimens using RNeasy kit (Qiagen, Hilden, Germany). Integrity of obtained RNA was assessed using Agilent 2100 BioAnalyzer (Agilent Technologies, Palo Alto, CA). All samples had RNA Integrity Number (RIN) greater than 5.0. Contaminant DNA was removed by digestion with RNase-free DNase (Qiagen).","biotin","cRNA was prepared using two-cycle target labeling and control reagents kit (Affymetrix, Santa Clara, CA).","9606","Hybridization and signal detection of HG-U133 Plus 2.0 arrays (Affymetrix) was performed following the manufacturer's instruction using the Affymetrix Fluidics Station 450.","GeneChips were scanned using Affymetrix GeneChip Scanner 3000.","Gene expression profile of surgically resected material","C118","The data was normalized by robust multichip analysis (RMA) using R/Bioconductor (affy package).","GPL570","Kaoru,,Mogushi","mogushi@bioinfo.tmd.ac.jp","+81-3-5803-4758","Information Center for Medical Sciences","Tokyo Medical and Dental University","1-5-45 Yushima","Bunkyo-ku","Tokyo","113-8510","Japan","http://bioinfo.tmd.ac.jp/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM537nnn/GSM537344/GSM537344_chip_array_C118T.CEL.gz","54675","Reanalysis of: GSM452563"
"GSM537345","patient 119, cancer, LCM [OPG study]","GSM537345","Public on Feb 28 2011","Apr 26 2010","Feb 28 2011","RNA","1","surgically resected material","Homo sapiens","metastasis: none","stage: 1","tissue: cancer, LCM","Tumor tissue was extracted using laser-capture microdissection.","total RNA","Total RNA was extracted from tissue specimens using RNeasy kit (Qiagen, Hilden, Germany). Integrity of obtained RNA was assessed using Agilent 2100 BioAnalyzer (Agilent Technologies, Palo Alto, CA). All samples had RNA Integrity Number (RIN) greater than 5.0. Contaminant DNA was removed by digestion with RNase-free DNase (Qiagen).","biotin","cRNA was prepared using two-cycle target labeling and control reagents kit (Affymetrix, Santa Clara, CA).","9606","Hybridization and signal detection of HG-U133 Plus 2.0 arrays (Affymetrix) was performed following the manufacturer's instruction using the Affymetrix Fluidics Station 450.","GeneChips were scanned using Affymetrix GeneChip Scanner 3000.","Gene expression profile of surgically resected material","C119","The data was normalized by robust multichip analysis (RMA) using R/Bioconductor (affy package).","GPL570","Kaoru,,Mogushi","mogushi@bioinfo.tmd.ac.jp","+81-3-5803-4758","Information Center for Medical Sciences","Tokyo Medical and Dental University","1-5-45 Yushima","Bunkyo-ku","Tokyo","113-8510","Japan","http://bioinfo.tmd.ac.jp/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM537nnn/GSM537345/GSM537345_chip_array_C119T.CEL.gz","54675","Reanalysis of: GSM452564"
"GSM537346","patient 011, cancer, LCM [OPG study]","GSM537346","Public on Feb 28 2011","Apr 26 2010","Feb 28 2011","RNA","1","surgically resected material","Homo sapiens","metastasis: metastasis","stage: 4","tissue: cancer, LCM","Tumor tissue was extracted using laser-capture microdissection.","total RNA","Total RNA was extracted from tissue specimens using RNeasy kit (Qiagen, Hilden, Germany). Integrity of obtained RNA was assessed using Agilent 2100 BioAnalyzer (Agilent Technologies, Palo Alto, CA). All samples had RNA Integrity Number (RIN) greater than 5.0. Contaminant DNA was removed by digestion with RNase-free DNase (Qiagen).","biotin","cRNA was prepared using two-cycle target labeling and control reagents kit (Affymetrix, Santa Clara, CA).","9606","Hybridization and signal detection of HG-U133 Plus 2.0 arrays (Affymetrix) was performed following the manufacturer's instruction using the Affymetrix Fluidics Station 450.","GeneChips were scanned using Affymetrix GeneChip Scanner 3000.","Gene expression profile of surgically resected material","C011","The data was normalized by robust multichip analysis (RMA) using R/Bioconductor (affy package).","GPL570","Kaoru,,Mogushi","mogushi@bioinfo.tmd.ac.jp","+81-3-5803-4758","Information Center for Medical Sciences","Tokyo Medical and Dental University","1-5-45 Yushima","Bunkyo-ku","Tokyo","113-8510","Japan","http://bioinfo.tmd.ac.jp/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM537nnn/GSM537346/GSM537346_chip_array_C11T.CEL.gz","54675","Reanalysis of: GSM452565"
"GSM537347","patient 123, cancer, LCM [OPG study]","GSM537347","Public on Feb 28 2011","Apr 26 2010","Feb 28 2011","RNA","1","surgically resected material","Homo sapiens","metastasis: none","stage: 2b","tissue: cancer, LCM","Tumor tissue was extracted using laser-capture microdissection.","total RNA","Total RNA was extracted from tissue specimens using RNeasy kit (Qiagen, Hilden, Germany). Integrity of obtained RNA was assessed using Agilent 2100 BioAnalyzer (Agilent Technologies, Palo Alto, CA). All samples had RNA Integrity Number (RIN) greater than 5.0. Contaminant DNA was removed by digestion with RNase-free DNase (Qiagen).","biotin","cRNA was prepared using two-cycle target labeling and control reagents kit (Affymetrix, Santa Clara, CA).","9606","Hybridization and signal detection of HG-U133 Plus 2.0 arrays (Affymetrix) was performed following the manufacturer's instruction using the Affymetrix Fluidics Station 450.","GeneChips were scanned using Affymetrix GeneChip Scanner 3000.","Gene expression profile of surgically resected material","C123","The data was normalized by robust multichip analysis (RMA) using R/Bioconductor (affy package).","GPL570","Kaoru,,Mogushi","mogushi@bioinfo.tmd.ac.jp","+81-3-5803-4758","Information Center for Medical Sciences","Tokyo Medical and Dental University","1-5-45 Yushima","Bunkyo-ku","Tokyo","113-8510","Japan","http://bioinfo.tmd.ac.jp/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM537nnn/GSM537347/GSM537347_chip_array_C123T.CEL.gz","54675","Reanalysis of: GSM452566"
"GSM537348","patient 124, cancer, LCM [OPG study]","GSM537348","Public on Feb 28 2011","Apr 26 2010","Feb 28 2011","RNA","1","surgically resected material","Homo sapiens","metastasis: none","stage: 2a","tissue: cancer, LCM","Tumor tissue was extracted using laser-capture microdissection.","total RNA","Total RNA was extracted from tissue specimens using RNeasy kit (Qiagen, Hilden, Germany). Integrity of obtained RNA was assessed using Agilent 2100 BioAnalyzer (Agilent Technologies, Palo Alto, CA). All samples had RNA Integrity Number (RIN) greater than 5.0. Contaminant DNA was removed by digestion with RNase-free DNase (Qiagen).","biotin","cRNA was prepared using two-cycle target labeling and control reagents kit (Affymetrix, Santa Clara, CA).","9606","Hybridization and signal detection of HG-U133 Plus 2.0 arrays (Affymetrix) was performed following the manufacturer's instruction using the Affymetrix Fluidics Station 450.","GeneChips were scanned using Affymetrix GeneChip Scanner 3000.","Gene expression profile of surgically resected material","C124","The data was normalized by robust multichip analysis (RMA) using R/Bioconductor (affy package).","GPL570","Kaoru,,Mogushi","mogushi@bioinfo.tmd.ac.jp","+81-3-5803-4758","Information Center for Medical Sciences","Tokyo Medical and Dental University","1-5-45 Yushima","Bunkyo-ku","Tokyo","113-8510","Japan","http://bioinfo.tmd.ac.jp/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM537nnn/GSM537348/GSM537348_chip_array_C124T.CEL.gz","54675","Reanalysis of: GSM452567"
"GSM537349","patient 125, cancer, LCM [OPG study]","GSM537349","Public on Feb 28 2011","Apr 26 2010","Feb 28 2011","RNA","1","surgically resected material","Homo sapiens","metastasis: none","stage: 2a","tissue: cancer, LCM","Tumor tissue was extracted using laser-capture microdissection.","total RNA","Total RNA was extracted from tissue specimens using RNeasy kit (Qiagen, Hilden, Germany). Integrity of obtained RNA was assessed using Agilent 2100 BioAnalyzer (Agilent Technologies, Palo Alto, CA). All samples had RNA Integrity Number (RIN) greater than 5.0. Contaminant DNA was removed by digestion with RNase-free DNase (Qiagen).","biotin","cRNA was prepared using two-cycle target labeling and control reagents kit (Affymetrix, Santa Clara, CA).","9606","Hybridization and signal detection of HG-U133 Plus 2.0 arrays (Affymetrix) was performed following the manufacturer's instruction using the Affymetrix Fluidics Station 450.","GeneChips were scanned using Affymetrix GeneChip Scanner 3000.","Gene expression profile of surgically resected material","C125","The data was normalized by robust multichip analysis (RMA) using R/Bioconductor (affy package).","GPL570","Kaoru,,Mogushi","mogushi@bioinfo.tmd.ac.jp","+81-3-5803-4758","Information Center for Medical Sciences","Tokyo Medical and Dental University","1-5-45 Yushima","Bunkyo-ku","Tokyo","113-8510","Japan","http://bioinfo.tmd.ac.jp/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM537nnn/GSM537349/GSM537349_chip_array_C125T.CEL.gz","54675","Reanalysis of: GSM452568"
"GSM537350","patient 127, cancer, LCM [OPG study]","GSM537350","Public on Feb 28 2011","Apr 26 2010","Feb 28 2011","RNA","1","surgically resected material","Homo sapiens","metastasis: none","stage: 2b","tissue: cancer, LCM","Tumor tissue was extracted using laser-capture microdissection.","total RNA","Total RNA was extracted from tissue specimens using RNeasy kit (Qiagen, Hilden, Germany). Integrity of obtained RNA was assessed using Agilent 2100 BioAnalyzer (Agilent Technologies, Palo Alto, CA). All samples had RNA Integrity Number (RIN) greater than 5.0. Contaminant DNA was removed by digestion with RNase-free DNase (Qiagen).","biotin","cRNA was prepared using two-cycle target labeling and control reagents kit (Affymetrix, Santa Clara, CA).","9606","Hybridization and signal detection of HG-U133 Plus 2.0 arrays (Affymetrix) was performed following the manufacturer's instruction using the Affymetrix Fluidics Station 450.","GeneChips were scanned using Affymetrix GeneChip Scanner 3000.","Gene expression profile of surgically resected material","C127","The data was normalized by robust multichip analysis (RMA) using R/Bioconductor (affy package).","GPL570","Kaoru,,Mogushi","mogushi@bioinfo.tmd.ac.jp","+81-3-5803-4758","Information Center for Medical Sciences","Tokyo Medical and Dental University","1-5-45 Yushima","Bunkyo-ku","Tokyo","113-8510","Japan","http://bioinfo.tmd.ac.jp/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM537nnn/GSM537350/GSM537350_chip_array_C127T.CEL.gz","54675","Reanalysis of: GSM452569"
"GSM537351","patient 128, cancer, LCM [OPG study]","GSM537351","Public on Feb 28 2011","Apr 26 2010","Feb 28 2011","RNA","1","surgically resected material","Homo sapiens","metastasis: metastasis","stage: 4","tissue: cancer, LCM","Tumor tissue was extracted using laser-capture microdissection.","total RNA","Total RNA was extracted from tissue specimens using RNeasy kit (Qiagen, Hilden, Germany). Integrity of obtained RNA was assessed using Agilent 2100 BioAnalyzer (Agilent Technologies, Palo Alto, CA). All samples had RNA Integrity Number (RIN) greater than 5.0. Contaminant DNA was removed by digestion with RNase-free DNase (Qiagen).","biotin","cRNA was prepared using two-cycle target labeling and control reagents kit (Affymetrix, Santa Clara, CA).","9606","Hybridization and signal detection of HG-U133 Plus 2.0 arrays (Affymetrix) was performed following the manufacturer's instruction using the Affymetrix Fluidics Station 450.","GeneChips were scanned using Affymetrix GeneChip Scanner 3000.","Gene expression profile of surgically resected material","C128","The data was normalized by robust multichip analysis (RMA) using R/Bioconductor (affy package).","GPL570","Kaoru,,Mogushi","mogushi@bioinfo.tmd.ac.jp","+81-3-5803-4758","Information Center for Medical Sciences","Tokyo Medical and Dental University","1-5-45 Yushima","Bunkyo-ku","Tokyo","113-8510","Japan","http://bioinfo.tmd.ac.jp/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM537nnn/GSM537351/GSM537351_chip_array_C128T.CEL.gz","54675","Reanalysis of: GSM452570"
"GSM537352","patient 134, cancer, LCM [OPG study]","GSM537352","Public on Feb 28 2011","Apr 26 2010","Feb 28 2011","RNA","1","surgically resected material","Homo sapiens","metastasis: metastasis","stage: 4","tissue: cancer, LCM","Tumor tissue was extracted using laser-capture microdissection.","total RNA","Total RNA was extracted from tissue specimens using RNeasy kit (Qiagen, Hilden, Germany). Integrity of obtained RNA was assessed using Agilent 2100 BioAnalyzer (Agilent Technologies, Palo Alto, CA). All samples had RNA Integrity Number (RIN) greater than 5.0. Contaminant DNA was removed by digestion with RNase-free DNase (Qiagen).","biotin","cRNA was prepared using two-cycle target labeling and control reagents kit (Affymetrix, Santa Clara, CA).","9606","Hybridization and signal detection of HG-U133 Plus 2.0 arrays (Affymetrix) was performed following the manufacturer's instruction using the Affymetrix Fluidics Station 450.","GeneChips were scanned using Affymetrix GeneChip Scanner 3000.","Gene expression profile of surgically resected material","C134","The data was normalized by robust multichip analysis (RMA) using R/Bioconductor (affy package).","GPL570","Kaoru,,Mogushi","mogushi@bioinfo.tmd.ac.jp","+81-3-5803-4758","Information Center for Medical Sciences","Tokyo Medical and Dental University","1-5-45 Yushima","Bunkyo-ku","Tokyo","113-8510","Japan","http://bioinfo.tmd.ac.jp/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM537nnn/GSM537352/GSM537352_chip_array_C134T.CEL.gz","54675","Reanalysis of: GSM452571"
"GSM537353","patient 135, cancer, LCM [OPG study]","GSM537353","Public on Feb 28 2011","Apr 26 2010","Feb 28 2011","RNA","1","surgically resected material","Homo sapiens","metastasis: none","stage: 3b","tissue: cancer, LCM","Tumor tissue was extracted using laser-capture microdissection.","total RNA","Total RNA was extracted from tissue specimens using RNeasy kit (Qiagen, Hilden, Germany). Integrity of obtained RNA was assessed using Agilent 2100 BioAnalyzer (Agilent Technologies, Palo Alto, CA). All samples had RNA Integrity Number (RIN) greater than 5.0. Contaminant DNA was removed by digestion with RNase-free DNase (Qiagen).","biotin","cRNA was prepared using two-cycle target labeling and control reagents kit (Affymetrix, Santa Clara, CA).","9606","Hybridization and signal detection of HG-U133 Plus 2.0 arrays (Affymetrix) was performed following the manufacturer's instruction using the Affymetrix Fluidics Station 450.","GeneChips were scanned using Affymetrix GeneChip Scanner 3000.","Gene expression profile of surgically resected material","C135","The data was normalized by robust multichip analysis (RMA) using R/Bioconductor (affy package).","GPL570","Kaoru,,Mogushi","mogushi@bioinfo.tmd.ac.jp","+81-3-5803-4758","Information Center for Medical Sciences","Tokyo Medical and Dental University","1-5-45 Yushima","Bunkyo-ku","Tokyo","113-8510","Japan","http://bioinfo.tmd.ac.jp/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM537nnn/GSM537353/GSM537353_chip_array_C135T.CEL.gz","54675","Reanalysis of: GSM452572"
"GSM537354","patient 136, cancer, LCM [OPG study]","GSM537354","Public on Feb 28 2011","Apr 26 2010","Feb 28 2011","RNA","1","surgically resected material","Homo sapiens","metastasis: none","stage: 3c","tissue: cancer, LCM","Tumor tissue was extracted using laser-capture microdissection.","total RNA","Total RNA was extracted from tissue specimens using RNeasy kit (Qiagen, Hilden, Germany). Integrity of obtained RNA was assessed using Agilent 2100 BioAnalyzer (Agilent Technologies, Palo Alto, CA). All samples had RNA Integrity Number (RIN) greater than 5.0. Contaminant DNA was removed by digestion with RNase-free DNase (Qiagen).","biotin","cRNA was prepared using two-cycle target labeling and control reagents kit (Affymetrix, Santa Clara, CA).","9606","Hybridization and signal detection of HG-U133 Plus 2.0 arrays (Affymetrix) was performed following the manufacturer's instruction using the Affymetrix Fluidics Station 450.","GeneChips were scanned using Affymetrix GeneChip Scanner 3000.","Gene expression profile of surgically resected material","C136","The data was normalized by robust multichip analysis (RMA) using R/Bioconductor (affy package).","GPL570","Kaoru,,Mogushi","mogushi@bioinfo.tmd.ac.jp","+81-3-5803-4758","Information Center for Medical Sciences","Tokyo Medical and Dental University","1-5-45 Yushima","Bunkyo-ku","Tokyo","113-8510","Japan","http://bioinfo.tmd.ac.jp/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM537nnn/GSM537354/GSM537354_chip_array_C136T.CEL.gz","54675","Reanalysis of: GSM452573"
"GSM537355","patient 138, cancer, LCM [OPG study]","GSM537355","Public on Feb 28 2011","Apr 26 2010","Feb 28 2011","RNA","1","surgically resected material","Homo sapiens","metastasis: none","stage: 1","tissue: cancer, LCM","Tumor tissue was extracted using laser-capture microdissection.","total RNA","Total RNA was extracted from tissue specimens using RNeasy kit (Qiagen, Hilden, Germany). Integrity of obtained RNA was assessed using Agilent 2100 BioAnalyzer (Agilent Technologies, Palo Alto, CA). All samples had RNA Integrity Number (RIN) greater than 5.0. Contaminant DNA was removed by digestion with RNase-free DNase (Qiagen).","biotin","cRNA was prepared using two-cycle target labeling and control reagents kit (Affymetrix, Santa Clara, CA).","9606","Hybridization and signal detection of HG-U133 Plus 2.0 arrays (Affymetrix) was performed following the manufacturer's instruction using the Affymetrix Fluidics Station 450.","GeneChips were scanned using Affymetrix GeneChip Scanner 3000.","Gene expression profile of surgically resected material","C138","The data was normalized by robust multichip analysis (RMA) using R/Bioconductor (affy package).","GPL570","Kaoru,,Mogushi","mogushi@bioinfo.tmd.ac.jp","+81-3-5803-4758","Information Center for Medical Sciences","Tokyo Medical and Dental University","1-5-45 Yushima","Bunkyo-ku","Tokyo","113-8510","Japan","http://bioinfo.tmd.ac.jp/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM537nnn/GSM537355/GSM537355_chip_array_C138T.CEL.gz","54675","Reanalysis of: GSM452574"
"GSM537356","patient 139, cancer, LCM [OPG study]","GSM537356","Public on Feb 28 2011","Apr 26 2010","Feb 28 2011","RNA","1","surgically resected material","Homo sapiens","metastasis: none","stage: 2a","tissue: cancer, LCM","Tumor tissue was extracted using laser-capture microdissection.","total RNA","Total RNA was extracted from tissue specimens using RNeasy kit (Qiagen, Hilden, Germany). Integrity of obtained RNA was assessed using Agilent 2100 BioAnalyzer (Agilent Technologies, Palo Alto, CA). All samples had RNA Integrity Number (RIN) greater than 5.0. Contaminant DNA was removed by digestion with RNase-free DNase (Qiagen).","biotin","cRNA was prepared using two-cycle target labeling and control reagents kit (Affymetrix, Santa Clara, CA).","9606","Hybridization and signal detection of HG-U133 Plus 2.0 arrays (Affymetrix) was performed following the manufacturer's instruction using the Affymetrix Fluidics Station 450.","GeneChips were scanned using Affymetrix GeneChip Scanner 3000.","Gene expression profile of surgically resected material","C139","The data was normalized by robust multichip analysis (RMA) using R/Bioconductor (affy package).","GPL570","Kaoru,,Mogushi","mogushi@bioinfo.tmd.ac.jp","+81-3-5803-4758","Information Center for Medical Sciences","Tokyo Medical and Dental University","1-5-45 Yushima","Bunkyo-ku","Tokyo","113-8510","Japan","http://bioinfo.tmd.ac.jp/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM537nnn/GSM537356/GSM537356_chip_array_C139T.CEL.gz","54675","Reanalysis of: GSM452575"
"GSM537357","patient 142, cancer, LCM [OPG study]","GSM537357","Public on Feb 28 2011","Apr 26 2010","Feb 28 2011","RNA","1","surgically resected material","Homo sapiens","metastasis: none","stage: 3b","tissue: cancer, LCM","Tumor tissue was extracted using laser-capture microdissection.","total RNA","Total RNA was extracted from tissue specimens using RNeasy kit (Qiagen, Hilden, Germany). Integrity of obtained RNA was assessed using Agilent 2100 BioAnalyzer (Agilent Technologies, Palo Alto, CA). All samples had RNA Integrity Number (RIN) greater than 5.0. Contaminant DNA was removed by digestion with RNase-free DNase (Qiagen).","biotin","cRNA was prepared using two-cycle target labeling and control reagents kit (Affymetrix, Santa Clara, CA).","9606","Hybridization and signal detection of HG-U133 Plus 2.0 arrays (Affymetrix) was performed following the manufacturer's instruction using the Affymetrix Fluidics Station 450.","GeneChips were scanned using Affymetrix GeneChip Scanner 3000.","Gene expression profile of surgically resected material","C142","The data was normalized by robust multichip analysis (RMA) using R/Bioconductor (affy package).","GPL570","Kaoru,,Mogushi","mogushi@bioinfo.tmd.ac.jp","+81-3-5803-4758","Information Center for Medical Sciences","Tokyo Medical and Dental University","1-5-45 Yushima","Bunkyo-ku","Tokyo","113-8510","Japan","http://bioinfo.tmd.ac.jp/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM537nnn/GSM537357/GSM537357_chip_array_C142T.CEL.gz","54675","Reanalysis of: GSM452576"
"GSM537358","patient 143, cancer, LCM [OPG study]","GSM537358","Public on Feb 28 2011","Apr 26 2010","Feb 28 2011","RNA","1","surgically resected material","Homo sapiens","metastasis: none","stage: 3b","tissue: cancer, LCM","Tumor tissue was extracted using laser-capture microdissection.","total RNA","Total RNA was extracted from tissue specimens using RNeasy kit (Qiagen, Hilden, Germany). Integrity of obtained RNA was assessed using Agilent 2100 BioAnalyzer (Agilent Technologies, Palo Alto, CA). All samples had RNA Integrity Number (RIN) greater than 5.0. Contaminant DNA was removed by digestion with RNase-free DNase (Qiagen).","biotin","cRNA was prepared using two-cycle target labeling and control reagents kit (Affymetrix, Santa Clara, CA).","9606","Hybridization and signal detection of HG-U133 Plus 2.0 arrays (Affymetrix) was performed following the manufacturer's instruction using the Affymetrix Fluidics Station 450.","GeneChips were scanned using Affymetrix GeneChip Scanner 3000.","Gene expression profile of surgically resected material","C143","The data was normalized by robust multichip analysis (RMA) using R/Bioconductor (affy package).","GPL570","Kaoru,,Mogushi","mogushi@bioinfo.tmd.ac.jp","+81-3-5803-4758","Information Center for Medical Sciences","Tokyo Medical and Dental University","1-5-45 Yushima","Bunkyo-ku","Tokyo","113-8510","Japan","http://bioinfo.tmd.ac.jp/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM537nnn/GSM537358/GSM537358_chip_array_C143T.CEL.gz","54675","Reanalysis of: GSM452577"
"GSM537359","patient 144, cancer, LCM [OPG study]","GSM537359","Public on Feb 28 2011","Apr 26 2010","Feb 28 2011","RNA","1","surgically resected material","Homo sapiens","metastasis: metastasis","stage: 4","tissue: cancer, LCM","Tumor tissue was extracted using laser-capture microdissection.","total RNA","Total RNA was extracted from tissue specimens using RNeasy kit (Qiagen, Hilden, Germany). Integrity of obtained RNA was assessed using Agilent 2100 BioAnalyzer (Agilent Technologies, Palo Alto, CA). All samples had RNA Integrity Number (RIN) greater than 5.0. Contaminant DNA was removed by digestion with RNase-free DNase (Qiagen).","biotin","cRNA was prepared using two-cycle target labeling and control reagents kit (Affymetrix, Santa Clara, CA).","9606","Hybridization and signal detection of HG-U133 Plus 2.0 arrays (Affymetrix) was performed following the manufacturer's instruction using the Affymetrix Fluidics Station 450.","GeneChips were scanned using Affymetrix GeneChip Scanner 3000.","Gene expression profile of surgically resected material","C144","The data was normalized by robust multichip analysis (RMA) using R/Bioconductor (affy package).","GPL570","Kaoru,,Mogushi","mogushi@bioinfo.tmd.ac.jp","+81-3-5803-4758","Information Center for Medical Sciences","Tokyo Medical and Dental University","1-5-45 Yushima","Bunkyo-ku","Tokyo","113-8510","Japan","http://bioinfo.tmd.ac.jp/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM537nnn/GSM537359/GSM537359_chip_array_C144T.CEL.gz","54675","Reanalysis of: GSM452578"
"GSM537360","patient 145, cancer, LCM [OPG study]","GSM537360","Public on Feb 28 2011","Apr 26 2010","Feb 28 2011","RNA","1","surgically resected material","Homo sapiens","metastasis: metastasis","stage: 4","tissue: cancer, LCM","Tumor tissue was extracted using laser-capture microdissection.","total RNA","Total RNA was extracted from tissue specimens using RNeasy kit (Qiagen, Hilden, Germany). Integrity of obtained RNA was assessed using Agilent 2100 BioAnalyzer (Agilent Technologies, Palo Alto, CA). All samples had RNA Integrity Number (RIN) greater than 5.0. Contaminant DNA was removed by digestion with RNase-free DNase (Qiagen).","biotin","cRNA was prepared using two-cycle target labeling and control reagents kit (Affymetrix, Santa Clara, CA).","9606","Hybridization and signal detection of HG-U133 Plus 2.0 arrays (Affymetrix) was performed following the manufacturer's instruction using the Affymetrix Fluidics Station 450.","GeneChips were scanned using Affymetrix GeneChip Scanner 3000.","Gene expression profile of surgically resected material","C145","The data was normalized by robust multichip analysis (RMA) using R/Bioconductor (affy package).","GPL570","Kaoru,,Mogushi","mogushi@bioinfo.tmd.ac.jp","+81-3-5803-4758","Information Center for Medical Sciences","Tokyo Medical and Dental University","1-5-45 Yushima","Bunkyo-ku","Tokyo","113-8510","Japan","http://bioinfo.tmd.ac.jp/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM537nnn/GSM537360/GSM537360_chip_array_C145T.CEL.gz","54675","Reanalysis of: GSM452579"
"GSM537361","patient 147, cancer, LCM [OPG study]","GSM537361","Public on Feb 28 2011","Apr 26 2010","Feb 28 2011","RNA","1","surgically resected material","Homo sapiens","metastasis: none","stage: 2a","tissue: cancer, LCM","Tumor tissue was extracted using laser-capture microdissection.","total RNA","Total RNA was extracted from tissue specimens using RNeasy kit (Qiagen, Hilden, Germany). Integrity of obtained RNA was assessed using Agilent 2100 BioAnalyzer (Agilent Technologies, Palo Alto, CA). All samples had RNA Integrity Number (RIN) greater than 5.0. Contaminant DNA was removed by digestion with RNase-free DNase (Qiagen).","biotin","cRNA was prepared using two-cycle target labeling and control reagents kit (Affymetrix, Santa Clara, CA).","9606","Hybridization and signal detection of HG-U133 Plus 2.0 arrays (Affymetrix) was performed following the manufacturer's instruction using the Affymetrix Fluidics Station 450.","GeneChips were scanned using Affymetrix GeneChip Scanner 3000.","Gene expression profile of surgically resected material","C147","The data was normalized by robust multichip analysis (RMA) using R/Bioconductor (affy package).","GPL570","Kaoru,,Mogushi","mogushi@bioinfo.tmd.ac.jp","+81-3-5803-4758","Information Center for Medical Sciences","Tokyo Medical and Dental University","1-5-45 Yushima","Bunkyo-ku","Tokyo","113-8510","Japan","http://bioinfo.tmd.ac.jp/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM537nnn/GSM537361/GSM537361_chip_array_C147T.CEL.gz","54675","Reanalysis of: GSM452580"
"GSM537362","patient 148, cancer, LCM [OPG study]","GSM537362","Public on Feb 28 2011","Apr 26 2010","Feb 28 2011","RNA","1","surgically resected material","Homo sapiens","metastasis: none","stage: 2b","tissue: cancer, LCM","Tumor tissue was extracted using laser-capture microdissection.","total RNA","Total RNA was extracted from tissue specimens using RNeasy kit (Qiagen, Hilden, Germany). Integrity of obtained RNA was assessed using Agilent 2100 BioAnalyzer (Agilent Technologies, Palo Alto, CA). All samples had RNA Integrity Number (RIN) greater than 5.0. Contaminant DNA was removed by digestion with RNase-free DNase (Qiagen).","biotin","cRNA was prepared using two-cycle target labeling and control reagents kit (Affymetrix, Santa Clara, CA).","9606","Hybridization and signal detection of HG-U133 Plus 2.0 arrays (Affymetrix) was performed following the manufacturer's instruction using the Affymetrix Fluidics Station 450.","GeneChips were scanned using Affymetrix GeneChip Scanner 3000.","Gene expression profile of surgically resected material","C148","The data was normalized by robust multichip analysis (RMA) using R/Bioconductor (affy package).","GPL570","Kaoru,,Mogushi","mogushi@bioinfo.tmd.ac.jp","+81-3-5803-4758","Information Center for Medical Sciences","Tokyo Medical and Dental University","1-5-45 Yushima","Bunkyo-ku","Tokyo","113-8510","Japan","http://bioinfo.tmd.ac.jp/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM537nnn/GSM537362/GSM537362_chip_array_C148T.CEL.gz","54675","Reanalysis of: GSM452581"
"GSM537363","patient 150, cancer, LCM [OPG study]","GSM537363","Public on Feb 28 2011","Apr 26 2010","Feb 28 2011","RNA","1","surgically resected material","Homo sapiens","metastasis: none","stage: 2b","tissue: cancer, LCM","Tumor tissue was extracted using laser-capture microdissection.","total RNA","Total RNA was extracted from tissue specimens using RNeasy kit (Qiagen, Hilden, Germany). Integrity of obtained RNA was assessed using Agilent 2100 BioAnalyzer (Agilent Technologies, Palo Alto, CA). All samples had RNA Integrity Number (RIN) greater than 5.0. Contaminant DNA was removed by digestion with RNase-free DNase (Qiagen).","biotin","cRNA was prepared using two-cycle target labeling and control reagents kit (Affymetrix, Santa Clara, CA).","9606","Hybridization and signal detection of HG-U133 Plus 2.0 arrays (Affymetrix) was performed following the manufacturer's instruction using the Affymetrix Fluidics Station 450.","GeneChips were scanned using Affymetrix GeneChip Scanner 3000.","Gene expression profile of surgically resected material","C150","The data was normalized by robust multichip analysis (RMA) using R/Bioconductor (affy package).","GPL570","Kaoru,,Mogushi","mogushi@bioinfo.tmd.ac.jp","+81-3-5803-4758","Information Center for Medical Sciences","Tokyo Medical and Dental University","1-5-45 Yushima","Bunkyo-ku","Tokyo","113-8510","Japan","http://bioinfo.tmd.ac.jp/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM537nnn/GSM537363/GSM537363_chip_array_C150T.CEL.gz","54675","Reanalysis of: GSM452582"
"GSM537364","patient 152, cancer, LCM [OPG study]","GSM537364","Public on Feb 28 2011","Apr 26 2010","Feb 28 2011","RNA","1","surgically resected material","Homo sapiens","metastasis: metastasis","stage: 4","tissue: cancer, LCM","Tumor tissue was extracted using laser-capture microdissection.","total RNA","Total RNA was extracted from tissue specimens using RNeasy kit (Qiagen, Hilden, Germany). Integrity of obtained RNA was assessed using Agilent 2100 BioAnalyzer (Agilent Technologies, Palo Alto, CA). All samples had RNA Integrity Number (RIN) greater than 5.0. Contaminant DNA was removed by digestion with RNase-free DNase (Qiagen).","biotin","cRNA was prepared using two-cycle target labeling and control reagents kit (Affymetrix, Santa Clara, CA).","9606","Hybridization and signal detection of HG-U133 Plus 2.0 arrays (Affymetrix) was performed following the manufacturer's instruction using the Affymetrix Fluidics Station 450.","GeneChips were scanned using Affymetrix GeneChip Scanner 3000.","Gene expression profile of surgically resected material","C152","The data was normalized by robust multichip analysis (RMA) using R/Bioconductor (affy package).","GPL570","Kaoru,,Mogushi","mogushi@bioinfo.tmd.ac.jp","+81-3-5803-4758","Information Center for Medical Sciences","Tokyo Medical and Dental University","1-5-45 Yushima","Bunkyo-ku","Tokyo","113-8510","Japan","http://bioinfo.tmd.ac.jp/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM537nnn/GSM537364/GSM537364_chip_array_C152T.CEL.gz","54675","Reanalysis of: GSM452583"
"GSM537365","patient 153, cancer, LCM [OPG study]","GSM537365","Public on Feb 28 2011","Apr 26 2010","Feb 28 2011","RNA","1","surgically resected material","Homo sapiens","metastasis: metastasis","stage: 4","tissue: cancer, LCM","Tumor tissue was extracted using laser-capture microdissection.","total RNA","Total RNA was extracted from tissue specimens using RNeasy kit (Qiagen, Hilden, Germany). Integrity of obtained RNA was assessed using Agilent 2100 BioAnalyzer (Agilent Technologies, Palo Alto, CA). All samples had RNA Integrity Number (RIN) greater than 5.0. Contaminant DNA was removed by digestion with RNase-free DNase (Qiagen).","biotin","cRNA was prepared using two-cycle target labeling and control reagents kit (Affymetrix, Santa Clara, CA).","9606","Hybridization and signal detection of HG-U133 Plus 2.0 arrays (Affymetrix) was performed following the manufacturer's instruction using the Affymetrix Fluidics Station 450.","GeneChips were scanned using Affymetrix GeneChip Scanner 3000.","Gene expression profile of surgically resected material","C153","The data was normalized by robust multichip analysis (RMA) using R/Bioconductor (affy package).","GPL570","Kaoru,,Mogushi","mogushi@bioinfo.tmd.ac.jp","+81-3-5803-4758","Information Center for Medical Sciences","Tokyo Medical and Dental University","1-5-45 Yushima","Bunkyo-ku","Tokyo","113-8510","Japan","http://bioinfo.tmd.ac.jp/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM537nnn/GSM537365/GSM537365_chip_array_C153T.CEL.gz","54675","Reanalysis of: GSM452584"
"GSM537366","patient 154, cancer, LCM [OPG study]","GSM537366","Public on Feb 28 2011","Apr 26 2010","Feb 28 2011","RNA","1","surgically resected material","Homo sapiens","metastasis: none","stage: 1","tissue: cancer, LCM","Tumor tissue was extracted using laser-capture microdissection.","total RNA","Total RNA was extracted from tissue specimens using RNeasy kit (Qiagen, Hilden, Germany). Integrity of obtained RNA was assessed using Agilent 2100 BioAnalyzer (Agilent Technologies, Palo Alto, CA). All samples had RNA Integrity Number (RIN) greater than 5.0. Contaminant DNA was removed by digestion with RNase-free DNase (Qiagen).","biotin","cRNA was prepared using two-cycle target labeling and control reagents kit (Affymetrix, Santa Clara, CA).","9606","Hybridization and signal detection of HG-U133 Plus 2.0 arrays (Affymetrix) was performed following the manufacturer's instruction using the Affymetrix Fluidics Station 450.","GeneChips were scanned using Affymetrix GeneChip Scanner 3000.","Gene expression profile of surgically resected material","C154","The data was normalized by robust multichip analysis (RMA) using R/Bioconductor (affy package).","GPL570","Kaoru,,Mogushi","mogushi@bioinfo.tmd.ac.jp","+81-3-5803-4758","Information Center for Medical Sciences","Tokyo Medical and Dental University","1-5-45 Yushima","Bunkyo-ku","Tokyo","113-8510","Japan","http://bioinfo.tmd.ac.jp/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM537nnn/GSM537366/GSM537366_chip_array_C154T.CEL.gz","54675","Reanalysis of: GSM452585"
"GSM537367","patient 155, cancer, LCM [OPG study]","GSM537367","Public on Feb 28 2011","Apr 26 2010","Feb 28 2011","RNA","1","surgically resected material","Homo sapiens","metastasis: metastatic recurrence","stage: 3b","tissue: cancer, LCM","Tumor tissue was extracted using laser-capture microdissection.","total RNA","Total RNA was extracted from tissue specimens using RNeasy kit (Qiagen, Hilden, Germany). Integrity of obtained RNA was assessed using Agilent 2100 BioAnalyzer (Agilent Technologies, Palo Alto, CA). All samples had RNA Integrity Number (RIN) greater than 5.0. Contaminant DNA was removed by digestion with RNase-free DNase (Qiagen).","biotin","cRNA was prepared using two-cycle target labeling and control reagents kit (Affymetrix, Santa Clara, CA).","9606","Hybridization and signal detection of HG-U133 Plus 2.0 arrays (Affymetrix) was performed following the manufacturer's instruction using the Affymetrix Fluidics Station 450.","GeneChips were scanned using Affymetrix GeneChip Scanner 3000.","Gene expression profile of surgically resected material","C155","The data was normalized by robust multichip analysis (RMA) using R/Bioconductor (affy package).","GPL570","Kaoru,,Mogushi","mogushi@bioinfo.tmd.ac.jp","+81-3-5803-4758","Information Center for Medical Sciences","Tokyo Medical and Dental University","1-5-45 Yushima","Bunkyo-ku","Tokyo","113-8510","Japan","http://bioinfo.tmd.ac.jp/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM537nnn/GSM537367/GSM537367_chip_array_C155T.CEL.gz","54675","Reanalysis of: GSM452586"
"GSM537368","patient 156, cancer, LCM [OPG study]","GSM537368","Public on Feb 28 2011","Apr 26 2010","Feb 28 2011","RNA","1","surgically resected material","Homo sapiens","metastasis: none","stage: 2b","tissue: cancer, LCM","Tumor tissue was extracted using laser-capture microdissection.","total RNA","Total RNA was extracted from tissue specimens using RNeasy kit (Qiagen, Hilden, Germany). Integrity of obtained RNA was assessed using Agilent 2100 BioAnalyzer (Agilent Technologies, Palo Alto, CA). All samples had RNA Integrity Number (RIN) greater than 5.0. Contaminant DNA was removed by digestion with RNase-free DNase (Qiagen).","biotin","cRNA was prepared using two-cycle target labeling and control reagents kit (Affymetrix, Santa Clara, CA).","9606","Hybridization and signal detection of HG-U133 Plus 2.0 arrays (Affymetrix) was performed following the manufacturer's instruction using the Affymetrix Fluidics Station 450.","GeneChips were scanned using Affymetrix GeneChip Scanner 3000.","Gene expression profile of surgically resected material","C156","The data was normalized by robust multichip analysis (RMA) using R/Bioconductor (affy package).","GPL570","Kaoru,,Mogushi","mogushi@bioinfo.tmd.ac.jp","+81-3-5803-4758","Information Center for Medical Sciences","Tokyo Medical and Dental University","1-5-45 Yushima","Bunkyo-ku","Tokyo","113-8510","Japan","http://bioinfo.tmd.ac.jp/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM537nnn/GSM537368/GSM537368_chip_array_C156T.CEL.gz","54675","Reanalysis of: GSM452587"
"GSM537369","patient 015, cancer, LCM [OPG study]","GSM537369","Public on Feb 28 2011","Apr 26 2010","Feb 28 2011","RNA","1","surgically resected material","Homo sapiens","metastasis: metastatic recurrence","stage: 2b","tissue: cancer, LCM","Tumor tissue was extracted using laser-capture microdissection.","total RNA","Total RNA was extracted from tissue specimens using RNeasy kit (Qiagen, Hilden, Germany). Integrity of obtained RNA was assessed using Agilent 2100 BioAnalyzer (Agilent Technologies, Palo Alto, CA). All samples had RNA Integrity Number (RIN) greater than 5.0. Contaminant DNA was removed by digestion with RNase-free DNase (Qiagen).","biotin","cRNA was prepared using two-cycle target labeling and control reagents kit (Affymetrix, Santa Clara, CA).","9606","Hybridization and signal detection of HG-U133 Plus 2.0 arrays (Affymetrix) was performed following the manufacturer's instruction using the Affymetrix Fluidics Station 450.","GeneChips were scanned using Affymetrix GeneChip Scanner 3000.","Gene expression profile of surgically resected material","C015","The data was normalized by robust multichip analysis (RMA) using R/Bioconductor (affy package).","GPL570","Kaoru,,Mogushi","mogushi@bioinfo.tmd.ac.jp","+81-3-5803-4758","Information Center for Medical Sciences","Tokyo Medical and Dental University","1-5-45 Yushima","Bunkyo-ku","Tokyo","113-8510","Japan","http://bioinfo.tmd.ac.jp/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM537nnn/GSM537369/GSM537369_chip_array_C15T.CEL.gz","54675","Reanalysis of: GSM452588"
"GSM537370","patient 022, cancer, LCM [OPG study]","GSM537370","Public on Feb 28 2011","Apr 26 2010","Feb 28 2011","RNA","1","surgically resected material","Homo sapiens","metastasis: none","stage: 1","tissue: cancer, LCM","Tumor tissue was extracted using laser-capture microdissection.","total RNA","Total RNA was extracted from tissue specimens using RNeasy kit (Qiagen, Hilden, Germany). Integrity of obtained RNA was assessed using Agilent 2100 BioAnalyzer (Agilent Technologies, Palo Alto, CA). All samples had RNA Integrity Number (RIN) greater than 5.0. Contaminant DNA was removed by digestion with RNase-free DNase (Qiagen).","biotin","cRNA was prepared using two-cycle target labeling and control reagents kit (Affymetrix, Santa Clara, CA).","9606","Hybridization and signal detection of HG-U133 Plus 2.0 arrays (Affymetrix) was performed following the manufacturer's instruction using the Affymetrix Fluidics Station 450.","GeneChips were scanned using Affymetrix GeneChip Scanner 3000.","Gene expression profile of surgically resected material","C022","The data was normalized by robust multichip analysis (RMA) using R/Bioconductor (affy package).","GPL570","Kaoru,,Mogushi","mogushi@bioinfo.tmd.ac.jp","+81-3-5803-4758","Information Center for Medical Sciences","Tokyo Medical and Dental University","1-5-45 Yushima","Bunkyo-ku","Tokyo","113-8510","Japan","http://bioinfo.tmd.ac.jp/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM537nnn/GSM537370/GSM537370_chip_array_C22T.CEL.gz","54675","Reanalysis of: GSM452589"
"GSM537371","patient 023, cancer, LCM [OPG study]","GSM537371","Public on Feb 28 2011","Apr 26 2010","Feb 28 2011","RNA","1","surgically resected material","Homo sapiens","metastasis: none","stage: 3a","tissue: cancer, LCM","Tumor tissue was extracted using laser-capture microdissection.","total RNA","Total RNA was extracted from tissue specimens using RNeasy kit (Qiagen, Hilden, Germany). Integrity of obtained RNA was assessed using Agilent 2100 BioAnalyzer (Agilent Technologies, Palo Alto, CA). All samples had RNA Integrity Number (RIN) greater than 5.0. Contaminant DNA was removed by digestion with RNase-free DNase (Qiagen).","biotin","cRNA was prepared using two-cycle target labeling and control reagents kit (Affymetrix, Santa Clara, CA).","9606","Hybridization and signal detection of HG-U133 Plus 2.0 arrays (Affymetrix) was performed following the manufacturer's instruction using the Affymetrix Fluidics Station 450.","GeneChips were scanned using Affymetrix GeneChip Scanner 3000.","Gene expression profile of surgically resected material","C023","The data was normalized by robust multichip analysis (RMA) using R/Bioconductor (affy package).","GPL570","Kaoru,,Mogushi","mogushi@bioinfo.tmd.ac.jp","+81-3-5803-4758","Information Center for Medical Sciences","Tokyo Medical and Dental University","1-5-45 Yushima","Bunkyo-ku","Tokyo","113-8510","Japan","http://bioinfo.tmd.ac.jp/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM537nnn/GSM537371/GSM537371_chip_array_C23T.CEL.gz","54675",""
"GSM537372","patient 024, cancer, LCM [OPG study]","GSM537372","Public on Feb 28 2011","Apr 26 2010","Feb 28 2011","RNA","1","surgically resected material","Homo sapiens","metastasis: metastasis","stage: 4","tissue: cancer, LCM","Tumor tissue was extracted using laser-capture microdissection.","total RNA","Total RNA was extracted from tissue specimens using RNeasy kit (Qiagen, Hilden, Germany). Integrity of obtained RNA was assessed using Agilent 2100 BioAnalyzer (Agilent Technologies, Palo Alto, CA). All samples had RNA Integrity Number (RIN) greater than 5.0. Contaminant DNA was removed by digestion with RNase-free DNase (Qiagen).","biotin","cRNA was prepared using two-cycle target labeling and control reagents kit (Affymetrix, Santa Clara, CA).","9606","Hybridization and signal detection of HG-U133 Plus 2.0 arrays (Affymetrix) was performed following the manufacturer's instruction using the Affymetrix Fluidics Station 450.","GeneChips were scanned using Affymetrix GeneChip Scanner 3000.","Gene expression profile of surgically resected material","C024","The data was normalized by robust multichip analysis (RMA) using R/Bioconductor (affy package).","GPL570","Kaoru,,Mogushi","mogushi@bioinfo.tmd.ac.jp","+81-3-5803-4758","Information Center for Medical Sciences","Tokyo Medical and Dental University","1-5-45 Yushima","Bunkyo-ku","Tokyo","113-8510","Japan","http://bioinfo.tmd.ac.jp/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM537nnn/GSM537372/GSM537372_chip_array_C24T.CEL.gz","54675","Reanalysis of: GSM452590"
"GSM537373","patient 025, cancer, LCM [OPG study]","GSM537373","Public on Feb 28 2011","Apr 26 2010","Feb 28 2011","RNA","1","surgically resected material","Homo sapiens","metastasis: metastatic recurrence","stage: 2b","tissue: cancer, LCM","Tumor tissue was extracted using laser-capture microdissection.","total RNA","Total RNA was extracted from tissue specimens using RNeasy kit (Qiagen, Hilden, Germany). Integrity of obtained RNA was assessed using Agilent 2100 BioAnalyzer (Agilent Technologies, Palo Alto, CA). All samples had RNA Integrity Number (RIN) greater than 5.0. Contaminant DNA was removed by digestion with RNase-free DNase (Qiagen).","biotin","cRNA was prepared using two-cycle target labeling and control reagents kit (Affymetrix, Santa Clara, CA).","9606","Hybridization and signal detection of HG-U133 Plus 2.0 arrays (Affymetrix) was performed following the manufacturer's instruction using the Affymetrix Fluidics Station 450.","GeneChips were scanned using Affymetrix GeneChip Scanner 3000.","Gene expression profile of surgically resected material","C025","The data was normalized by robust multichip analysis (RMA) using R/Bioconductor (affy package).","GPL570","Kaoru,,Mogushi","mogushi@bioinfo.tmd.ac.jp","+81-3-5803-4758","Information Center for Medical Sciences","Tokyo Medical and Dental University","1-5-45 Yushima","Bunkyo-ku","Tokyo","113-8510","Japan","http://bioinfo.tmd.ac.jp/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM537nnn/GSM537373/GSM537373_chip_array_C25T.CEL.gz","54675","Reanalysis of: GSM452591"
"GSM537374","patient 026, cancer, LCM [OPG study]","GSM537374","Public on Feb 28 2011","Apr 26 2010","Feb 28 2011","RNA","1","surgically resected material","Homo sapiens","metastasis: none","stage: 2a","tissue: cancer, LCM","Tumor tissue was extracted using laser-capture microdissection.","total RNA","Total RNA was extracted from tissue specimens using RNeasy kit (Qiagen, Hilden, Germany). Integrity of obtained RNA was assessed using Agilent 2100 BioAnalyzer (Agilent Technologies, Palo Alto, CA). All samples had RNA Integrity Number (RIN) greater than 5.0. Contaminant DNA was removed by digestion with RNase-free DNase (Qiagen).","biotin","cRNA was prepared using two-cycle target labeling and control reagents kit (Affymetrix, Santa Clara, CA).","9606","Hybridization and signal detection of HG-U133 Plus 2.0 arrays (Affymetrix) was performed following the manufacturer's instruction using the Affymetrix Fluidics Station 450.","GeneChips were scanned using Affymetrix GeneChip Scanner 3000.","Gene expression profile of surgically resected material","C026","The data was normalized by robust multichip analysis (RMA) using R/Bioconductor (affy package).","GPL570","Kaoru,,Mogushi","mogushi@bioinfo.tmd.ac.jp","+81-3-5803-4758","Information Center for Medical Sciences","Tokyo Medical and Dental University","1-5-45 Yushima","Bunkyo-ku","Tokyo","113-8510","Japan","http://bioinfo.tmd.ac.jp/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM537nnn/GSM537374/GSM537374_chip_array_C26T.CEL.gz","54675",""
"GSM537375","patient 030, cancer, LCM [OPG study]","GSM537375","Public on Feb 28 2011","Apr 26 2010","Feb 28 2011","RNA","1","surgically resected material","Homo sapiens","metastasis: none","stage: 3b","tissue: cancer, LCM","Tumor tissue was extracted using laser-capture microdissection.","total RNA","Total RNA was extracted from tissue specimens using RNeasy kit (Qiagen, Hilden, Germany). Integrity of obtained RNA was assessed using Agilent 2100 BioAnalyzer (Agilent Technologies, Palo Alto, CA). All samples had RNA Integrity Number (RIN) greater than 5.0. Contaminant DNA was removed by digestion with RNase-free DNase (Qiagen).","biotin","cRNA was prepared using two-cycle target labeling and control reagents kit (Affymetrix, Santa Clara, CA).","9606","Hybridization and signal detection of HG-U133 Plus 2.0 arrays (Affymetrix) was performed following the manufacturer's instruction using the Affymetrix Fluidics Station 450.","GeneChips were scanned using Affymetrix GeneChip Scanner 3000.","Gene expression profile of surgically resected material","C030","The data was normalized by robust multichip analysis (RMA) using R/Bioconductor (affy package).","GPL570","Kaoru,,Mogushi","mogushi@bioinfo.tmd.ac.jp","+81-3-5803-4758","Information Center for Medical Sciences","Tokyo Medical and Dental University","1-5-45 Yushima","Bunkyo-ku","Tokyo","113-8510","Japan","http://bioinfo.tmd.ac.jp/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM537nnn/GSM537375/GSM537375_chip_array_C30T.CEL.gz","54675",""
"GSM537376","patient 031, cancer, LCM [OPG study]","GSM537376","Public on Feb 28 2011","Apr 26 2010","Feb 28 2011","RNA","1","surgically resected material","Homo sapiens","metastasis: none","stage: 2b","tissue: cancer, LCM","Tumor tissue was extracted using laser-capture microdissection.","total RNA","Total RNA was extracted from tissue specimens using RNeasy kit (Qiagen, Hilden, Germany). Integrity of obtained RNA was assessed using Agilent 2100 BioAnalyzer (Agilent Technologies, Palo Alto, CA). All samples had RNA Integrity Number (RIN) greater than 5.0. Contaminant DNA was removed by digestion with RNase-free DNase (Qiagen).","biotin","cRNA was prepared using two-cycle target labeling and control reagents kit (Affymetrix, Santa Clara, CA).","9606","Hybridization and signal detection of HG-U133 Plus 2.0 arrays (Affymetrix) was performed following the manufacturer's instruction using the Affymetrix Fluidics Station 450.","GeneChips were scanned using Affymetrix GeneChip Scanner 3000.","Gene expression profile of surgically resected material","C031","The data was normalized by robust multichip analysis (RMA) using R/Bioconductor (affy package).","GPL570","Kaoru,,Mogushi","mogushi@bioinfo.tmd.ac.jp","+81-3-5803-4758","Information Center for Medical Sciences","Tokyo Medical and Dental University","1-5-45 Yushima","Bunkyo-ku","Tokyo","113-8510","Japan","http://bioinfo.tmd.ac.jp/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM537nnn/GSM537376/GSM537376_chip_array_C31T.CEL.gz","54675",""
"GSM537377","patient 033, cancer, LCM [OPG study]","GSM537377","Public on Feb 28 2011","Apr 26 2010","Feb 28 2011","RNA","1","surgically resected material","Homo sapiens","metastasis: none","stage: 2a","tissue: cancer, LCM","Tumor tissue was extracted using laser-capture microdissection.","total RNA","Total RNA was extracted from tissue specimens using RNeasy kit (Qiagen, Hilden, Germany). Integrity of obtained RNA was assessed using Agilent 2100 BioAnalyzer (Agilent Technologies, Palo Alto, CA). All samples had RNA Integrity Number (RIN) greater than 5.0. Contaminant DNA was removed by digestion with RNase-free DNase (Qiagen).","biotin","cRNA was prepared using two-cycle target labeling and control reagents kit (Affymetrix, Santa Clara, CA).","9606","Hybridization and signal detection of HG-U133 Plus 2.0 arrays (Affymetrix) was performed following the manufacturer's instruction using the Affymetrix Fluidics Station 450.","GeneChips were scanned using Affymetrix GeneChip Scanner 3000.","Gene expression profile of surgically resected material","C033","The data was normalized by robust multichip analysis (RMA) using R/Bioconductor (affy package).","GPL570","Kaoru,,Mogushi","mogushi@bioinfo.tmd.ac.jp","+81-3-5803-4758","Information Center for Medical Sciences","Tokyo Medical and Dental University","1-5-45 Yushima","Bunkyo-ku","Tokyo","113-8510","Japan","http://bioinfo.tmd.ac.jp/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM537nnn/GSM537377/GSM537377_chip_array_C33T.CEL.gz","54675","Reanalysis of: GSM452592"
"GSM537378","patient 034, cancer, LCM [OPG study]","GSM537378","Public on Feb 28 2011","Apr 26 2010","Feb 28 2011","RNA","1","surgically resected material","Homo sapiens","metastasis: none","stage: 2a","tissue: cancer, LCM","Tumor tissue was extracted using laser-capture microdissection.","total RNA","Total RNA was extracted from tissue specimens using RNeasy kit (Qiagen, Hilden, Germany). Integrity of obtained RNA was assessed using Agilent 2100 BioAnalyzer (Agilent Technologies, Palo Alto, CA). All samples had RNA Integrity Number (RIN) greater than 5.0. Contaminant DNA was removed by digestion with RNase-free DNase (Qiagen).","biotin","cRNA was prepared using two-cycle target labeling and control reagents kit (Affymetrix, Santa Clara, CA).","9606","Hybridization and signal detection of HG-U133 Plus 2.0 arrays (Affymetrix) was performed following the manufacturer's instruction using the Affymetrix Fluidics Station 450.","GeneChips were scanned using Affymetrix GeneChip Scanner 3000.","Gene expression profile of surgically resected material","C034","The data was normalized by robust multichip analysis (RMA) using R/Bioconductor (affy package).","GPL570","Kaoru,,Mogushi","mogushi@bioinfo.tmd.ac.jp","+81-3-5803-4758","Information Center for Medical Sciences","Tokyo Medical and Dental University","1-5-45 Yushima","Bunkyo-ku","Tokyo","113-8510","Japan","http://bioinfo.tmd.ac.jp/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM537nnn/GSM537378/GSM537378_chip_array_C34T.CEL.gz","54675","Reanalysis of: GSM452593"
"GSM537379","patient 036, cancer, LCM [OPG study]","GSM537379","Public on Feb 28 2011","Apr 26 2010","Feb 28 2011","RNA","1","surgically resected material","Homo sapiens","metastasis: none","stage: 2a","tissue: cancer, LCM","Tumor tissue was extracted using laser-capture microdissection.","total RNA","Total RNA was extracted from tissue specimens using RNeasy kit (Qiagen, Hilden, Germany). Integrity of obtained RNA was assessed using Agilent 2100 BioAnalyzer (Agilent Technologies, Palo Alto, CA). All samples had RNA Integrity Number (RIN) greater than 5.0. Contaminant DNA was removed by digestion with RNase-free DNase (Qiagen).","biotin","cRNA was prepared using two-cycle target labeling and control reagents kit (Affymetrix, Santa Clara, CA).","9606","Hybridization and signal detection of HG-U133 Plus 2.0 arrays (Affymetrix) was performed following the manufacturer's instruction using the Affymetrix Fluidics Station 450.","GeneChips were scanned using Affymetrix GeneChip Scanner 3000.","Gene expression profile of surgically resected material","C036","The data was normalized by robust multichip analysis (RMA) using R/Bioconductor (affy package).","GPL570","Kaoru,,Mogushi","mogushi@bioinfo.tmd.ac.jp","+81-3-5803-4758","Information Center for Medical Sciences","Tokyo Medical and Dental University","1-5-45 Yushima","Bunkyo-ku","Tokyo","113-8510","Japan","http://bioinfo.tmd.ac.jp/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM537nnn/GSM537379/GSM537379_chip_array_C36T.CEL.gz","54675","Reanalysis of: GSM452594"
"GSM537380","patient 037, cancer, LCM [OPG study]","GSM537380","Public on Feb 28 2011","Apr 26 2010","Feb 28 2011","RNA","1","surgically resected material","Homo sapiens","metastasis: none","stage: 1","tissue: cancer, LCM","Tumor tissue was extracted using laser-capture microdissection.","total RNA","Total RNA was extracted from tissue specimens using RNeasy kit (Qiagen, Hilden, Germany). Integrity of obtained RNA was assessed using Agilent 2100 BioAnalyzer (Agilent Technologies, Palo Alto, CA). All samples had RNA Integrity Number (RIN) greater than 5.0. Contaminant DNA was removed by digestion with RNase-free DNase (Qiagen).","biotin","cRNA was prepared using two-cycle target labeling and control reagents kit (Affymetrix, Santa Clara, CA).","9606","Hybridization and signal detection of HG-U133 Plus 2.0 arrays (Affymetrix) was performed following the manufacturer's instruction using the Affymetrix Fluidics Station 450.","GeneChips were scanned using Affymetrix GeneChip Scanner 3000.","Gene expression profile of surgically resected material","C037","The data was normalized by robust multichip analysis (RMA) using R/Bioconductor (affy package).","GPL570","Kaoru,,Mogushi","mogushi@bioinfo.tmd.ac.jp","+81-3-5803-4758","Information Center for Medical Sciences","Tokyo Medical and Dental University","1-5-45 Yushima","Bunkyo-ku","Tokyo","113-8510","Japan","http://bioinfo.tmd.ac.jp/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM537nnn/GSM537380/GSM537380_chip_array_C37T.CEL.gz","54675","Reanalysis of: GSM452595"
"GSM537381","patient 038, cancer, LCM [OPG study]","GSM537381","Public on Feb 28 2011","Apr 26 2010","Feb 28 2011","RNA","1","surgically resected material","Homo sapiens","metastasis: none","stage: 2b","tissue: cancer, LCM","Tumor tissue was extracted using laser-capture microdissection.","total RNA","Total RNA was extracted from tissue specimens using RNeasy kit (Qiagen, Hilden, Germany). Integrity of obtained RNA was assessed using Agilent 2100 BioAnalyzer (Agilent Technologies, Palo Alto, CA). All samples had RNA Integrity Number (RIN) greater than 5.0. Contaminant DNA was removed by digestion with RNase-free DNase (Qiagen).","biotin","cRNA was prepared using two-cycle target labeling and control reagents kit (Affymetrix, Santa Clara, CA).","9606","Hybridization and signal detection of HG-U133 Plus 2.0 arrays (Affymetrix) was performed following the manufacturer's instruction using the Affymetrix Fluidics Station 450.","GeneChips were scanned using Affymetrix GeneChip Scanner 3000.","Gene expression profile of surgically resected material","C038","The data was normalized by robust multichip analysis (RMA) using R/Bioconductor (affy package).","GPL570","Kaoru,,Mogushi","mogushi@bioinfo.tmd.ac.jp","+81-3-5803-4758","Information Center for Medical Sciences","Tokyo Medical and Dental University","1-5-45 Yushima","Bunkyo-ku","Tokyo","113-8510","Japan","http://bioinfo.tmd.ac.jp/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM537nnn/GSM537381/GSM537381_chip_array_C38T.CEL.gz","54675","Reanalysis of: GSM452596"
"GSM537382","patient 041, cancer, LCM [OPG study]","GSM537382","Public on Feb 28 2011","Apr 26 2010","Feb 28 2011","RNA","1","surgically resected material","Homo sapiens","metastasis: metastatic recurrence","stage: 3b","tissue: cancer, LCM","Tumor tissue was extracted using laser-capture microdissection.","total RNA","Total RNA was extracted from tissue specimens using RNeasy kit (Qiagen, Hilden, Germany). Integrity of obtained RNA was assessed using Agilent 2100 BioAnalyzer (Agilent Technologies, Palo Alto, CA). All samples had RNA Integrity Number (RIN) greater than 5.0. Contaminant DNA was removed by digestion with RNase-free DNase (Qiagen).","biotin","cRNA was prepared using two-cycle target labeling and control reagents kit (Affymetrix, Santa Clara, CA).","9606","Hybridization and signal detection of HG-U133 Plus 2.0 arrays (Affymetrix) was performed following the manufacturer's instruction using the Affymetrix Fluidics Station 450.","GeneChips were scanned using Affymetrix GeneChip Scanner 3000.","Gene expression profile of surgically resected material","C041","The data was normalized by robust multichip analysis (RMA) using R/Bioconductor (affy package).","GPL570","Kaoru,,Mogushi","mogushi@bioinfo.tmd.ac.jp","+81-3-5803-4758","Information Center for Medical Sciences","Tokyo Medical and Dental University","1-5-45 Yushima","Bunkyo-ku","Tokyo","113-8510","Japan","http://bioinfo.tmd.ac.jp/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM537nnn/GSM537382/GSM537382_chip_array_C41T.CEL.gz","54675",""
"GSM537383","patient 046, cancer, LCM [OPG study]","GSM537383","Public on Feb 28 2011","Apr 26 2010","Feb 28 2011","RNA","1","surgically resected material","Homo sapiens","metastasis: none","stage: 2a","tissue: cancer, LCM","Tumor tissue was extracted using laser-capture microdissection.","total RNA","Total RNA was extracted from tissue specimens using RNeasy kit (Qiagen, Hilden, Germany). Integrity of obtained RNA was assessed using Agilent 2100 BioAnalyzer (Agilent Technologies, Palo Alto, CA). All samples had RNA Integrity Number (RIN) greater than 5.0. Contaminant DNA was removed by digestion with RNase-free DNase (Qiagen).","biotin","cRNA was prepared using two-cycle target labeling and control reagents kit (Affymetrix, Santa Clara, CA).","9606","Hybridization and signal detection of HG-U133 Plus 2.0 arrays (Affymetrix) was performed following the manufacturer's instruction using the Affymetrix Fluidics Station 450.","GeneChips were scanned using Affymetrix GeneChip Scanner 3000.","Gene expression profile of surgically resected material","C046","The data was normalized by robust multichip analysis (RMA) using R/Bioconductor (affy package).","GPL570","Kaoru,,Mogushi","mogushi@bioinfo.tmd.ac.jp","+81-3-5803-4758","Information Center for Medical Sciences","Tokyo Medical and Dental University","1-5-45 Yushima","Bunkyo-ku","Tokyo","113-8510","Japan","http://bioinfo.tmd.ac.jp/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM537nnn/GSM537383/GSM537383_chip_array_C46T.CEL.gz","54675","Reanalysis of: GSM452597"
"GSM537384","patient 048, cancer, LCM [OPG study]","GSM537384","Public on Feb 28 2011","Apr 26 2010","Feb 28 2011","RNA","1","surgically resected material","Homo sapiens","metastasis: metastasis","stage: 4","tissue: cancer, LCM","Tumor tissue was extracted using laser-capture microdissection.","total RNA","Total RNA was extracted from tissue specimens using RNeasy kit (Qiagen, Hilden, Germany). Integrity of obtained RNA was assessed using Agilent 2100 BioAnalyzer (Agilent Technologies, Palo Alto, CA). All samples had RNA Integrity Number (RIN) greater than 5.0. Contaminant DNA was removed by digestion with RNase-free DNase (Qiagen).","biotin","cRNA was prepared using two-cycle target labeling and control reagents kit (Affymetrix, Santa Clara, CA).","9606","Hybridization and signal detection of HG-U133 Plus 2.0 arrays (Affymetrix) was performed following the manufacturer's instruction using the Affymetrix Fluidics Station 450.","GeneChips were scanned using Affymetrix GeneChip Scanner 3000.","Gene expression profile of surgically resected material","C048","The data was normalized by robust multichip analysis (RMA) using R/Bioconductor (affy package).","GPL570","Kaoru,,Mogushi","mogushi@bioinfo.tmd.ac.jp","+81-3-5803-4758","Information Center for Medical Sciences","Tokyo Medical and Dental University","1-5-45 Yushima","Bunkyo-ku","Tokyo","113-8510","Japan","http://bioinfo.tmd.ac.jp/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM537nnn/GSM537384/GSM537384_chip_array_C48T.CEL.gz","54675","Reanalysis of: GSM452598"
"GSM537385","patient 053, cancer, LCM [OPG study]","GSM537385","Public on Feb 28 2011","Apr 26 2010","Feb 28 2011","RNA","1","surgically resected material","Homo sapiens","metastasis: metastatic recurrence","stage: 3b","tissue: cancer, LCM","Tumor tissue was extracted using laser-capture microdissection.","total RNA","Total RNA was extracted from tissue specimens using RNeasy kit (Qiagen, Hilden, Germany). Integrity of obtained RNA was assessed using Agilent 2100 BioAnalyzer (Agilent Technologies, Palo Alto, CA). All samples had RNA Integrity Number (RIN) greater than 5.0. Contaminant DNA was removed by digestion with RNase-free DNase (Qiagen).","biotin","cRNA was prepared using two-cycle target labeling and control reagents kit (Affymetrix, Santa Clara, CA).","9606","Hybridization and signal detection of HG-U133 Plus 2.0 arrays (Affymetrix) was performed following the manufacturer's instruction using the Affymetrix Fluidics Station 450.","GeneChips were scanned using Affymetrix GeneChip Scanner 3000.","Gene expression profile of surgically resected material","C053","The data was normalized by robust multichip analysis (RMA) using R/Bioconductor (affy package).","GPL570","Kaoru,,Mogushi","mogushi@bioinfo.tmd.ac.jp","+81-3-5803-4758","Information Center for Medical Sciences","Tokyo Medical and Dental University","1-5-45 Yushima","Bunkyo-ku","Tokyo","113-8510","Japan","http://bioinfo.tmd.ac.jp/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM537nnn/GSM537385/GSM537385_chip_array_C53T.CEL.gz","54675","Reanalysis of: GSM452599"
"GSM537386","patient 057, cancer, LCM [OPG study]","GSM537386","Public on Feb 28 2011","Apr 26 2010","Feb 28 2011","RNA","1","surgically resected material","Homo sapiens","metastasis: none","stage: 2b","tissue: cancer, LCM","Tumor tissue was extracted using laser-capture microdissection.","total RNA","Total RNA was extracted from tissue specimens using RNeasy kit (Qiagen, Hilden, Germany). Integrity of obtained RNA was assessed using Agilent 2100 BioAnalyzer (Agilent Technologies, Palo Alto, CA). All samples had RNA Integrity Number (RIN) greater than 5.0. Contaminant DNA was removed by digestion with RNase-free DNase (Qiagen).","biotin","cRNA was prepared using two-cycle target labeling and control reagents kit (Affymetrix, Santa Clara, CA).","9606","Hybridization and signal detection of HG-U133 Plus 2.0 arrays (Affymetrix) was performed following the manufacturer's instruction using the Affymetrix Fluidics Station 450.","GeneChips were scanned using Affymetrix GeneChip Scanner 3000.","Gene expression profile of surgically resected material","C057","The data was normalized by robust multichip analysis (RMA) using R/Bioconductor (affy package).","GPL570","Kaoru,,Mogushi","mogushi@bioinfo.tmd.ac.jp","+81-3-5803-4758","Information Center for Medical Sciences","Tokyo Medical and Dental University","1-5-45 Yushima","Bunkyo-ku","Tokyo","113-8510","Japan","http://bioinfo.tmd.ac.jp/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM537nnn/GSM537386/GSM537386_chip_array_C57T.CEL.gz","54675","Reanalysis of: GSM452600"
"GSM537387","patient 061, cancer, LCM [OPG study]","GSM537387","Public on Feb 28 2011","Apr 26 2010","Feb 28 2011","RNA","1","surgically resected material","Homo sapiens","metastasis: metastatic recurrence","stage: 3c","tissue: cancer, LCM","Tumor tissue was extracted using laser-capture microdissection.","total RNA","Total RNA was extracted from tissue specimens using RNeasy kit (Qiagen, Hilden, Germany). Integrity of obtained RNA was assessed using Agilent 2100 BioAnalyzer (Agilent Technologies, Palo Alto, CA). All samples had RNA Integrity Number (RIN) greater than 5.0. Contaminant DNA was removed by digestion with RNase-free DNase (Qiagen).","biotin","cRNA was prepared using two-cycle target labeling and control reagents kit (Affymetrix, Santa Clara, CA).","9606","Hybridization and signal detection of HG-U133 Plus 2.0 arrays (Affymetrix) was performed following the manufacturer's instruction using the Affymetrix Fluidics Station 450.","GeneChips were scanned using Affymetrix GeneChip Scanner 3000.","Gene expression profile of surgically resected material","C061","The data was normalized by robust multichip analysis (RMA) using R/Bioconductor (affy package).","GPL570","Kaoru,,Mogushi","mogushi@bioinfo.tmd.ac.jp","+81-3-5803-4758","Information Center for Medical Sciences","Tokyo Medical and Dental University","1-5-45 Yushima","Bunkyo-ku","Tokyo","113-8510","Japan","http://bioinfo.tmd.ac.jp/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM537nnn/GSM537387/GSM537387_chip_array_C61T.CEL.gz","54675",""
"GSM537388","patient 063, cancer, LCM [OPG study]","GSM537388","Public on Feb 28 2011","Apr 26 2010","Feb 28 2011","RNA","1","surgically resected material","Homo sapiens","metastasis: none","stage: 2a","tissue: cancer, LCM","Tumor tissue was extracted using laser-capture microdissection.","total RNA","Total RNA was extracted from tissue specimens using RNeasy kit (Qiagen, Hilden, Germany). Integrity of obtained RNA was assessed using Agilent 2100 BioAnalyzer (Agilent Technologies, Palo Alto, CA). All samples had RNA Integrity Number (RIN) greater than 5.0. Contaminant DNA was removed by digestion with RNase-free DNase (Qiagen).","biotin","cRNA was prepared using two-cycle target labeling and control reagents kit (Affymetrix, Santa Clara, CA).","9606","Hybridization and signal detection of HG-U133 Plus 2.0 arrays (Affymetrix) was performed following the manufacturer's instruction using the Affymetrix Fluidics Station 450.","GeneChips were scanned using Affymetrix GeneChip Scanner 3000.","Gene expression profile of surgically resected material","C063","The data was normalized by robust multichip analysis (RMA) using R/Bioconductor (affy package).","GPL570","Kaoru,,Mogushi","mogushi@bioinfo.tmd.ac.jp","+81-3-5803-4758","Information Center for Medical Sciences","Tokyo Medical and Dental University","1-5-45 Yushima","Bunkyo-ku","Tokyo","113-8510","Japan","http://bioinfo.tmd.ac.jp/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM537nnn/GSM537388/GSM537388_chip_array_C63T.CEL.gz","54675",""
"GSM537389","patient 068, cancer, LCM [OPG study]","GSM537389","Public on Feb 28 2011","Apr 26 2010","Feb 28 2011","RNA","1","surgically resected material","Homo sapiens","metastasis: none","stage: 3b","tissue: cancer, LCM","Tumor tissue was extracted using laser-capture microdissection.","total RNA","Total RNA was extracted from tissue specimens using RNeasy kit (Qiagen, Hilden, Germany). Integrity of obtained RNA was assessed using Agilent 2100 BioAnalyzer (Agilent Technologies, Palo Alto, CA). All samples had RNA Integrity Number (RIN) greater than 5.0. Contaminant DNA was removed by digestion with RNase-free DNase (Qiagen).","biotin","cRNA was prepared using two-cycle target labeling and control reagents kit (Affymetrix, Santa Clara, CA).","9606","Hybridization and signal detection of HG-U133 Plus 2.0 arrays (Affymetrix) was performed following the manufacturer's instruction using the Affymetrix Fluidics Station 450.","GeneChips were scanned using Affymetrix GeneChip Scanner 3000.","Gene expression profile of surgically resected material","C068","The data was normalized by robust multichip analysis (RMA) using R/Bioconductor (affy package).","GPL570","Kaoru,,Mogushi","mogushi@bioinfo.tmd.ac.jp","+81-3-5803-4758","Information Center for Medical Sciences","Tokyo Medical and Dental University","1-5-45 Yushima","Bunkyo-ku","Tokyo","113-8510","Japan","http://bioinfo.tmd.ac.jp/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM537nnn/GSM537389/GSM537389_chip_array_C68T.CEL.gz","54675",""
"GSM537390","patient 072, cancer, LCM [OPG study]","GSM537390","Public on Feb 28 2011","Apr 26 2010","Feb 28 2011","RNA","1","surgically resected material","Homo sapiens","metastasis: none","stage: 3b","tissue: cancer, LCM","Tumor tissue was extracted using laser-capture microdissection.","total RNA","Total RNA was extracted from tissue specimens using RNeasy kit (Qiagen, Hilden, Germany). Integrity of obtained RNA was assessed using Agilent 2100 BioAnalyzer (Agilent Technologies, Palo Alto, CA). All samples had RNA Integrity Number (RIN) greater than 5.0. Contaminant DNA was removed by digestion with RNase-free DNase (Qiagen).","biotin","cRNA was prepared using two-cycle target labeling and control reagents kit (Affymetrix, Santa Clara, CA).","9606","Hybridization and signal detection of HG-U133 Plus 2.0 arrays (Affymetrix) was performed following the manufacturer's instruction using the Affymetrix Fluidics Station 450.","GeneChips were scanned using Affymetrix GeneChip Scanner 3000.","Gene expression profile of surgically resected material","C072","The data was normalized by robust multichip analysis (RMA) using R/Bioconductor (affy package).","GPL570","Kaoru,,Mogushi","mogushi@bioinfo.tmd.ac.jp","+81-3-5803-4758","Information Center for Medical Sciences","Tokyo Medical and Dental University","1-5-45 Yushima","Bunkyo-ku","Tokyo","113-8510","Japan","http://bioinfo.tmd.ac.jp/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM537nnn/GSM537390/GSM537390_chip_array_C72T.CEL.gz","54675",""
"GSM537391","patient 073, cancer, LCM [OPG study]","GSM537391","Public on Feb 28 2011","Apr 26 2010","Feb 28 2011","RNA","1","surgically resected material","Homo sapiens","metastasis: metastatic recurrence","stage: 3b","tissue: cancer, LCM","Tumor tissue was extracted using laser-capture microdissection.","total RNA","Total RNA was extracted from tissue specimens using RNeasy kit (Qiagen, Hilden, Germany). Integrity of obtained RNA was assessed using Agilent 2100 BioAnalyzer (Agilent Technologies, Palo Alto, CA). All samples had RNA Integrity Number (RIN) greater than 5.0. Contaminant DNA was removed by digestion with RNase-free DNase (Qiagen).","biotin","cRNA was prepared using two-cycle target labeling and control reagents kit (Affymetrix, Santa Clara, CA).","9606","Hybridization and signal detection of HG-U133 Plus 2.0 arrays (Affymetrix) was performed following the manufacturer's instruction using the Affymetrix Fluidics Station 450.","GeneChips were scanned using Affymetrix GeneChip Scanner 3000.","Gene expression profile of surgically resected material","C073","The data was normalized by robust multichip analysis (RMA) using R/Bioconductor (affy package).","GPL570","Kaoru,,Mogushi","mogushi@bioinfo.tmd.ac.jp","+81-3-5803-4758","Information Center for Medical Sciences","Tokyo Medical and Dental University","1-5-45 Yushima","Bunkyo-ku","Tokyo","113-8510","Japan","http://bioinfo.tmd.ac.jp/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM537nnn/GSM537391/GSM537391_chip_array_C73T.CEL.gz","54675","Reanalysis of: GSM452601"
"GSM537392","patient 077, cancer, LCM [OPG study]","GSM537392","Public on Feb 28 2011","Apr 26 2010","Feb 28 2011","RNA","1","surgically resected material","Homo sapiens","metastasis: none","stage: 1","tissue: cancer, LCM","Tumor tissue was extracted using laser-capture microdissection.","total RNA","Total RNA was extracted from tissue specimens using RNeasy kit (Qiagen, Hilden, Germany). Integrity of obtained RNA was assessed using Agilent 2100 BioAnalyzer (Agilent Technologies, Palo Alto, CA). All samples had RNA Integrity Number (RIN) greater than 5.0. Contaminant DNA was removed by digestion with RNase-free DNase (Qiagen).","biotin","cRNA was prepared using two-cycle target labeling and control reagents kit (Affymetrix, Santa Clara, CA).","9606","Hybridization and signal detection of HG-U133 Plus 2.0 arrays (Affymetrix) was performed following the manufacturer's instruction using the Affymetrix Fluidics Station 450.","GeneChips were scanned using Affymetrix GeneChip Scanner 3000.","Gene expression profile of surgically resected material","C077","The data was normalized by robust multichip analysis (RMA) using R/Bioconductor (affy package).","GPL570","Kaoru,,Mogushi","mogushi@bioinfo.tmd.ac.jp","+81-3-5803-4758","Information Center for Medical Sciences","Tokyo Medical and Dental University","1-5-45 Yushima","Bunkyo-ku","Tokyo","113-8510","Japan","http://bioinfo.tmd.ac.jp/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM537nnn/GSM537392/GSM537392_chip_array_C77T.CEL.gz","54675","Reanalysis of: GSM452602"
"GSM537393","patient 078, cancer, LCM [OPG study]","GSM537393","Public on Feb 28 2011","Apr 26 2010","Feb 28 2011","RNA","1","surgically resected material","Homo sapiens","metastasis: none","stage: 3b","tissue: cancer, LCM","Tumor tissue was extracted using laser-capture microdissection.","total RNA","Total RNA was extracted from tissue specimens using RNeasy kit (Qiagen, Hilden, Germany). Integrity of obtained RNA was assessed using Agilent 2100 BioAnalyzer (Agilent Technologies, Palo Alto, CA). All samples had RNA Integrity Number (RIN) greater than 5.0. Contaminant DNA was removed by digestion with RNase-free DNase (Qiagen).","biotin","cRNA was prepared using two-cycle target labeling and control reagents kit (Affymetrix, Santa Clara, CA).","9606","Hybridization and signal detection of HG-U133 Plus 2.0 arrays (Affymetrix) was performed following the manufacturer's instruction using the Affymetrix Fluidics Station 450.","GeneChips were scanned using Affymetrix GeneChip Scanner 3000.","Gene expression profile of surgically resected material","C078","The data was normalized by robust multichip analysis (RMA) using R/Bioconductor (affy package).","GPL570","Kaoru,,Mogushi","mogushi@bioinfo.tmd.ac.jp","+81-3-5803-4758","Information Center for Medical Sciences","Tokyo Medical and Dental University","1-5-45 Yushima","Bunkyo-ku","Tokyo","113-8510","Japan","http://bioinfo.tmd.ac.jp/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM537nnn/GSM537393/GSM537393_chip_array_C78T.CEL.gz","54675","Reanalysis of: GSM452603"
"GSM537394","patient 081, cancer, LCM [OPG study]","GSM537394","Public on Feb 28 2011","Apr 26 2010","Feb 28 2011","RNA","1","surgically resected material","Homo sapiens","metastasis: metastasis","stage: 4","tissue: cancer, LCM","Tumor tissue was extracted using laser-capture microdissection.","total RNA","Total RNA was extracted from tissue specimens using RNeasy kit (Qiagen, Hilden, Germany). Integrity of obtained RNA was assessed using Agilent 2100 BioAnalyzer (Agilent Technologies, Palo Alto, CA). All samples had RNA Integrity Number (RIN) greater than 5.0. Contaminant DNA was removed by digestion with RNase-free DNase (Qiagen).","biotin","cRNA was prepared using two-cycle target labeling and control reagents kit (Affymetrix, Santa Clara, CA).","9606","Hybridization and signal detection of HG-U133 Plus 2.0 arrays (Affymetrix) was performed following the manufacturer's instruction using the Affymetrix Fluidics Station 450.","GeneChips were scanned using Affymetrix GeneChip Scanner 3000.","Gene expression profile of surgically resected material","C081","The data was normalized by robust multichip analysis (RMA) using R/Bioconductor (affy package).","GPL570","Kaoru,,Mogushi","mogushi@bioinfo.tmd.ac.jp","+81-3-5803-4758","Information Center for Medical Sciences","Tokyo Medical and Dental University","1-5-45 Yushima","Bunkyo-ku","Tokyo","113-8510","Japan","http://bioinfo.tmd.ac.jp/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM537nnn/GSM537394/GSM537394_chip_array_C81T.CEL.gz","54675","Reanalysis of: GSM452604"
"GSM537395","patient 082, cancer, LCM [OPG study]","GSM537395","Public on Feb 28 2011","Apr 26 2010","Feb 28 2011","RNA","1","surgically resected material","Homo sapiens","metastasis: none","stage: 2a","tissue: cancer, LCM","Tumor tissue was extracted using laser-capture microdissection.","total RNA","Total RNA was extracted from tissue specimens using RNeasy kit (Qiagen, Hilden, Germany). Integrity of obtained RNA was assessed using Agilent 2100 BioAnalyzer (Agilent Technologies, Palo Alto, CA). All samples had RNA Integrity Number (RIN) greater than 5.0. Contaminant DNA was removed by digestion with RNase-free DNase (Qiagen).","biotin","cRNA was prepared using two-cycle target labeling and control reagents kit (Affymetrix, Santa Clara, CA).","9606","Hybridization and signal detection of HG-U133 Plus 2.0 arrays (Affymetrix) was performed following the manufacturer's instruction using the Affymetrix Fluidics Station 450.","GeneChips were scanned using Affymetrix GeneChip Scanner 3000.","Gene expression profile of surgically resected material","C082","The data was normalized by robust multichip analysis (RMA) using R/Bioconductor (affy package).","GPL570","Kaoru,,Mogushi","mogushi@bioinfo.tmd.ac.jp","+81-3-5803-4758","Information Center for Medical Sciences","Tokyo Medical and Dental University","1-5-45 Yushima","Bunkyo-ku","Tokyo","113-8510","Japan","http://bioinfo.tmd.ac.jp/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM537nnn/GSM537395/GSM537395_chip_array_C82T.CEL.gz","54675",""
"GSM537396","patient 083, cancer, LCM [OPG study]","GSM537396","Public on Feb 28 2011","Apr 26 2010","Feb 28 2011","RNA","1","surgically resected material","Homo sapiens","metastasis: metastatic recurrence","stage: 2a","tissue: cancer, LCM","Tumor tissue was extracted using laser-capture microdissection.","total RNA","Total RNA was extracted from tissue specimens using RNeasy kit (Qiagen, Hilden, Germany). Integrity of obtained RNA was assessed using Agilent 2100 BioAnalyzer (Agilent Technologies, Palo Alto, CA). All samples had RNA Integrity Number (RIN) greater than 5.0. Contaminant DNA was removed by digestion with RNase-free DNase (Qiagen).","biotin","cRNA was prepared using two-cycle target labeling and control reagents kit (Affymetrix, Santa Clara, CA).","9606","Hybridization and signal detection of HG-U133 Plus 2.0 arrays (Affymetrix) was performed following the manufacturer's instruction using the Affymetrix Fluidics Station 450.","GeneChips were scanned using Affymetrix GeneChip Scanner 3000.","Gene expression profile of surgically resected material","C083","The data was normalized by robust multichip analysis (RMA) using R/Bioconductor (affy package).","GPL570","Kaoru,,Mogushi","mogushi@bioinfo.tmd.ac.jp","+81-3-5803-4758","Information Center for Medical Sciences","Tokyo Medical and Dental University","1-5-45 Yushima","Bunkyo-ku","Tokyo","113-8510","Japan","http://bioinfo.tmd.ac.jp/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM537nnn/GSM537396/GSM537396_chip_array_C83T.CEL.gz","54675","Reanalysis of: GSM452605"
"GSM537397","patient 088, cancer, LCM [OPG study]","GSM537397","Public on Feb 28 2011","Apr 26 2010","Feb 28 2011","RNA","1","surgically resected material","Homo sapiens","metastasis: metastatic recurrence","stage: 2a","tissue: cancer, LCM","Tumor tissue was extracted using laser-capture microdissection.","total RNA","Total RNA was extracted from tissue specimens using RNeasy kit (Qiagen, Hilden, Germany). Integrity of obtained RNA was assessed using Agilent 2100 BioAnalyzer (Agilent Technologies, Palo Alto, CA). All samples had RNA Integrity Number (RIN) greater than 5.0. Contaminant DNA was removed by digestion with RNase-free DNase (Qiagen).","biotin","cRNA was prepared using two-cycle target labeling and control reagents kit (Affymetrix, Santa Clara, CA).","9606","Hybridization and signal detection of HG-U133 Plus 2.0 arrays (Affymetrix) was performed following the manufacturer's instruction using the Affymetrix Fluidics Station 450.","GeneChips were scanned using Affymetrix GeneChip Scanner 3000.","Gene expression profile of surgically resected material","C088","The data was normalized by robust multichip analysis (RMA) using R/Bioconductor (affy package).","GPL570","Kaoru,,Mogushi","mogushi@bioinfo.tmd.ac.jp","+81-3-5803-4758","Information Center for Medical Sciences","Tokyo Medical and Dental University","1-5-45 Yushima","Bunkyo-ku","Tokyo","113-8510","Japan","http://bioinfo.tmd.ac.jp/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM537nnn/GSM537397/GSM537397_chip_array_C88T.CEL.gz","54675",""
"GSM537398","patient 094, cancer, LCM [OPG study]","GSM537398","Public on Feb 28 2011","Apr 26 2010","Feb 28 2011","RNA","1","surgically resected material","Homo sapiens","metastasis: none","stage: 2b","tissue: cancer, LCM","Tumor tissue was extracted using laser-capture microdissection.","total RNA","Total RNA was extracted from tissue specimens using RNeasy kit (Qiagen, Hilden, Germany). Integrity of obtained RNA was assessed using Agilent 2100 BioAnalyzer (Agilent Technologies, Palo Alto, CA). All samples had RNA Integrity Number (RIN) greater than 5.0. Contaminant DNA was removed by digestion with RNase-free DNase (Qiagen).","biotin","cRNA was prepared using two-cycle target labeling and control reagents kit (Affymetrix, Santa Clara, CA).","9606","Hybridization and signal detection of HG-U133 Plus 2.0 arrays (Affymetrix) was performed following the manufacturer's instruction using the Affymetrix Fluidics Station 450.","GeneChips were scanned using Affymetrix GeneChip Scanner 3000.","Gene expression profile of surgically resected material","C094","The data was normalized by robust multichip analysis (RMA) using R/Bioconductor (affy package).","GPL570","Kaoru,,Mogushi","mogushi@bioinfo.tmd.ac.jp","+81-3-5803-4758","Information Center for Medical Sciences","Tokyo Medical and Dental University","1-5-45 Yushima","Bunkyo-ku","Tokyo","113-8510","Japan","http://bioinfo.tmd.ac.jp/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM537nnn/GSM537398/GSM537398_chip_array_C94T.CEL.gz","54675",""
"GSM537399","patient 095, cancer, LCM [OPG study]","GSM537399","Public on Feb 28 2011","Apr 26 2010","Feb 28 2011","RNA","1","surgically resected material","Homo sapiens","metastasis: none","stage: 3b","tissue: cancer, LCM","Tumor tissue was extracted using laser-capture microdissection.","total RNA","Total RNA was extracted from tissue specimens using RNeasy kit (Qiagen, Hilden, Germany). Integrity of obtained RNA was assessed using Agilent 2100 BioAnalyzer (Agilent Technologies, Palo Alto, CA). All samples had RNA Integrity Number (RIN) greater than 5.0. Contaminant DNA was removed by digestion with RNase-free DNase (Qiagen).","biotin","cRNA was prepared using two-cycle target labeling and control reagents kit (Affymetrix, Santa Clara, CA).","9606","Hybridization and signal detection of HG-U133 Plus 2.0 arrays (Affymetrix) was performed following the manufacturer's instruction using the Affymetrix Fluidics Station 450.","GeneChips were scanned using Affymetrix GeneChip Scanner 3000.","Gene expression profile of surgically resected material","C095","The data was normalized by robust multichip analysis (RMA) using R/Bioconductor (affy package).","GPL570","Kaoru,,Mogushi","mogushi@bioinfo.tmd.ac.jp","+81-3-5803-4758","Information Center for Medical Sciences","Tokyo Medical and Dental University","1-5-45 Yushima","Bunkyo-ku","Tokyo","113-8510","Japan","http://bioinfo.tmd.ac.jp/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM537nnn/GSM537399/GSM537399_chip_array_C95T.CEL.gz","54675",""
"GSM537400","patient 099, cancer, LCM [OPG study]","GSM537400","Public on Feb 28 2011","Apr 26 2010","Feb 28 2011","RNA","1","surgically resected material","Homo sapiens","metastasis: none","stage: 2a","tissue: cancer, LCM","Tumor tissue was extracted using laser-capture microdissection.","total RNA","Total RNA was extracted from tissue specimens using RNeasy kit (Qiagen, Hilden, Germany). Integrity of obtained RNA was assessed using Agilent 2100 BioAnalyzer (Agilent Technologies, Palo Alto, CA). All samples had RNA Integrity Number (RIN) greater than 5.0. Contaminant DNA was removed by digestion with RNase-free DNase (Qiagen).","biotin","cRNA was prepared using two-cycle target labeling and control reagents kit (Affymetrix, Santa Clara, CA).","9606","Hybridization and signal detection of HG-U133 Plus 2.0 arrays (Affymetrix) was performed following the manufacturer's instruction using the Affymetrix Fluidics Station 450.","GeneChips were scanned using Affymetrix GeneChip Scanner 3000.","Gene expression profile of surgically resected material","C099","The data was normalized by robust multichip analysis (RMA) using R/Bioconductor (affy package).","GPL570","Kaoru,,Mogushi","mogushi@bioinfo.tmd.ac.jp","+81-3-5803-4758","Information Center for Medical Sciences","Tokyo Medical and Dental University","1-5-45 Yushima","Bunkyo-ku","Tokyo","113-8510","Japan","http://bioinfo.tmd.ac.jp/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM537nnn/GSM537400/GSM537400_chip_array_C99T.CEL.gz","54675",""
"GSM537401","patient 106, cancer, LCM [OPG study]","GSM537401","Public on Feb 28 2011","Apr 26 2010","Feb 28 2011","RNA","1","surgically resected material","Homo sapiens","metastasis: metastatic recurrence","stage: 2b","tissue: cancer, LCM","Tumor tissue was extracted using laser-capture microdissection.","total RNA","Total RNA was extracted from tissue specimens using RNeasy kit (Qiagen, Hilden, Germany). Integrity of obtained RNA was assessed using Agilent 2100 BioAnalyzer (Agilent Technologies, Palo Alto, CA). All samples had RNA Integrity Number (RIN) greater than 5.0. Contaminant DNA was removed by digestion with RNase-free DNase (Qiagen).","biotin","cRNA was prepared using two-cycle target labeling and control reagents kit (Affymetrix, Santa Clara, CA).","9606","Hybridization and signal detection of HG-U133 Plus 2.0 arrays (Affymetrix) was performed following the manufacturer's instruction using the Affymetrix Fluidics Station 450.","GeneChips were scanned using Affymetrix GeneChip Scanner 3000.","Gene expression profile of surgically resected material","C106","The data was normalized by robust multichip analysis (RMA) using R/Bioconductor (affy package).","GPL570","Kaoru,,Mogushi","mogushi@bioinfo.tmd.ac.jp","+81-3-5803-4758","Information Center for Medical Sciences","Tokyo Medical and Dental University","1-5-45 Yushima","Bunkyo-ku","Tokyo","113-8510","Japan","http://bioinfo.tmd.ac.jp/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM537nnn/GSM537401/GSM537401_chip_array_C106T.CEL.gz","54675","Reanalysis of: GSM452606"
"GSM537402","patient 109, cancer, LCM [OPG study]","GSM537402","Public on Feb 28 2011","Apr 26 2010","Feb 28 2011","RNA","1","surgically resected material","Homo sapiens","metastasis: none","stage: 2b","tissue: cancer, LCM","Tumor tissue was extracted using laser-capture microdissection.","total RNA","Total RNA was extracted from tissue specimens using RNeasy kit (Qiagen, Hilden, Germany). Integrity of obtained RNA was assessed using Agilent 2100 BioAnalyzer (Agilent Technologies, Palo Alto, CA). All samples had RNA Integrity Number (RIN) greater than 5.0. Contaminant DNA was removed by digestion with RNase-free DNase (Qiagen).","biotin","cRNA was prepared using two-cycle target labeling and control reagents kit (Affymetrix, Santa Clara, CA).","9606","Hybridization and signal detection of HG-U133 Plus 2.0 arrays (Affymetrix) was performed following the manufacturer's instruction using the Affymetrix Fluidics Station 450.","GeneChips were scanned using Affymetrix GeneChip Scanner 3000.","Gene expression profile of surgically resected material","C109","The data was normalized by robust multichip analysis (RMA) using R/Bioconductor (affy package).","GPL570","Kaoru,,Mogushi","mogushi@bioinfo.tmd.ac.jp","+81-3-5803-4758","Information Center for Medical Sciences","Tokyo Medical and Dental University","1-5-45 Yushima","Bunkyo-ku","Tokyo","113-8510","Japan","http://bioinfo.tmd.ac.jp/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM537nnn/GSM537402/GSM537402_chip_array_C109T.CEL.gz","54675",""
"GSM537403","patient 121, cancer, LCM [OPG study]","GSM537403","Public on Feb 28 2011","Apr 26 2010","Feb 28 2011","RNA","1","surgically resected material","Homo sapiens","metastasis: metastasis","stage: 4","tissue: cancer, LCM","Tumor tissue was extracted using laser-capture microdissection.","total RNA","Total RNA was extracted from tissue specimens using RNeasy kit (Qiagen, Hilden, Germany). Integrity of obtained RNA was assessed using Agilent 2100 BioAnalyzer (Agilent Technologies, Palo Alto, CA). All samples had RNA Integrity Number (RIN) greater than 5.0. Contaminant DNA was removed by digestion with RNase-free DNase (Qiagen).","biotin","cRNA was prepared using two-cycle target labeling and control reagents kit (Affymetrix, Santa Clara, CA).","9606","Hybridization and signal detection of HG-U133 Plus 2.0 arrays (Affymetrix) was performed following the manufacturer's instruction using the Affymetrix Fluidics Station 450.","GeneChips were scanned using Affymetrix GeneChip Scanner 3000.","Gene expression profile of surgically resected material","C121","The data was normalized by robust multichip analysis (RMA) using R/Bioconductor (affy package).","GPL570","Kaoru,,Mogushi","mogushi@bioinfo.tmd.ac.jp","+81-3-5803-4758","Information Center for Medical Sciences","Tokyo Medical and Dental University","1-5-45 Yushima","Bunkyo-ku","Tokyo","113-8510","Japan","http://bioinfo.tmd.ac.jp/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM537nnn/GSM537403/GSM537403_chip_array_C121T.CEL.gz","54675","Reanalysis of: GSM452607"
"GSM537404","patient 129, cancer, LCM [OPG study]","GSM537404","Public on Feb 28 2011","Apr 26 2010","Feb 28 2011","RNA","1","surgically resected material","Homo sapiens","metastasis: none","stage: 2a","tissue: cancer, LCM","Tumor tissue was extracted using laser-capture microdissection.","total RNA","Total RNA was extracted from tissue specimens using RNeasy kit (Qiagen, Hilden, Germany). Integrity of obtained RNA was assessed using Agilent 2100 BioAnalyzer (Agilent Technologies, Palo Alto, CA). All samples had RNA Integrity Number (RIN) greater than 5.0. Contaminant DNA was removed by digestion with RNase-free DNase (Qiagen).","biotin","cRNA was prepared using two-cycle target labeling and control reagents kit (Affymetrix, Santa Clara, CA).","9606","Hybridization and signal detection of HG-U133 Plus 2.0 arrays (Affymetrix) was performed following the manufacturer's instruction using the Affymetrix Fluidics Station 450.","GeneChips were scanned using Affymetrix GeneChip Scanner 3000.","Gene expression profile of surgically resected material","C129","The data was normalized by robust multichip analysis (RMA) using R/Bioconductor (affy package).","GPL570","Kaoru,,Mogushi","mogushi@bioinfo.tmd.ac.jp","+81-3-5803-4758","Information Center for Medical Sciences","Tokyo Medical and Dental University","1-5-45 Yushima","Bunkyo-ku","Tokyo","113-8510","Japan","http://bioinfo.tmd.ac.jp/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM537nnn/GSM537404/GSM537404_chip_array_C129T.CEL.gz","54675","Reanalysis of: GSM452608"
"GSM537405","patient 130, cancer, LCM [OPG study]","GSM537405","Public on Feb 28 2011","Apr 26 2010","Feb 28 2011","RNA","1","surgically resected material","Homo sapiens","metastasis: none","stage: 2b","tissue: cancer, LCM","Tumor tissue was extracted using laser-capture microdissection.","total RNA","Total RNA was extracted from tissue specimens using RNeasy kit (Qiagen, Hilden, Germany). Integrity of obtained RNA was assessed using Agilent 2100 BioAnalyzer (Agilent Technologies, Palo Alto, CA). All samples had RNA Integrity Number (RIN) greater than 5.0. Contaminant DNA was removed by digestion with RNase-free DNase (Qiagen).","biotin","cRNA was prepared using two-cycle target labeling and control reagents kit (Affymetrix, Santa Clara, CA).","9606","Hybridization and signal detection of HG-U133 Plus 2.0 arrays (Affymetrix) was performed following the manufacturer's instruction using the Affymetrix Fluidics Station 450.","GeneChips were scanned using Affymetrix GeneChip Scanner 3000.","Gene expression profile of surgically resected material","C130","The data was normalized by robust multichip analysis (RMA) using R/Bioconductor (affy package).","GPL570","Kaoru,,Mogushi","mogushi@bioinfo.tmd.ac.jp","+81-3-5803-4758","Information Center for Medical Sciences","Tokyo Medical and Dental University","1-5-45 Yushima","Bunkyo-ku","Tokyo","113-8510","Japan","http://bioinfo.tmd.ac.jp/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM537nnn/GSM537405/GSM537405_chip_array_C130T.CEL.gz","54675","Reanalysis of: GSM452609"
"GSM537406","patient 131, cancer, LCM [OPG study]","GSM537406","Public on Feb 28 2011","Apr 26 2010","Feb 28 2011","RNA","1","surgically resected material","Homo sapiens","metastasis: metastasis","stage: 4","tissue: cancer, LCM","Tumor tissue was extracted using laser-capture microdissection.","total RNA","Total RNA was extracted from tissue specimens using RNeasy kit (Qiagen, Hilden, Germany). Integrity of obtained RNA was assessed using Agilent 2100 BioAnalyzer (Agilent Technologies, Palo Alto, CA). All samples had RNA Integrity Number (RIN) greater than 5.0. Contaminant DNA was removed by digestion with RNase-free DNase (Qiagen).","biotin","cRNA was prepared using two-cycle target labeling and control reagents kit (Affymetrix, Santa Clara, CA).","9606","Hybridization and signal detection of HG-U133 Plus 2.0 arrays (Affymetrix) was performed following the manufacturer's instruction using the Affymetrix Fluidics Station 450.","GeneChips were scanned using Affymetrix GeneChip Scanner 3000.","Gene expression profile of surgically resected material","C131","The data was normalized by robust multichip analysis (RMA) using R/Bioconductor (affy package).","GPL570","Kaoru,,Mogushi","mogushi@bioinfo.tmd.ac.jp","+81-3-5803-4758","Information Center for Medical Sciences","Tokyo Medical and Dental University","1-5-45 Yushima","Bunkyo-ku","Tokyo","113-8510","Japan","http://bioinfo.tmd.ac.jp/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM537nnn/GSM537406/GSM537406_chip_array_C131T.CEL.gz","54675","Reanalysis of: GSM452610"
"GSM537407","patient 133, cancer, LCM [OPG study]","GSM537407","Public on Feb 28 2011","Apr 26 2010","Feb 28 2011","RNA","1","surgically resected material","Homo sapiens","metastasis: none","stage: 3b","tissue: cancer, LCM","Tumor tissue was extracted using laser-capture microdissection.","total RNA","Total RNA was extracted from tissue specimens using RNeasy kit (Qiagen, Hilden, Germany). Integrity of obtained RNA was assessed using Agilent 2100 BioAnalyzer (Agilent Technologies, Palo Alto, CA). All samples had RNA Integrity Number (RIN) greater than 5.0. Contaminant DNA was removed by digestion with RNase-free DNase (Qiagen).","biotin","cRNA was prepared using two-cycle target labeling and control reagents kit (Affymetrix, Santa Clara, CA).","9606","Hybridization and signal detection of HG-U133 Plus 2.0 arrays (Affymetrix) was performed following the manufacturer's instruction using the Affymetrix Fluidics Station 450.","GeneChips were scanned using Affymetrix GeneChip Scanner 3000.","Gene expression profile of surgically resected material","C133","The data was normalized by robust multichip analysis (RMA) using R/Bioconductor (affy package).","GPL570","Kaoru,,Mogushi","mogushi@bioinfo.tmd.ac.jp","+81-3-5803-4758","Information Center for Medical Sciences","Tokyo Medical and Dental University","1-5-45 Yushima","Bunkyo-ku","Tokyo","113-8510","Japan","http://bioinfo.tmd.ac.jp/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM537nnn/GSM537407/GSM537407_chip_array_C133T.CEL.gz","54675","Reanalysis of: GSM452611"
"GSM537408","patient 140, cancer, LCM [OPG study]","GSM537408","Public on Feb 28 2011","Apr 26 2010","Feb 28 2011","RNA","1","surgically resected material","Homo sapiens","metastasis: none","stage: 3b","tissue: cancer, LCM","Tumor tissue was extracted using laser-capture microdissection.","total RNA","Total RNA was extracted from tissue specimens using RNeasy kit (Qiagen, Hilden, Germany). Integrity of obtained RNA was assessed using Agilent 2100 BioAnalyzer (Agilent Technologies, Palo Alto, CA). All samples had RNA Integrity Number (RIN) greater than 5.0. Contaminant DNA was removed by digestion with RNase-free DNase (Qiagen).","biotin","cRNA was prepared using two-cycle target labeling and control reagents kit (Affymetrix, Santa Clara, CA).","9606","Hybridization and signal detection of HG-U133 Plus 2.0 arrays (Affymetrix) was performed following the manufacturer's instruction using the Affymetrix Fluidics Station 450.","GeneChips were scanned using Affymetrix GeneChip Scanner 3000.","Gene expression profile of surgically resected material","C140","The data was normalized by robust multichip analysis (RMA) using R/Bioconductor (affy package).","GPL570","Kaoru,,Mogushi","mogushi@bioinfo.tmd.ac.jp","+81-3-5803-4758","Information Center for Medical Sciences","Tokyo Medical and Dental University","1-5-45 Yushima","Bunkyo-ku","Tokyo","113-8510","Japan","http://bioinfo.tmd.ac.jp/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM537nnn/GSM537408/GSM537408_chip_array_C140T.CEL.gz","54675","Reanalysis of: GSM452612"
"GSM537409","patient 141, cancer, LCM [OPG study]","GSM537409","Public on Feb 28 2011","Apr 26 2010","Feb 28 2011","RNA","1","surgically resected material","Homo sapiens","metastasis: none","stage: 2a","tissue: cancer, LCM","Tumor tissue was extracted using laser-capture microdissection.","total RNA","Total RNA was extracted from tissue specimens using RNeasy kit (Qiagen, Hilden, Germany). Integrity of obtained RNA was assessed using Agilent 2100 BioAnalyzer (Agilent Technologies, Palo Alto, CA). All samples had RNA Integrity Number (RIN) greater than 5.0. Contaminant DNA was removed by digestion with RNase-free DNase (Qiagen).","biotin","cRNA was prepared using two-cycle target labeling and control reagents kit (Affymetrix, Santa Clara, CA).","9606","Hybridization and signal detection of HG-U133 Plus 2.0 arrays (Affymetrix) was performed following the manufacturer's instruction using the Affymetrix Fluidics Station 450.","GeneChips were scanned using Affymetrix GeneChip Scanner 3000.","Gene expression profile of surgically resected material","C141","The data was normalized by robust multichip analysis (RMA) using R/Bioconductor (affy package).","GPL570","Kaoru,,Mogushi","mogushi@bioinfo.tmd.ac.jp","+81-3-5803-4758","Information Center for Medical Sciences","Tokyo Medical and Dental University","1-5-45 Yushima","Bunkyo-ku","Tokyo","113-8510","Japan","http://bioinfo.tmd.ac.jp/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM537nnn/GSM537409/GSM537409_chip_array_C141T.CEL.gz","54675","Reanalysis of: GSM452613"
"GSM537410","patient 146, cancer, LCM [OPG study]","GSM537410","Public on Feb 28 2011","Apr 26 2010","Feb 28 2011","RNA","1","surgically resected material","Homo sapiens","metastasis: none","stage: 3c","tissue: cancer, LCM","Tumor tissue was extracted using laser-capture microdissection.","total RNA","Total RNA was extracted from tissue specimens using RNeasy kit (Qiagen, Hilden, Germany). Integrity of obtained RNA was assessed using Agilent 2100 BioAnalyzer (Agilent Technologies, Palo Alto, CA). All samples had RNA Integrity Number (RIN) greater than 5.0. Contaminant DNA was removed by digestion with RNase-free DNase (Qiagen).","biotin","cRNA was prepared using two-cycle target labeling and control reagents kit (Affymetrix, Santa Clara, CA).","9606","Hybridization and signal detection of HG-U133 Plus 2.0 arrays (Affymetrix) was performed following the manufacturer's instruction using the Affymetrix Fluidics Station 450.","GeneChips were scanned using Affymetrix GeneChip Scanner 3000.","Gene expression profile of surgically resected material","C146","The data was normalized by robust multichip analysis (RMA) using R/Bioconductor (affy package).","GPL570","Kaoru,,Mogushi","mogushi@bioinfo.tmd.ac.jp","+81-3-5803-4758","Information Center for Medical Sciences","Tokyo Medical and Dental University","1-5-45 Yushima","Bunkyo-ku","Tokyo","113-8510","Japan","http://bioinfo.tmd.ac.jp/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM537nnn/GSM537410/GSM537410_chip_array_C146T.CEL.gz","54675","Reanalysis of: GSM452614"
"GSM537411","patient 149, cancer, LCM [OPG study]","GSM537411","Public on Feb 28 2011","Apr 26 2010","Feb 28 2011","RNA","1","surgically resected material","Homo sapiens","metastasis: metastasis","stage: 4","tissue: cancer, LCM","Tumor tissue was extracted using laser-capture microdissection.","total RNA","Total RNA was extracted from tissue specimens using RNeasy kit (Qiagen, Hilden, Germany). Integrity of obtained RNA was assessed using Agilent 2100 BioAnalyzer (Agilent Technologies, Palo Alto, CA). All samples had RNA Integrity Number (RIN) greater than 5.0. Contaminant DNA was removed by digestion with RNase-free DNase (Qiagen).","biotin","cRNA was prepared using two-cycle target labeling and control reagents kit (Affymetrix, Santa Clara, CA).","9606","Hybridization and signal detection of HG-U133 Plus 2.0 arrays (Affymetrix) was performed following the manufacturer's instruction using the Affymetrix Fluidics Station 450.","GeneChips were scanned using Affymetrix GeneChip Scanner 3000.","Gene expression profile of surgically resected material","C149","The data was normalized by robust multichip analysis (RMA) using R/Bioconductor (affy package).","GPL570","Kaoru,,Mogushi","mogushi@bioinfo.tmd.ac.jp","+81-3-5803-4758","Information Center for Medical Sciences","Tokyo Medical and Dental University","1-5-45 Yushima","Bunkyo-ku","Tokyo","113-8510","Japan","http://bioinfo.tmd.ac.jp/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM537nnn/GSM537411/GSM537411_chip_array_C149T.CEL.gz","54675","Reanalysis of: GSM452615"
"GSM537412","patient 019, cancer, LCM [OPG study]","GSM537412","Public on Feb 28 2011","Apr 26 2010","Feb 28 2011","RNA","1","surgically resected material","Homo sapiens","metastasis: metastasis","stage: 4","tissue: cancer, LCM","Tumor tissue was extracted using laser-capture microdissection.","total RNA","Total RNA was extracted from tissue specimens using RNeasy kit (Qiagen, Hilden, Germany). Integrity of obtained RNA was assessed using Agilent 2100 BioAnalyzer (Agilent Technologies, Palo Alto, CA). All samples had RNA Integrity Number (RIN) greater than 5.0. Contaminant DNA was removed by digestion with RNase-free DNase (Qiagen).","biotin","cRNA was prepared using two-cycle target labeling and control reagents kit (Affymetrix, Santa Clara, CA).","9606","Hybridization and signal detection of HG-U133 Plus 2.0 arrays (Affymetrix) was performed following the manufacturer's instruction using the Affymetrix Fluidics Station 450.","GeneChips were scanned using Affymetrix GeneChip Scanner 3000.","Gene expression profile of surgically resected material","C019","The data was normalized by robust multichip analysis (RMA) using R/Bioconductor (affy package).","GPL570","Kaoru,,Mogushi","mogushi@bioinfo.tmd.ac.jp","+81-3-5803-4758","Information Center for Medical Sciences","Tokyo Medical and Dental University","1-5-45 Yushima","Bunkyo-ku","Tokyo","113-8510","Japan","http://bioinfo.tmd.ac.jp/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM537nnn/GSM537412/GSM537412_chip_array_C19T.CEL.gz","54675","Reanalysis of: GSM452616"
"GSM537413","patient 027, cancer, LCM [OPG study]","GSM537413","Public on Feb 28 2011","Apr 26 2010","Feb 28 2011","RNA","1","surgically resected material","Homo sapiens","metastasis: none","stage: 3c","tissue: cancer, LCM","Tumor tissue was extracted using laser-capture microdissection.","total RNA","Total RNA was extracted from tissue specimens using RNeasy kit (Qiagen, Hilden, Germany). Integrity of obtained RNA was assessed using Agilent 2100 BioAnalyzer (Agilent Technologies, Palo Alto, CA). All samples had RNA Integrity Number (RIN) greater than 5.0. Contaminant DNA was removed by digestion with RNase-free DNase (Qiagen).","biotin","cRNA was prepared using two-cycle target labeling and control reagents kit (Affymetrix, Santa Clara, CA).","9606","Hybridization and signal detection of HG-U133 Plus 2.0 arrays (Affymetrix) was performed following the manufacturer's instruction using the Affymetrix Fluidics Station 450.","GeneChips were scanned using Affymetrix GeneChip Scanner 3000.","Gene expression profile of surgically resected material","C027","The data was normalized by robust multichip analysis (RMA) using R/Bioconductor (affy package).","GPL570","Kaoru,,Mogushi","mogushi@bioinfo.tmd.ac.jp","+81-3-5803-4758","Information Center for Medical Sciences","Tokyo Medical and Dental University","1-5-45 Yushima","Bunkyo-ku","Tokyo","113-8510","Japan","http://bioinfo.tmd.ac.jp/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM537nnn/GSM537413/GSM537413_chip_array_C27T.CEL.gz","54675","Reanalysis of: GSM452617"
"GSM537414","patient 028, cancer, LCM [OPG study]","GSM537414","Public on Feb 28 2011","Apr 26 2010","Feb 28 2011","RNA","1","surgically resected material","Homo sapiens","metastasis: metastatic recurrence","stage: 3c","tissue: cancer, LCM","Tumor tissue was extracted using laser-capture microdissection.","total RNA","Total RNA was extracted from tissue specimens using RNeasy kit (Qiagen, Hilden, Germany). Integrity of obtained RNA was assessed using Agilent 2100 BioAnalyzer (Agilent Technologies, Palo Alto, CA). All samples had RNA Integrity Number (RIN) greater than 5.0. Contaminant DNA was removed by digestion with RNase-free DNase (Qiagen).","biotin","cRNA was prepared using two-cycle target labeling and control reagents kit (Affymetrix, Santa Clara, CA).","9606","Hybridization and signal detection of HG-U133 Plus 2.0 arrays (Affymetrix) was performed following the manufacturer's instruction using the Affymetrix Fluidics Station 450.","GeneChips were scanned using Affymetrix GeneChip Scanner 3000.","Gene expression profile of surgically resected material","C028","The data was normalized by robust multichip analysis (RMA) using R/Bioconductor (affy package).","GPL570","Kaoru,,Mogushi","mogushi@bioinfo.tmd.ac.jp","+81-3-5803-4758","Information Center for Medical Sciences","Tokyo Medical and Dental University","1-5-45 Yushima","Bunkyo-ku","Tokyo","113-8510","Japan","http://bioinfo.tmd.ac.jp/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM537nnn/GSM537414/GSM537414_chip_array_C28T.CEL.gz","54675",""
"GSM537415","patient 032, cancer, LCM [OPG study]","GSM537415","Public on Feb 28 2011","Apr 26 2010","Feb 28 2011","RNA","1","surgically resected material","Homo sapiens","metastasis: none","stage: 1","tissue: cancer, LCM","Tumor tissue was extracted using laser-capture microdissection.","total RNA","Total RNA was extracted from tissue specimens using RNeasy kit (Qiagen, Hilden, Germany). Integrity of obtained RNA was assessed using Agilent 2100 BioAnalyzer (Agilent Technologies, Palo Alto, CA). All samples had RNA Integrity Number (RIN) greater than 5.0. Contaminant DNA was removed by digestion with RNase-free DNase (Qiagen).","biotin","cRNA was prepared using two-cycle target labeling and control reagents kit (Affymetrix, Santa Clara, CA).","9606","Hybridization and signal detection of HG-U133 Plus 2.0 arrays (Affymetrix) was performed following the manufacturer's instruction using the Affymetrix Fluidics Station 450.","GeneChips were scanned using Affymetrix GeneChip Scanner 3000.","Gene expression profile of surgically resected material","C032","The data was normalized by robust multichip analysis (RMA) using R/Bioconductor (affy package).","GPL570","Kaoru,,Mogushi","mogushi@bioinfo.tmd.ac.jp","+81-3-5803-4758","Information Center for Medical Sciences","Tokyo Medical and Dental University","1-5-45 Yushima","Bunkyo-ku","Tokyo","113-8510","Japan","http://bioinfo.tmd.ac.jp/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM537nnn/GSM537415/GSM537415_chip_array_C32T.CEL.gz","54675","Reanalysis of: GSM452618"
"GSM537416","patient 035, cancer, LCM [OPG study]","GSM537416","Public on Feb 28 2011","Apr 26 2010","Feb 28 2011","RNA","1","surgically resected material","Homo sapiens","metastasis: metastasis","stage: 4","tissue: cancer, LCM","Tumor tissue was extracted using laser-capture microdissection.","total RNA","Total RNA was extracted from tissue specimens using RNeasy kit (Qiagen, Hilden, Germany). Integrity of obtained RNA was assessed using Agilent 2100 BioAnalyzer (Agilent Technologies, Palo Alto, CA). All samples had RNA Integrity Number (RIN) greater than 5.0. Contaminant DNA was removed by digestion with RNase-free DNase (Qiagen).","biotin","cRNA was prepared using two-cycle target labeling and control reagents kit (Affymetrix, Santa Clara, CA).","9606","Hybridization and signal detection of HG-U133 Plus 2.0 arrays (Affymetrix) was performed following the manufacturer's instruction using the Affymetrix Fluidics Station 450.","GeneChips were scanned using Affymetrix GeneChip Scanner 3000.","Gene expression profile of surgically resected material","C035","The data was normalized by robust multichip analysis (RMA) using R/Bioconductor (affy package).","GPL570","Kaoru,,Mogushi","mogushi@bioinfo.tmd.ac.jp","+81-3-5803-4758","Information Center for Medical Sciences","Tokyo Medical and Dental University","1-5-45 Yushima","Bunkyo-ku","Tokyo","113-8510","Japan","http://bioinfo.tmd.ac.jp/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM537nnn/GSM537416/GSM537416_chip_array_C35T.CEL.gz","54675","Reanalysis of: GSM452619"
"GSM537417","patient 042, cancer, LCM [OPG study]","GSM537417","Public on Feb 28 2011","Apr 26 2010","Feb 28 2011","RNA","1","surgically resected material","Homo sapiens","metastasis: none","stage: 1","tissue: cancer, LCM","Tumor tissue was extracted using laser-capture microdissection.","total RNA","Total RNA was extracted from tissue specimens using RNeasy kit (Qiagen, Hilden, Germany). Integrity of obtained RNA was assessed using Agilent 2100 BioAnalyzer (Agilent Technologies, Palo Alto, CA). All samples had RNA Integrity Number (RIN) greater than 5.0. Contaminant DNA was removed by digestion with RNase-free DNase (Qiagen).","biotin","cRNA was prepared using two-cycle target labeling and control reagents kit (Affymetrix, Santa Clara, CA).","9606","Hybridization and signal detection of HG-U133 Plus 2.0 arrays (Affymetrix) was performed following the manufacturer's instruction using the Affymetrix Fluidics Station 450.","GeneChips were scanned using Affymetrix GeneChip Scanner 3000.","Gene expression profile of surgically resected material","C042","The data was normalized by robust multichip analysis (RMA) using R/Bioconductor (affy package).","GPL570","Kaoru,,Mogushi","mogushi@bioinfo.tmd.ac.jp","+81-3-5803-4758","Information Center for Medical Sciences","Tokyo Medical and Dental University","1-5-45 Yushima","Bunkyo-ku","Tokyo","113-8510","Japan","http://bioinfo.tmd.ac.jp/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM537nnn/GSM537417/GSM537417_chip_array_C42T.CEL.gz","54675","Reanalysis of: GSM452620"
"GSM537418","patient 044, cancer, LCM [OPG study]","GSM537418","Public on Feb 28 2011","Apr 26 2010","Feb 28 2011","RNA","1","surgically resected material","Homo sapiens","metastasis: none","stage: 2a","tissue: cancer, LCM","Tumor tissue was extracted using laser-capture microdissection.","total RNA","Total RNA was extracted from tissue specimens using RNeasy kit (Qiagen, Hilden, Germany). Integrity of obtained RNA was assessed using Agilent 2100 BioAnalyzer (Agilent Technologies, Palo Alto, CA). All samples had RNA Integrity Number (RIN) greater than 5.0. Contaminant DNA was removed by digestion with RNase-free DNase (Qiagen).","biotin","cRNA was prepared using two-cycle target labeling and control reagents kit (Affymetrix, Santa Clara, CA).","9606","Hybridization and signal detection of HG-U133 Plus 2.0 arrays (Affymetrix) was performed following the manufacturer's instruction using the Affymetrix Fluidics Station 450.","GeneChips were scanned using Affymetrix GeneChip Scanner 3000.","Gene expression profile of surgically resected material","C044","The data was normalized by robust multichip analysis (RMA) using R/Bioconductor (affy package).","GPL570","Kaoru,,Mogushi","mogushi@bioinfo.tmd.ac.jp","+81-3-5803-4758","Information Center for Medical Sciences","Tokyo Medical and Dental University","1-5-45 Yushima","Bunkyo-ku","Tokyo","113-8510","Japan","http://bioinfo.tmd.ac.jp/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM537nnn/GSM537418/GSM537418_chip_array_C44T.CEL.gz","54675",""
"GSM537419","patient 045, cancer, LCM [OPG study]","GSM537419","Public on Feb 28 2011","Apr 26 2010","Feb 28 2011","RNA","1","surgically resected material","Homo sapiens","metastasis: metastatic recurrence","stage: 3b","tissue: cancer, LCM","Tumor tissue was extracted using laser-capture microdissection.","total RNA","Total RNA was extracted from tissue specimens using RNeasy kit (Qiagen, Hilden, Germany). Integrity of obtained RNA was assessed using Agilent 2100 BioAnalyzer (Agilent Technologies, Palo Alto, CA). All samples had RNA Integrity Number (RIN) greater than 5.0. Contaminant DNA was removed by digestion with RNase-free DNase (Qiagen).","biotin","cRNA was prepared using two-cycle target labeling and control reagents kit (Affymetrix, Santa Clara, CA).","9606","Hybridization and signal detection of HG-U133 Plus 2.0 arrays (Affymetrix) was performed following the manufacturer's instruction using the Affymetrix Fluidics Station 450.","GeneChips were scanned using Affymetrix GeneChip Scanner 3000.","Gene expression profile of surgically resected material","C045","The data was normalized by robust multichip analysis (RMA) using R/Bioconductor (affy package).","GPL570","Kaoru,,Mogushi","mogushi@bioinfo.tmd.ac.jp","+81-3-5803-4758","Information Center for Medical Sciences","Tokyo Medical and Dental University","1-5-45 Yushima","Bunkyo-ku","Tokyo","113-8510","Japan","http://bioinfo.tmd.ac.jp/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM537nnn/GSM537419/GSM537419_chip_array_C45T.CEL.gz","54675","Reanalysis of: GSM452621"
"GSM537420","patient 052, cancer, LCM [OPG study]","GSM537420","Public on Feb 28 2011","Apr 26 2010","Feb 28 2011","RNA","1","surgically resected material","Homo sapiens","metastasis: metastatic recurrence","stage: 3b","tissue: cancer, LCM","Tumor tissue was extracted using laser-capture microdissection.","total RNA","Total RNA was extracted from tissue specimens using RNeasy kit (Qiagen, Hilden, Germany). Integrity of obtained RNA was assessed using Agilent 2100 BioAnalyzer (Agilent Technologies, Palo Alto, CA). All samples had RNA Integrity Number (RIN) greater than 5.0. Contaminant DNA was removed by digestion with RNase-free DNase (Qiagen).","biotin","cRNA was prepared using two-cycle target labeling and control reagents kit (Affymetrix, Santa Clara, CA).","9606","Hybridization and signal detection of HG-U133 Plus 2.0 arrays (Affymetrix) was performed following the manufacturer's instruction using the Affymetrix Fluidics Station 450.","GeneChips were scanned using Affymetrix GeneChip Scanner 3000.","Gene expression profile of surgically resected material","C052","The data was normalized by robust multichip analysis (RMA) using R/Bioconductor (affy package).","GPL570","Kaoru,,Mogushi","mogushi@bioinfo.tmd.ac.jp","+81-3-5803-4758","Information Center for Medical Sciences","Tokyo Medical and Dental University","1-5-45 Yushima","Bunkyo-ku","Tokyo","113-8510","Japan","http://bioinfo.tmd.ac.jp/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM537nnn/GSM537420/GSM537420_chip_array_C52T.CEL.gz","54675",""
"GSM537421","patient 055, cancer, LCM [OPG study]","GSM537421","Public on Feb 28 2011","Apr 26 2010","Feb 28 2011","RNA","1","surgically resected material","Homo sapiens","metastasis: none","stage: 3a","tissue: cancer, LCM","Tumor tissue was extracted using laser-capture microdissection.","total RNA","Total RNA was extracted from tissue specimens using RNeasy kit (Qiagen, Hilden, Germany). Integrity of obtained RNA was assessed using Agilent 2100 BioAnalyzer (Agilent Technologies, Palo Alto, CA). All samples had RNA Integrity Number (RIN) greater than 5.0. Contaminant DNA was removed by digestion with RNase-free DNase (Qiagen).","biotin","cRNA was prepared using two-cycle target labeling and control reagents kit (Affymetrix, Santa Clara, CA).","9606","Hybridization and signal detection of HG-U133 Plus 2.0 arrays (Affymetrix) was performed following the manufacturer's instruction using the Affymetrix Fluidics Station 450.","GeneChips were scanned using Affymetrix GeneChip Scanner 3000.","Gene expression profile of surgically resected material","C055","The data was normalized by robust multichip analysis (RMA) using R/Bioconductor (affy package).","GPL570","Kaoru,,Mogushi","mogushi@bioinfo.tmd.ac.jp","+81-3-5803-4758","Information Center for Medical Sciences","Tokyo Medical and Dental University","1-5-45 Yushima","Bunkyo-ku","Tokyo","113-8510","Japan","http://bioinfo.tmd.ac.jp/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM537nnn/GSM537421/GSM537421_chip_array_C55T.CEL.gz","54675",""
"GSM537422","patient 059, cancer, LCM [OPG study]","GSM537422","Public on Feb 28 2011","Apr 26 2010","Feb 28 2011","RNA","1","surgically resected material","Homo sapiens","metastasis: none","stage: 1","tissue: cancer, LCM","Tumor tissue was extracted using laser-capture microdissection.","total RNA","Total RNA was extracted from tissue specimens using RNeasy kit (Qiagen, Hilden, Germany). Integrity of obtained RNA was assessed using Agilent 2100 BioAnalyzer (Agilent Technologies, Palo Alto, CA). All samples had RNA Integrity Number (RIN) greater than 5.0. Contaminant DNA was removed by digestion with RNase-free DNase (Qiagen).","biotin","cRNA was prepared using two-cycle target labeling and control reagents kit (Affymetrix, Santa Clara, CA).","9606","Hybridization and signal detection of HG-U133 Plus 2.0 arrays (Affymetrix) was performed following the manufacturer's instruction using the Affymetrix Fluidics Station 450.","GeneChips were scanned using Affymetrix GeneChip Scanner 3000.","Gene expression profile of surgically resected material","C059","The data was normalized by robust multichip analysis (RMA) using R/Bioconductor (affy package).","GPL570","Kaoru,,Mogushi","mogushi@bioinfo.tmd.ac.jp","+81-3-5803-4758","Information Center for Medical Sciences","Tokyo Medical and Dental University","1-5-45 Yushima","Bunkyo-ku","Tokyo","113-8510","Japan","http://bioinfo.tmd.ac.jp/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM537nnn/GSM537422/GSM537422_chip_array_C59T.CEL.gz","54675","Reanalysis of: GSM452622"
"GSM537423","patient 064, cancer, LCM [OPG study]","GSM537423","Public on Feb 28 2011","Apr 26 2010","Feb 28 2011","RNA","1","surgically resected material","Homo sapiens","metastasis: none","stage: 1","tissue: cancer, LCM","Tumor tissue was extracted using laser-capture microdissection.","total RNA","Total RNA was extracted from tissue specimens using RNeasy kit (Qiagen, Hilden, Germany). Integrity of obtained RNA was assessed using Agilent 2100 BioAnalyzer (Agilent Technologies, Palo Alto, CA). All samples had RNA Integrity Number (RIN) greater than 5.0. Contaminant DNA was removed by digestion with RNase-free DNase (Qiagen).","biotin","cRNA was prepared using two-cycle target labeling and control reagents kit (Affymetrix, Santa Clara, CA).","9606","Hybridization and signal detection of HG-U133 Plus 2.0 arrays (Affymetrix) was performed following the manufacturer's instruction using the Affymetrix Fluidics Station 450.","GeneChips were scanned using Affymetrix GeneChip Scanner 3000.","Gene expression profile of surgically resected material","C064","The data was normalized by robust multichip analysis (RMA) using R/Bioconductor (affy package).","GPL570","Kaoru,,Mogushi","mogushi@bioinfo.tmd.ac.jp","+81-3-5803-4758","Information Center for Medical Sciences","Tokyo Medical and Dental University","1-5-45 Yushima","Bunkyo-ku","Tokyo","113-8510","Japan","http://bioinfo.tmd.ac.jp/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM537nnn/GSM537423/GSM537423_chip_array_C64T.CEL.gz","54675","Reanalysis of: GSM452623"
"GSM537424","patient 065, cancer, LCM [OPG study]","GSM537424","Public on Feb 28 2011","Apr 26 2010","Feb 28 2011","RNA","1","surgically resected material","Homo sapiens","metastasis: none","stage: 3a","tissue: cancer, LCM","Tumor tissue was extracted using laser-capture microdissection.","total RNA","Total RNA was extracted from tissue specimens using RNeasy kit (Qiagen, Hilden, Germany). Integrity of obtained RNA was assessed using Agilent 2100 BioAnalyzer (Agilent Technologies, Palo Alto, CA). All samples had RNA Integrity Number (RIN) greater than 5.0. Contaminant DNA was removed by digestion with RNase-free DNase (Qiagen).","biotin","cRNA was prepared using two-cycle target labeling and control reagents kit (Affymetrix, Santa Clara, CA).","9606","Hybridization and signal detection of HG-U133 Plus 2.0 arrays (Affymetrix) was performed following the manufacturer's instruction using the Affymetrix Fluidics Station 450.","GeneChips were scanned using Affymetrix GeneChip Scanner 3000.","Gene expression profile of surgically resected material","C065","The data was normalized by robust multichip analysis (RMA) using R/Bioconductor (affy package).","GPL570","Kaoru,,Mogushi","mogushi@bioinfo.tmd.ac.jp","+81-3-5803-4758","Information Center for Medical Sciences","Tokyo Medical and Dental University","1-5-45 Yushima","Bunkyo-ku","Tokyo","113-8510","Japan","http://bioinfo.tmd.ac.jp/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM537nnn/GSM537424/GSM537424_chip_array_C65T.CEL.gz","54675",""
"GSM537425","patient 070, cancer, LCM [OPG study]","GSM537425","Public on Feb 28 2011","Apr 26 2010","Feb 28 2011","RNA","1","surgically resected material","Homo sapiens","metastasis: none","stage: 2a","tissue: cancer, LCM","Tumor tissue was extracted using laser-capture microdissection.","total RNA","Total RNA was extracted from tissue specimens using RNeasy kit (Qiagen, Hilden, Germany). Integrity of obtained RNA was assessed using Agilent 2100 BioAnalyzer (Agilent Technologies, Palo Alto, CA). All samples had RNA Integrity Number (RIN) greater than 5.0. Contaminant DNA was removed by digestion with RNase-free DNase (Qiagen).","biotin","cRNA was prepared using two-cycle target labeling and control reagents kit (Affymetrix, Santa Clara, CA).","9606","Hybridization and signal detection of HG-U133 Plus 2.0 arrays (Affymetrix) was performed following the manufacturer's instruction using the Affymetrix Fluidics Station 450.","GeneChips were scanned using Affymetrix GeneChip Scanner 3000.","Gene expression profile of surgically resected material","C070","The data was normalized by robust multichip analysis (RMA) using R/Bioconductor (affy package).","GPL570","Kaoru,,Mogushi","mogushi@bioinfo.tmd.ac.jp","+81-3-5803-4758","Information Center for Medical Sciences","Tokyo Medical and Dental University","1-5-45 Yushima","Bunkyo-ku","Tokyo","113-8510","Japan","http://bioinfo.tmd.ac.jp/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM537nnn/GSM537425/GSM537425_chip_array_C70T.CEL.gz","54675",""
"GSM537426","patient 079, cancer, LCM [OPG study]","GSM537426","Public on Feb 28 2011","Apr 26 2010","Feb 28 2011","RNA","1","surgically resected material","Homo sapiens","metastasis: metastasis","stage: 4","tissue: cancer, LCM","Tumor tissue was extracted using laser-capture microdissection.","total RNA","Total RNA was extracted from tissue specimens using RNeasy kit (Qiagen, Hilden, Germany). Integrity of obtained RNA was assessed using Agilent 2100 BioAnalyzer (Agilent Technologies, Palo Alto, CA). All samples had RNA Integrity Number (RIN) greater than 5.0. Contaminant DNA was removed by digestion with RNase-free DNase (Qiagen).","biotin","cRNA was prepared using two-cycle target labeling and control reagents kit (Affymetrix, Santa Clara, CA).","9606","Hybridization and signal detection of HG-U133 Plus 2.0 arrays (Affymetrix) was performed following the manufacturer's instruction using the Affymetrix Fluidics Station 450.","GeneChips were scanned using Affymetrix GeneChip Scanner 3000.","Gene expression profile of surgically resected material","C079","The data was normalized by robust multichip analysis (RMA) using R/Bioconductor (affy package).","GPL570","Kaoru,,Mogushi","mogushi@bioinfo.tmd.ac.jp","+81-3-5803-4758","Information Center for Medical Sciences","Tokyo Medical and Dental University","1-5-45 Yushima","Bunkyo-ku","Tokyo","113-8510","Japan","http://bioinfo.tmd.ac.jp/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM537nnn/GSM537426/GSM537426_chip_array_C79T.CEL.gz","54675","Reanalysis of: GSM452624"
"GSM537427","patient 084, cancer, LCM [OPG study]","GSM537427","Public on Feb 28 2011","Apr 26 2010","Feb 28 2011","RNA","1","surgically resected material","Homo sapiens","metastasis: none","stage: 1","tissue: cancer, LCM","Tumor tissue was extracted using laser-capture microdissection.","total RNA","Total RNA was extracted from tissue specimens using RNeasy kit (Qiagen, Hilden, Germany). Integrity of obtained RNA was assessed using Agilent 2100 BioAnalyzer (Agilent Technologies, Palo Alto, CA). All samples had RNA Integrity Number (RIN) greater than 5.0. Contaminant DNA was removed by digestion with RNase-free DNase (Qiagen).","biotin","cRNA was prepared using two-cycle target labeling and control reagents kit (Affymetrix, Santa Clara, CA).","9606","Hybridization and signal detection of HG-U133 Plus 2.0 arrays (Affymetrix) was performed following the manufacturer's instruction using the Affymetrix Fluidics Station 450.","GeneChips were scanned using Affymetrix GeneChip Scanner 3000.","Gene expression profile of surgically resected material","C084","The data was normalized by robust multichip analysis (RMA) using R/Bioconductor (affy package).","GPL570","Kaoru,,Mogushi","mogushi@bioinfo.tmd.ac.jp","+81-3-5803-4758","Information Center for Medical Sciences","Tokyo Medical and Dental University","1-5-45 Yushima","Bunkyo-ku","Tokyo","113-8510","Japan","http://bioinfo.tmd.ac.jp/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM537nnn/GSM537427/GSM537427_chip_array_C84T.CEL.gz","54675","Reanalysis of: GSM452625"
"GSM537428","patient 086, cancer, LCM [OPG study]","GSM537428","Public on Feb 28 2011","Apr 26 2010","Feb 28 2011","RNA","1","surgically resected material","Homo sapiens","metastasis: none","stage: 3b","tissue: cancer, LCM","Tumor tissue was extracted using laser-capture microdissection.","total RNA","Total RNA was extracted from tissue specimens using RNeasy kit (Qiagen, Hilden, Germany). Integrity of obtained RNA was assessed using Agilent 2100 BioAnalyzer (Agilent Technologies, Palo Alto, CA). All samples had RNA Integrity Number (RIN) greater than 5.0. Contaminant DNA was removed by digestion with RNase-free DNase (Qiagen).","biotin","cRNA was prepared using two-cycle target labeling and control reagents kit (Affymetrix, Santa Clara, CA).","9606","Hybridization and signal detection of HG-U133 Plus 2.0 arrays (Affymetrix) was performed following the manufacturer's instruction using the Affymetrix Fluidics Station 450.","GeneChips were scanned using Affymetrix GeneChip Scanner 3000.","Gene expression profile of surgically resected material","C086","The data was normalized by robust multichip analysis (RMA) using R/Bioconductor (affy package).","GPL570","Kaoru,,Mogushi","mogushi@bioinfo.tmd.ac.jp","+81-3-5803-4758","Information Center for Medical Sciences","Tokyo Medical and Dental University","1-5-45 Yushima","Bunkyo-ku","Tokyo","113-8510","Japan","http://bioinfo.tmd.ac.jp/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM537nnn/GSM537428/GSM537428_chip_array_C86T.CEL.gz","54675","Reanalysis of: GSM452626"
"GSM537429","patient 089, cancer, LCM [OPG study]","GSM537429","Public on Feb 28 2011","Apr 26 2010","Feb 28 2011","RNA","1","surgically resected material","Homo sapiens","metastasis: metastatic recurrence","stage: 3b","tissue: cancer, LCM","Tumor tissue was extracted using laser-capture microdissection.","total RNA","Total RNA was extracted from tissue specimens using RNeasy kit (Qiagen, Hilden, Germany). Integrity of obtained RNA was assessed using Agilent 2100 BioAnalyzer (Agilent Technologies, Palo Alto, CA). All samples had RNA Integrity Number (RIN) greater than 5.0. Contaminant DNA was removed by digestion with RNase-free DNase (Qiagen).","biotin","cRNA was prepared using two-cycle target labeling and control reagents kit (Affymetrix, Santa Clara, CA).","9606","Hybridization and signal detection of HG-U133 Plus 2.0 arrays (Affymetrix) was performed following the manufacturer's instruction using the Affymetrix Fluidics Station 450.","GeneChips were scanned using Affymetrix GeneChip Scanner 3000.","Gene expression profile of surgically resected material","C089","The data was normalized by robust multichip analysis (RMA) using R/Bioconductor (affy package).","GPL570","Kaoru,,Mogushi","mogushi@bioinfo.tmd.ac.jp","+81-3-5803-4758","Information Center for Medical Sciences","Tokyo Medical and Dental University","1-5-45 Yushima","Bunkyo-ku","Tokyo","113-8510","Japan","http://bioinfo.tmd.ac.jp/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM537nnn/GSM537429/GSM537429_chip_array_C89T.CEL.gz","54675",""
"GSM537430","patient 090, cancer, LCM [OPG study]","GSM537430","Public on Feb 28 2011","Apr 26 2010","Feb 28 2011","RNA","1","surgically resected material","Homo sapiens","metastasis: none","stage: 1","tissue: cancer, LCM","Tumor tissue was extracted using laser-capture microdissection.","total RNA","Total RNA was extracted from tissue specimens using RNeasy kit (Qiagen, Hilden, Germany). Integrity of obtained RNA was assessed using Agilent 2100 BioAnalyzer (Agilent Technologies, Palo Alto, CA). All samples had RNA Integrity Number (RIN) greater than 5.0. Contaminant DNA was removed by digestion with RNase-free DNase (Qiagen).","biotin","cRNA was prepared using two-cycle target labeling and control reagents kit (Affymetrix, Santa Clara, CA).","9606","Hybridization and signal detection of HG-U133 Plus 2.0 arrays (Affymetrix) was performed following the manufacturer's instruction using the Affymetrix Fluidics Station 450.","GeneChips were scanned using Affymetrix GeneChip Scanner 3000.","Gene expression profile of surgically resected material","C090","The data was normalized by robust multichip analysis (RMA) using R/Bioconductor (affy package).","GPL570","Kaoru,,Mogushi","mogushi@bioinfo.tmd.ac.jp","+81-3-5803-4758","Information Center for Medical Sciences","Tokyo Medical and Dental University","1-5-45 Yushima","Bunkyo-ku","Tokyo","113-8510","Japan","http://bioinfo.tmd.ac.jp/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM537nnn/GSM537430/GSM537430_chip_array_C90T.CEL.gz","54675","Reanalysis of: GSM452627"
"GSM537431","patient 096, cancer, LCM [OPG study]","GSM537431","Public on Feb 28 2011","Apr 26 2010","Feb 28 2011","RNA","1","surgically resected material","Homo sapiens","metastasis: metastatic recurrence","stage: 3b","tissue: cancer, LCM","Tumor tissue was extracted using laser-capture microdissection.","total RNA","Total RNA was extracted from tissue specimens using RNeasy kit (Qiagen, Hilden, Germany). Integrity of obtained RNA was assessed using Agilent 2100 BioAnalyzer (Agilent Technologies, Palo Alto, CA). All samples had RNA Integrity Number (RIN) greater than 5.0. Contaminant DNA was removed by digestion with RNase-free DNase (Qiagen).","biotin","cRNA was prepared using two-cycle target labeling and control reagents kit (Affymetrix, Santa Clara, CA).","9606","Hybridization and signal detection of HG-U133 Plus 2.0 arrays (Affymetrix) was performed following the manufacturer's instruction using the Affymetrix Fluidics Station 450.","GeneChips were scanned using Affymetrix GeneChip Scanner 3000.","Gene expression profile of surgically resected material","C096","The data was normalized by robust multichip analysis (RMA) using R/Bioconductor (affy package).","GPL570","Kaoru,,Mogushi","mogushi@bioinfo.tmd.ac.jp","+81-3-5803-4758","Information Center for Medical Sciences","Tokyo Medical and Dental University","1-5-45 Yushima","Bunkyo-ku","Tokyo","113-8510","Japan","http://bioinfo.tmd.ac.jp/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM537nnn/GSM537431/GSM537431_chip_array_C96T.CEL.gz","54675","Reanalysis of: GSM452628"
"GSM537432","patient 097, cancer, LCM [OPG study]","GSM537432","Public on Feb 28 2011","Apr 26 2010","Feb 28 2011","RNA","1","surgically resected material","Homo sapiens","metastasis: none","stage: 3a","tissue: cancer, LCM","Tumor tissue was extracted using laser-capture microdissection.","total RNA","Total RNA was extracted from tissue specimens using RNeasy kit (Qiagen, Hilden, Germany). Integrity of obtained RNA was assessed using Agilent 2100 BioAnalyzer (Agilent Technologies, Palo Alto, CA). All samples had RNA Integrity Number (RIN) greater than 5.0. Contaminant DNA was removed by digestion with RNase-free DNase (Qiagen).","biotin","cRNA was prepared using two-cycle target labeling and control reagents kit (Affymetrix, Santa Clara, CA).","9606","Hybridization and signal detection of HG-U133 Plus 2.0 arrays (Affymetrix) was performed following the manufacturer's instruction using the Affymetrix Fluidics Station 450.","GeneChips were scanned using Affymetrix GeneChip Scanner 3000.","Gene expression profile of surgically resected material","C097","The data was normalized by robust multichip analysis (RMA) using R/Bioconductor (affy package).","GPL570","Kaoru,,Mogushi","mogushi@bioinfo.tmd.ac.jp","+81-3-5803-4758","Information Center for Medical Sciences","Tokyo Medical and Dental University","1-5-45 Yushima","Bunkyo-ku","Tokyo","113-8510","Japan","http://bioinfo.tmd.ac.jp/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM537nnn/GSM537432/GSM537432_chip_array_C97T.CEL.gz","54675",""
"GSM537433","patient 098, cancer, LCM [OPG study]","GSM537433","Public on Feb 28 2011","Apr 26 2010","Feb 28 2011","RNA","1","surgically resected material","Homo sapiens","metastasis: metastatic recurrence","stage: 3c","tissue: cancer, LCM","Tumor tissue was extracted using laser-capture microdissection.","total RNA","Total RNA was extracted from tissue specimens using RNeasy kit (Qiagen, Hilden, Germany). Integrity of obtained RNA was assessed using Agilent 2100 BioAnalyzer (Agilent Technologies, Palo Alto, CA). All samples had RNA Integrity Number (RIN) greater than 5.0. Contaminant DNA was removed by digestion with RNase-free DNase (Qiagen).","biotin","cRNA was prepared using two-cycle target labeling and control reagents kit (Affymetrix, Santa Clara, CA).","9606","Hybridization and signal detection of HG-U133 Plus 2.0 arrays (Affymetrix) was performed following the manufacturer's instruction using the Affymetrix Fluidics Station 450.","GeneChips were scanned using Affymetrix GeneChip Scanner 3000.","Gene expression profile of surgically resected material","C098","The data was normalized by robust multichip analysis (RMA) using R/Bioconductor (affy package).","GPL570","Kaoru,,Mogushi","mogushi@bioinfo.tmd.ac.jp","+81-3-5803-4758","Information Center for Medical Sciences","Tokyo Medical and Dental University","1-5-45 Yushima","Bunkyo-ku","Tokyo","113-8510","Japan","http://bioinfo.tmd.ac.jp/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM537nnn/GSM537433/GSM537433_chip_array_CR98T.CEL.gz","54675",""
"GSM549099","patient 107, normal, homogenized [OPG study]","GSM549099","Public on Feb 28 2011","Jun 02 2010","Feb 28 2011","RNA","1","surgically resected material","Homo sapiens","metastasis: none","stage: 2a","tissue: normal, homogenized","Tumor tissue was extracted using laser-capture microdissection.","total RNA","Total RNA was extracted from tissue specimens using RNeasy kit (Qiagen, Hilden, Germany). Integrity of obtained RNA was assessed using Agilent 2100 BioAnalyzer (Agilent Technologies, Palo Alto, CA). All samples had RNA Integrity Number (RIN) greater than 5.0. Contaminant DNA was removed by digestion with RNase-free DNase (Qiagen).","biotin","cRNA was prepared using two-cycle target labeling and control reagents kit (Affymetrix, Santa Clara, CA).","9606","Hybridization and signal detection of HG-U133 Plus 2.0 arrays (Affymetrix) was performed following the manufacturer's instruction using the Affymetrix Fluidics Station 450.","GeneChips were scanned using Affymetrix GeneChip Scanner 3000.","Gene expression profile of surgically resected material","NH107","The data was normalized by robust multichip analysis (RMA) using R/Bioconductor.","GPL570","Kaoru,,Mogushi","mogushi@bioinfo.tmd.ac.jp","+81-3-5803-4758","Information Center for Medical Sciences","Tokyo Medical and Dental University","1-5-45 Yushima","Bunkyo-ku","Tokyo","113-8510","Japan","http://bioinfo.tmd.ac.jp/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM549nnn/GSM549099/GSM549099_chip_array_C107N-H.CEL.gz","54675",""
"GSM549100","patient 110, normal, homogenized [OPG study]","GSM549100","Public on Feb 28 2011","Jun 02 2010","Feb 28 2011","RNA","1","surgically resected material","Homo sapiens","metastasis: none","stage: 3b","tissue: normal, homogenized","Tumor tissue was extracted using laser-capture microdissection.","total RNA","Total RNA was extracted from tissue specimens using RNeasy kit (Qiagen, Hilden, Germany). Integrity of obtained RNA was assessed using Agilent 2100 BioAnalyzer (Agilent Technologies, Palo Alto, CA). All samples had RNA Integrity Number (RIN) greater than 5.0. Contaminant DNA was removed by digestion with RNase-free DNase (Qiagen).","biotin","cRNA was prepared using two-cycle target labeling and control reagents kit (Affymetrix, Santa Clara, CA).","9606","Hybridization and signal detection of HG-U133 Plus 2.0 arrays (Affymetrix) was performed following the manufacturer's instruction using the Affymetrix Fluidics Station 450.","GeneChips were scanned using Affymetrix GeneChip Scanner 3000.","Gene expression profile of surgically resected material","NH110","The data was normalized by robust multichip analysis (RMA) using R/Bioconductor.","GPL570","Kaoru,,Mogushi","mogushi@bioinfo.tmd.ac.jp","+81-3-5803-4758","Information Center for Medical Sciences","Tokyo Medical and Dental University","1-5-45 Yushima","Bunkyo-ku","Tokyo","113-8510","Japan","http://bioinfo.tmd.ac.jp/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM549nnn/GSM549100/GSM549100_chip_array_C110N-H.CEL.gz","54675",""
"GSM549101","patient 111, normal, homogenized [OPG study]","GSM549101","Public on Feb 28 2011","Jun 02 2010","Feb 28 2011","RNA","1","surgically resected material","Homo sapiens","metastasis: metastasis","stage: 4","tissue: normal, homogenized","Tumor tissue was extracted using laser-capture microdissection.","total RNA","Total RNA was extracted from tissue specimens using RNeasy kit (Qiagen, Hilden, Germany). Integrity of obtained RNA was assessed using Agilent 2100 BioAnalyzer (Agilent Technologies, Palo Alto, CA). All samples had RNA Integrity Number (RIN) greater than 5.0. Contaminant DNA was removed by digestion with RNase-free DNase (Qiagen).","biotin","cRNA was prepared using two-cycle target labeling and control reagents kit (Affymetrix, Santa Clara, CA).","9606","Hybridization and signal detection of HG-U133 Plus 2.0 arrays (Affymetrix) was performed following the manufacturer's instruction using the Affymetrix Fluidics Station 450.","GeneChips were scanned using Affymetrix GeneChip Scanner 3000.","Gene expression profile of surgically resected material","NH111","The data was normalized by robust multichip analysis (RMA) using R/Bioconductor.","GPL570","Kaoru,,Mogushi","mogushi@bioinfo.tmd.ac.jp","+81-3-5803-4758","Information Center for Medical Sciences","Tokyo Medical and Dental University","1-5-45 Yushima","Bunkyo-ku","Tokyo","113-8510","Japan","http://bioinfo.tmd.ac.jp/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM549nnn/GSM549101/GSM549101_chip_array_C111N-H.CEL.gz","54675",""
"GSM549102","patient 115, normal, homogenized [OPG study]","GSM549102","Public on Feb 28 2011","Jun 02 2010","Feb 28 2011","RNA","1","surgically resected material","Homo sapiens","metastasis: none","stage: 1","tissue: normal, homogenized","Tumor tissue was extracted using laser-capture microdissection.","total RNA","Total RNA was extracted from tissue specimens using RNeasy kit (Qiagen, Hilden, Germany). Integrity of obtained RNA was assessed using Agilent 2100 BioAnalyzer (Agilent Technologies, Palo Alto, CA). All samples had RNA Integrity Number (RIN) greater than 5.0. Contaminant DNA was removed by digestion with RNase-free DNase (Qiagen).","biotin","cRNA was prepared using two-cycle target labeling and control reagents kit (Affymetrix, Santa Clara, CA).","9606","Hybridization and signal detection of HG-U133 Plus 2.0 arrays (Affymetrix) was performed following the manufacturer's instruction using the Affymetrix Fluidics Station 450.","GeneChips were scanned using Affymetrix GeneChip Scanner 3000.","Gene expression profile of surgically resected material","NH115","The data was normalized by robust multichip analysis (RMA) using R/Bioconductor.","GPL570","Kaoru,,Mogushi","mogushi@bioinfo.tmd.ac.jp","+81-3-5803-4758","Information Center for Medical Sciences","Tokyo Medical and Dental University","1-5-45 Yushima","Bunkyo-ku","Tokyo","113-8510","Japan","http://bioinfo.tmd.ac.jp/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM549nnn/GSM549102/GSM549102_chip_array_C115N-H.CEL.gz","54675",""
"GSM549103","patient 117, normal, homogenized [OPG study]","GSM549103","Public on Feb 28 2011","Jun 02 2010","Feb 28 2011","RNA","1","surgically resected material","Homo sapiens","metastasis: metastatic recurrence","stage: 3b","tissue: normal, homogenized","Tumor tissue was extracted using laser-capture microdissection.","total RNA","Total RNA was extracted from tissue specimens using RNeasy kit (Qiagen, Hilden, Germany). Integrity of obtained RNA was assessed using Agilent 2100 BioAnalyzer (Agilent Technologies, Palo Alto, CA). All samples had RNA Integrity Number (RIN) greater than 5.0. Contaminant DNA was removed by digestion with RNase-free DNase (Qiagen).","biotin","cRNA was prepared using two-cycle target labeling and control reagents kit (Affymetrix, Santa Clara, CA).","9606","Hybridization and signal detection of HG-U133 Plus 2.0 arrays (Affymetrix) was performed following the manufacturer's instruction using the Affymetrix Fluidics Station 450.","GeneChips were scanned using Affymetrix GeneChip Scanner 3000.","Gene expression profile of surgically resected material","NH117","The data was normalized by robust multichip analysis (RMA) using R/Bioconductor.","GPL570","Kaoru,,Mogushi","mogushi@bioinfo.tmd.ac.jp","+81-3-5803-4758","Information Center for Medical Sciences","Tokyo Medical and Dental University","1-5-45 Yushima","Bunkyo-ku","Tokyo","113-8510","Japan","http://bioinfo.tmd.ac.jp/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM549nnn/GSM549103/GSM549103_chip_array_C117N-H.CEL.gz","54675",""
"GSM549104","patient 119, normal, homogenized [OPG study]","GSM549104","Public on Feb 28 2011","Jun 02 2010","Feb 28 2011","RNA","1","surgically resected material","Homo sapiens","metastasis: none","stage: 1","tissue: normal, homogenized","Tumor tissue was extracted using laser-capture microdissection.","total RNA","Total RNA was extracted from tissue specimens using RNeasy kit (Qiagen, Hilden, Germany). Integrity of obtained RNA was assessed using Agilent 2100 BioAnalyzer (Agilent Technologies, Palo Alto, CA). All samples had RNA Integrity Number (RIN) greater than 5.0. Contaminant DNA was removed by digestion with RNase-free DNase (Qiagen).","biotin","cRNA was prepared using two-cycle target labeling and control reagents kit (Affymetrix, Santa Clara, CA).","9606","Hybridization and signal detection of HG-U133 Plus 2.0 arrays (Affymetrix) was performed following the manufacturer's instruction using the Affymetrix Fluidics Station 450.","GeneChips were scanned using Affymetrix GeneChip Scanner 3000.","Gene expression profile of surgically resected material","NH119","The data was normalized by robust multichip analysis (RMA) using R/Bioconductor.","GPL570","Kaoru,,Mogushi","mogushi@bioinfo.tmd.ac.jp","+81-3-5803-4758","Information Center for Medical Sciences","Tokyo Medical and Dental University","1-5-45 Yushima","Bunkyo-ku","Tokyo","113-8510","Japan","http://bioinfo.tmd.ac.jp/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM549nnn/GSM549104/GSM549104_chip_array_C119N-H.CEL.gz","54675",""
"GSM549105","patient 128, normal, homogenized [OPG study]","GSM549105","Public on Feb 28 2011","Jun 02 2010","Feb 28 2011","RNA","1","surgically resected material","Homo sapiens","metastasis: metastasis","stage: 4","tissue: normal, homogenized","Tumor tissue was extracted using laser-capture microdissection.","total RNA","Total RNA was extracted from tissue specimens using RNeasy kit (Qiagen, Hilden, Germany). Integrity of obtained RNA was assessed using Agilent 2100 BioAnalyzer (Agilent Technologies, Palo Alto, CA). All samples had RNA Integrity Number (RIN) greater than 5.0. Contaminant DNA was removed by digestion with RNase-free DNase (Qiagen).","biotin","cRNA was prepared using two-cycle target labeling and control reagents kit (Affymetrix, Santa Clara, CA).","9606","Hybridization and signal detection of HG-U133 Plus 2.0 arrays (Affymetrix) was performed following the manufacturer's instruction using the Affymetrix Fluidics Station 450.","GeneChips were scanned using Affymetrix GeneChip Scanner 3000.","Gene expression profile of surgically resected material","NH128","The data was normalized by robust multichip analysis (RMA) using R/Bioconductor.","GPL570","Kaoru,,Mogushi","mogushi@bioinfo.tmd.ac.jp","+81-3-5803-4758","Information Center for Medical Sciences","Tokyo Medical and Dental University","1-5-45 Yushima","Bunkyo-ku","Tokyo","113-8510","Japan","http://bioinfo.tmd.ac.jp/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM549nnn/GSM549105/GSM549105_chip_array_C128N-H.CEL.gz","54675",""
"GSM549106","patient 134, normal, homogenized [OPG study]","GSM549106","Public on Feb 28 2011","Jun 02 2010","Feb 28 2011","RNA","1","surgically resected material","Homo sapiens","metastasis: metastasis","stage: 4","tissue: normal, homogenized","Tumor tissue was extracted using laser-capture microdissection.","total RNA","Total RNA was extracted from tissue specimens using RNeasy kit (Qiagen, Hilden, Germany). Integrity of obtained RNA was assessed using Agilent 2100 BioAnalyzer (Agilent Technologies, Palo Alto, CA). All samples had RNA Integrity Number (RIN) greater than 5.0. Contaminant DNA was removed by digestion with RNase-free DNase (Qiagen).","biotin","cRNA was prepared using two-cycle target labeling and control reagents kit (Affymetrix, Santa Clara, CA).","9606","Hybridization and signal detection of HG-U133 Plus 2.0 arrays (Affymetrix) was performed following the manufacturer's instruction using the Affymetrix Fluidics Station 450.","GeneChips were scanned using Affymetrix GeneChip Scanner 3000.","Gene expression profile of surgically resected material","NH134","The data was normalized by robust multichip analysis (RMA) using R/Bioconductor.","GPL570","Kaoru,,Mogushi","mogushi@bioinfo.tmd.ac.jp","+81-3-5803-4758","Information Center for Medical Sciences","Tokyo Medical and Dental University","1-5-45 Yushima","Bunkyo-ku","Tokyo","113-8510","Japan","http://bioinfo.tmd.ac.jp/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM549nnn/GSM549106/GSM549106_chip_array_C134N-H.CEL.gz","54675",""
"GSM549107","patient 135, normal, homogenized [OPG study]","GSM549107","Public on Feb 28 2011","Jun 02 2010","Feb 28 2011","RNA","1","surgically resected material","Homo sapiens","metastasis: none","stage: 3b","tissue: normal, homogenized","Tumor tissue was extracted using laser-capture microdissection.","total RNA","Total RNA was extracted from tissue specimens using RNeasy kit (Qiagen, Hilden, Germany). Integrity of obtained RNA was assessed using Agilent 2100 BioAnalyzer (Agilent Technologies, Palo Alto, CA). All samples had RNA Integrity Number (RIN) greater than 5.0. Contaminant DNA was removed by digestion with RNase-free DNase (Qiagen).","biotin","cRNA was prepared using two-cycle target labeling and control reagents kit (Affymetrix, Santa Clara, CA).","9606","Hybridization and signal detection of HG-U133 Plus 2.0 arrays (Affymetrix) was performed following the manufacturer's instruction using the Affymetrix Fluidics Station 450.","GeneChips were scanned using Affymetrix GeneChip Scanner 3000.","Gene expression profile of surgically resected material","NH135","The data was normalized by robust multichip analysis (RMA) using R/Bioconductor.","GPL570","Kaoru,,Mogushi","mogushi@bioinfo.tmd.ac.jp","+81-3-5803-4758","Information Center for Medical Sciences","Tokyo Medical and Dental University","1-5-45 Yushima","Bunkyo-ku","Tokyo","113-8510","Japan","http://bioinfo.tmd.ac.jp/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM549nnn/GSM549107/GSM549107_chip_array_C135N-H.CEL.gz","54675",""
"GSM549108","patient 138, normal, homogenized [OPG study]","GSM549108","Public on Feb 28 2011","Jun 02 2010","Feb 28 2011","RNA","1","surgically resected material","Homo sapiens","metastasis: none","stage: 1","tissue: normal, homogenized","Tumor tissue was extracted using laser-capture microdissection.","total RNA","Total RNA was extracted from tissue specimens using RNeasy kit (Qiagen, Hilden, Germany). Integrity of obtained RNA was assessed using Agilent 2100 BioAnalyzer (Agilent Technologies, Palo Alto, CA). All samples had RNA Integrity Number (RIN) greater than 5.0. Contaminant DNA was removed by digestion with RNase-free DNase (Qiagen).","biotin","cRNA was prepared using two-cycle target labeling and control reagents kit (Affymetrix, Santa Clara, CA).","9606","Hybridization and signal detection of HG-U133 Plus 2.0 arrays (Affymetrix) was performed following the manufacturer's instruction using the Affymetrix Fluidics Station 450.","GeneChips were scanned using Affymetrix GeneChip Scanner 3000.","Gene expression profile of surgically resected material","NH138","The data was normalized by robust multichip analysis (RMA) using R/Bioconductor.","GPL570","Kaoru,,Mogushi","mogushi@bioinfo.tmd.ac.jp","+81-3-5803-4758","Information Center for Medical Sciences","Tokyo Medical and Dental University","1-5-45 Yushima","Bunkyo-ku","Tokyo","113-8510","Japan","http://bioinfo.tmd.ac.jp/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM549nnn/GSM549108/GSM549108_chip_array_C138N-H.CEL.gz","54675",""
"GSM549109","patient 139, normal, homogenized [OPG study]","GSM549109","Public on Feb 28 2011","Jun 02 2010","Feb 28 2011","RNA","1","surgically resected material","Homo sapiens","metastasis: none","stage: 2a","tissue: normal, homogenized","Tumor tissue was extracted using laser-capture microdissection.","total RNA","Total RNA was extracted from tissue specimens using RNeasy kit (Qiagen, Hilden, Germany). Integrity of obtained RNA was assessed using Agilent 2100 BioAnalyzer (Agilent Technologies, Palo Alto, CA). All samples had RNA Integrity Number (RIN) greater than 5.0. Contaminant DNA was removed by digestion with RNase-free DNase (Qiagen).","biotin","cRNA was prepared using two-cycle target labeling and control reagents kit (Affymetrix, Santa Clara, CA).","9606","Hybridization and signal detection of HG-U133 Plus 2.0 arrays (Affymetrix) was performed following the manufacturer's instruction using the Affymetrix Fluidics Station 450.","GeneChips were scanned using Affymetrix GeneChip Scanner 3000.","Gene expression profile of surgically resected material","NH139","The data was normalized by robust multichip analysis (RMA) using R/Bioconductor.","GPL570","Kaoru,,Mogushi","mogushi@bioinfo.tmd.ac.jp","+81-3-5803-4758","Information Center for Medical Sciences","Tokyo Medical and Dental University","1-5-45 Yushima","Bunkyo-ku","Tokyo","113-8510","Japan","http://bioinfo.tmd.ac.jp/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM549nnn/GSM549109/GSM549109_chip_array_C139N-H.CEL.gz","54675",""
"GSM549110","patient 046, normal, homogenized [OPG study]","GSM549110","Public on Feb 28 2011","Jun 02 2010","Feb 28 2011","RNA","1","surgically resected material","Homo sapiens","metastasis: none","stage: 2a","tissue: normal, homogenized","Tumor tissue was extracted using laser-capture microdissection.","total RNA","Total RNA was extracted from tissue specimens using RNeasy kit (Qiagen, Hilden, Germany). Integrity of obtained RNA was assessed using Agilent 2100 BioAnalyzer (Agilent Technologies, Palo Alto, CA). All samples had RNA Integrity Number (RIN) greater than 5.0. Contaminant DNA was removed by digestion with RNase-free DNase (Qiagen).","biotin","cRNA was prepared using two-cycle target labeling and control reagents kit (Affymetrix, Santa Clara, CA).","9606","Hybridization and signal detection of HG-U133 Plus 2.0 arrays (Affymetrix) was performed following the manufacturer's instruction using the Affymetrix Fluidics Station 450.","GeneChips were scanned using Affymetrix GeneChip Scanner 3000.","Gene expression profile of surgically resected material","NH046","The data was normalized by robust multichip analysis (RMA) using R/Bioconductor.","GPL570","Kaoru,,Mogushi","mogushi@bioinfo.tmd.ac.jp","+81-3-5803-4758","Information Center for Medical Sciences","Tokyo Medical and Dental University","1-5-45 Yushima","Bunkyo-ku","Tokyo","113-8510","Japan","http://bioinfo.tmd.ac.jp/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM549nnn/GSM549110/GSM549110_chip_array_C46N-H.CEL.gz","54675",""
"GSM549111","patient 047, normal, homogenized [OPG study]","GSM549111","Public on Feb 28 2011","Jun 02 2010","Feb 28 2011","RNA","1","surgically resected material","Homo sapiens","metastasis: none","stage: 2b","tissue: normal, homogenized","Tumor tissue was extracted using laser-capture microdissection.","total RNA","Total RNA was extracted from tissue specimens using RNeasy kit (Qiagen, Hilden, Germany). Integrity of obtained RNA was assessed using Agilent 2100 BioAnalyzer (Agilent Technologies, Palo Alto, CA). All samples had RNA Integrity Number (RIN) greater than 5.0. Contaminant DNA was removed by digestion with RNase-free DNase (Qiagen).","biotin","cRNA was prepared using two-cycle target labeling and control reagents kit (Affymetrix, Santa Clara, CA).","9606","Hybridization and signal detection of HG-U133 Plus 2.0 arrays (Affymetrix) was performed following the manufacturer's instruction using the Affymetrix Fluidics Station 450.","GeneChips were scanned using Affymetrix GeneChip Scanner 3000.","Gene expression profile of surgically resected material","NH047","The data was normalized by robust multichip analysis (RMA) using R/Bioconductor.","GPL570","Kaoru,,Mogushi","mogushi@bioinfo.tmd.ac.jp","+81-3-5803-4758","Information Center for Medical Sciences","Tokyo Medical and Dental University","1-5-45 Yushima","Bunkyo-ku","Tokyo","113-8510","Japan","http://bioinfo.tmd.ac.jp/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM549nnn/GSM549111/GSM549111_chip_array_C47N-H.CEL.gz","54675",""
"GSM549112","patient 048, normal, homogenized [OPG study]","GSM549112","Public on Feb 28 2011","Jun 02 2010","Feb 28 2011","RNA","1","surgically resected material","Homo sapiens","metastasis: metastasis","stage: 4","tissue: normal, homogenized","Tumor tissue was extracted using laser-capture microdissection.","total RNA","Total RNA was extracted from tissue specimens using RNeasy kit (Qiagen, Hilden, Germany). Integrity of obtained RNA was assessed using Agilent 2100 BioAnalyzer (Agilent Technologies, Palo Alto, CA). All samples had RNA Integrity Number (RIN) greater than 5.0. Contaminant DNA was removed by digestion with RNase-free DNase (Qiagen).","biotin","cRNA was prepared using two-cycle target labeling and control reagents kit (Affymetrix, Santa Clara, CA).","9606","Hybridization and signal detection of HG-U133 Plus 2.0 arrays (Affymetrix) was performed following the manufacturer's instruction using the Affymetrix Fluidics Station 450.","GeneChips were scanned using Affymetrix GeneChip Scanner 3000.","Gene expression profile of surgically resected material","NH048","The data was normalized by robust multichip analysis (RMA) using R/Bioconductor.","GPL570","Kaoru,,Mogushi","mogushi@bioinfo.tmd.ac.jp","+81-3-5803-4758","Information Center for Medical Sciences","Tokyo Medical and Dental University","1-5-45 Yushima","Bunkyo-ku","Tokyo","113-8510","Japan","http://bioinfo.tmd.ac.jp/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM549nnn/GSM549112/GSM549112_chip_array_C48N-H.CEL.gz","54675",""
"GSM549113","patient 057, normal, homogenized [OPG study]","GSM549113","Public on Feb 28 2011","Jun 02 2010","Feb 28 2011","RNA","1","surgically resected material","Homo sapiens","metastasis: none","stage: 2b","tissue: normal, homogenized","Tumor tissue was extracted using laser-capture microdissection.","total RNA","Total RNA was extracted from tissue specimens using RNeasy kit (Qiagen, Hilden, Germany). Integrity of obtained RNA was assessed using Agilent 2100 BioAnalyzer (Agilent Technologies, Palo Alto, CA). All samples had RNA Integrity Number (RIN) greater than 5.0. Contaminant DNA was removed by digestion with RNase-free DNase (Qiagen).","biotin","cRNA was prepared using two-cycle target labeling and control reagents kit (Affymetrix, Santa Clara, CA).","9606","Hybridization and signal detection of HG-U133 Plus 2.0 arrays (Affymetrix) was performed following the manufacturer's instruction using the Affymetrix Fluidics Station 450.","GeneChips were scanned using Affymetrix GeneChip Scanner 3000.","Gene expression profile of surgically resected material","NH057","The data was normalized by robust multichip analysis (RMA) using R/Bioconductor.","GPL570","Kaoru,,Mogushi","mogushi@bioinfo.tmd.ac.jp","+81-3-5803-4758","Information Center for Medical Sciences","Tokyo Medical and Dental University","1-5-45 Yushima","Bunkyo-ku","Tokyo","113-8510","Japan","http://bioinfo.tmd.ac.jp/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM549nnn/GSM549113/GSM549113_chip_array_C57N-H.CEL.gz","54675",""
"GSM549114","patient 063, normal, homogenized [OPG study]","GSM549114","Public on Feb 28 2011","Jun 02 2010","Feb 28 2011","RNA","1","surgically resected material","Homo sapiens","metastasis: none","stage: 2a","tissue: normal, homogenized","Tumor tissue was extracted using laser-capture microdissection.","total RNA","Total RNA was extracted from tissue specimens using RNeasy kit (Qiagen, Hilden, Germany). Integrity of obtained RNA was assessed using Agilent 2100 BioAnalyzer (Agilent Technologies, Palo Alto, CA). All samples had RNA Integrity Number (RIN) greater than 5.0. Contaminant DNA was removed by digestion with RNase-free DNase (Qiagen).","biotin","cRNA was prepared using two-cycle target labeling and control reagents kit (Affymetrix, Santa Clara, CA).","9606","Hybridization and signal detection of HG-U133 Plus 2.0 arrays (Affymetrix) was performed following the manufacturer's instruction using the Affymetrix Fluidics Station 450.","GeneChips were scanned using Affymetrix GeneChip Scanner 3000.","Gene expression profile of surgically resected material","NH063","The data was normalized by robust multichip analysis (RMA) using R/Bioconductor.","GPL570","Kaoru,,Mogushi","mogushi@bioinfo.tmd.ac.jp","+81-3-5803-4758","Information Center for Medical Sciences","Tokyo Medical and Dental University","1-5-45 Yushima","Bunkyo-ku","Tokyo","113-8510","Japan","http://bioinfo.tmd.ac.jp/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM549nnn/GSM549114/GSM549114_chip_array_C63N-H.CEL.gz","54675",""
"GSM549115","patient 068, normal, homogenized [OPG study]","GSM549115","Public on Feb 28 2011","Jun 02 2010","Feb 28 2011","RNA","1","surgically resected material","Homo sapiens","metastasis: none","stage: 3b","tissue: normal, homogenized","Tumor tissue was extracted using laser-capture microdissection.","total RNA","Total RNA was extracted from tissue specimens using RNeasy kit (Qiagen, Hilden, Germany). Integrity of obtained RNA was assessed using Agilent 2100 BioAnalyzer (Agilent Technologies, Palo Alto, CA). All samples had RNA Integrity Number (RIN) greater than 5.0. Contaminant DNA was removed by digestion with RNase-free DNase (Qiagen).","biotin","cRNA was prepared using two-cycle target labeling and control reagents kit (Affymetrix, Santa Clara, CA).","9606","Hybridization and signal detection of HG-U133 Plus 2.0 arrays (Affymetrix) was performed following the manufacturer's instruction using the Affymetrix Fluidics Station 450.","GeneChips were scanned using Affymetrix GeneChip Scanner 3000.","Gene expression profile of surgically resected material","NH068","The data was normalized by robust multichip analysis (RMA) using R/Bioconductor.","GPL570","Kaoru,,Mogushi","mogushi@bioinfo.tmd.ac.jp","+81-3-5803-4758","Information Center for Medical Sciences","Tokyo Medical and Dental University","1-5-45 Yushima","Bunkyo-ku","Tokyo","113-8510","Japan","http://bioinfo.tmd.ac.jp/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM549nnn/GSM549115/GSM549115_chip_array_C68N-H.CEL.gz","54675",""
"GSM549116","patient 072, normal, homogenized [OPG study]","GSM549116","Public on Feb 28 2011","Jun 02 2010","Feb 28 2011","RNA","1","surgically resected material","Homo sapiens","metastasis: none","stage: 3b","tissue: normal, homogenized","Tumor tissue was extracted using laser-capture microdissection.","total RNA","Total RNA was extracted from tissue specimens using RNeasy kit (Qiagen, Hilden, Germany). Integrity of obtained RNA was assessed using Agilent 2100 BioAnalyzer (Agilent Technologies, Palo Alto, CA). All samples had RNA Integrity Number (RIN) greater than 5.0. Contaminant DNA was removed by digestion with RNase-free DNase (Qiagen).","biotin","cRNA was prepared using two-cycle target labeling and control reagents kit (Affymetrix, Santa Clara, CA).","9606","Hybridization and signal detection of HG-U133 Plus 2.0 arrays (Affymetrix) was performed following the manufacturer's instruction using the Affymetrix Fluidics Station 450.","GeneChips were scanned using Affymetrix GeneChip Scanner 3000.","Gene expression profile of surgically resected material","NH072","The data was normalized by robust multichip analysis (RMA) using R/Bioconductor.","GPL570","Kaoru,,Mogushi","mogushi@bioinfo.tmd.ac.jp","+81-3-5803-4758","Information Center for Medical Sciences","Tokyo Medical and Dental University","1-5-45 Yushima","Bunkyo-ku","Tokyo","113-8510","Japan","http://bioinfo.tmd.ac.jp/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM549nnn/GSM549116/GSM549116_chip_array_C72N-H.CEL.gz","54675",""
"GSM549117","patient 073, normal, homogenized [OPG study]","GSM549117","Public on Feb 28 2011","Jun 02 2010","Feb 28 2011","RNA","1","surgically resected material","Homo sapiens","metastasis: metastatic recurrence","stage: 3b","tissue: normal, homogenized","Tumor tissue was extracted using laser-capture microdissection.","total RNA","Total RNA was extracted from tissue specimens using RNeasy kit (Qiagen, Hilden, Germany). Integrity of obtained RNA was assessed using Agilent 2100 BioAnalyzer (Agilent Technologies, Palo Alto, CA). All samples had RNA Integrity Number (RIN) greater than 5.0. Contaminant DNA was removed by digestion with RNase-free DNase (Qiagen).","biotin","cRNA was prepared using two-cycle target labeling and control reagents kit (Affymetrix, Santa Clara, CA).","9606","Hybridization and signal detection of HG-U133 Plus 2.0 arrays (Affymetrix) was performed following the manufacturer's instruction using the Affymetrix Fluidics Station 450.","GeneChips were scanned using Affymetrix GeneChip Scanner 3000.","Gene expression profile of surgically resected material","NH073","The data was normalized by robust multichip analysis (RMA) using R/Bioconductor.","GPL570","Kaoru,,Mogushi","mogushi@bioinfo.tmd.ac.jp","+81-3-5803-4758","Information Center for Medical Sciences","Tokyo Medical and Dental University","1-5-45 Yushima","Bunkyo-ku","Tokyo","113-8510","Japan","http://bioinfo.tmd.ac.jp/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM549nnn/GSM549117/GSM549117_chip_array_C73N-H.CEL.gz","54675",""
"GSM549118","patient 074, normal, homogenized [OPG study]","GSM549118","Public on Feb 28 2011","Jun 02 2010","Feb 28 2011","RNA","1","surgically resected material","Homo sapiens","metastasis: none","stage: 3c","tissue: normal, homogenized","Tumor tissue was extracted using laser-capture microdissection.","total RNA","Total RNA was extracted from tissue specimens using RNeasy kit (Qiagen, Hilden, Germany). Integrity of obtained RNA was assessed using Agilent 2100 BioAnalyzer (Agilent Technologies, Palo Alto, CA). All samples had RNA Integrity Number (RIN) greater than 5.0. Contaminant DNA was removed by digestion with RNase-free DNase (Qiagen).","biotin","cRNA was prepared using two-cycle target labeling and control reagents kit (Affymetrix, Santa Clara, CA).","9606","Hybridization and signal detection of HG-U133 Plus 2.0 arrays (Affymetrix) was performed following the manufacturer's instruction using the Affymetrix Fluidics Station 450.","GeneChips were scanned using Affymetrix GeneChip Scanner 3000.","Gene expression profile of surgically resected material","NH074","The data was normalized by robust multichip analysis (RMA) using R/Bioconductor.","GPL570","Kaoru,,Mogushi","mogushi@bioinfo.tmd.ac.jp","+81-3-5803-4758","Information Center for Medical Sciences","Tokyo Medical and Dental University","1-5-45 Yushima","Bunkyo-ku","Tokyo","113-8510","Japan","http://bioinfo.tmd.ac.jp/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM549nnn/GSM549118/GSM549118_chip_array_C74N-H.CEL.gz","54675",""
"GSM549119","patient 077, normal, homogenized [OPG study]","GSM549119","Public on Feb 28 2011","Jun 02 2010","Feb 28 2011","RNA","1","surgically resected material","Homo sapiens","metastasis: none","stage: 1","tissue: normal, homogenized","Tumor tissue was extracted using laser-capture microdissection.","total RNA","Total RNA was extracted from tissue specimens using RNeasy kit (Qiagen, Hilden, Germany). Integrity of obtained RNA was assessed using Agilent 2100 BioAnalyzer (Agilent Technologies, Palo Alto, CA). All samples had RNA Integrity Number (RIN) greater than 5.0. Contaminant DNA was removed by digestion with RNase-free DNase (Qiagen).","biotin","cRNA was prepared using two-cycle target labeling and control reagents kit (Affymetrix, Santa Clara, CA).","9606","Hybridization and signal detection of HG-U133 Plus 2.0 arrays (Affymetrix) was performed following the manufacturer's instruction using the Affymetrix Fluidics Station 450.","GeneChips were scanned using Affymetrix GeneChip Scanner 3000.","Gene expression profile of surgically resected material","NH077","The data was normalized by robust multichip analysis (RMA) using R/Bioconductor.","GPL570","Kaoru,,Mogushi","mogushi@bioinfo.tmd.ac.jp","+81-3-5803-4758","Information Center for Medical Sciences","Tokyo Medical and Dental University","1-5-45 Yushima","Bunkyo-ku","Tokyo","113-8510","Japan","http://bioinfo.tmd.ac.jp/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM549nnn/GSM549119/GSM549119_chip_array_C77N-H.CEL.gz","54675",""
"GSM549120","patient 078, normal, homogenized [OPG study]","GSM549120","Public on Feb 28 2011","Jun 02 2010","Feb 28 2011","RNA","1","surgically resected material","Homo sapiens","metastasis: none","stage: 3b","tissue: normal, homogenized","Tumor tissue was extracted using laser-capture microdissection.","total RNA","Total RNA was extracted from tissue specimens using RNeasy kit (Qiagen, Hilden, Germany). Integrity of obtained RNA was assessed using Agilent 2100 BioAnalyzer (Agilent Technologies, Palo Alto, CA). All samples had RNA Integrity Number (RIN) greater than 5.0. Contaminant DNA was removed by digestion with RNase-free DNase (Qiagen).","biotin","cRNA was prepared using two-cycle target labeling and control reagents kit (Affymetrix, Santa Clara, CA).","9606","Hybridization and signal detection of HG-U133 Plus 2.0 arrays (Affymetrix) was performed following the manufacturer's instruction using the Affymetrix Fluidics Station 450.","GeneChips were scanned using Affymetrix GeneChip Scanner 3000.","Gene expression profile of surgically resected material","NH078","The data was normalized by robust multichip analysis (RMA) using R/Bioconductor.","GPL570","Kaoru,,Mogushi","mogushi@bioinfo.tmd.ac.jp","+81-3-5803-4758","Information Center for Medical Sciences","Tokyo Medical and Dental University","1-5-45 Yushima","Bunkyo-ku","Tokyo","113-8510","Japan","http://bioinfo.tmd.ac.jp/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM549nnn/GSM549120/GSM549120_chip_array_C78N-H.CEL.gz","54675",""
"GSM549121","patient 080, normal, homogenized [OPG study]","GSM549121","Public on Feb 28 2011","Jun 02 2010","Feb 28 2011","RNA","1","surgically resected material","Homo sapiens","metastasis: none","stage: 0","tissue: normal, homogenized","Tumor tissue was extracted using laser-capture microdissection.","total RNA","Total RNA was extracted from tissue specimens using RNeasy kit (Qiagen, Hilden, Germany). Integrity of obtained RNA was assessed using Agilent 2100 BioAnalyzer (Agilent Technologies, Palo Alto, CA). All samples had RNA Integrity Number (RIN) greater than 5.0. Contaminant DNA was removed by digestion with RNase-free DNase (Qiagen).","biotin","cRNA was prepared using two-cycle target labeling and control reagents kit (Affymetrix, Santa Clara, CA).","9606","Hybridization and signal detection of HG-U133 Plus 2.0 arrays (Affymetrix) was performed following the manufacturer's instruction using the Affymetrix Fluidics Station 450.","GeneChips were scanned using Affymetrix GeneChip Scanner 3000.","Gene expression profile of surgically resected material","NH080","The data was normalized by robust multichip analysis (RMA) using R/Bioconductor.","GPL570","Kaoru,,Mogushi","mogushi@bioinfo.tmd.ac.jp","+81-3-5803-4758","Information Center for Medical Sciences","Tokyo Medical and Dental University","1-5-45 Yushima","Bunkyo-ku","Tokyo","113-8510","Japan","http://bioinfo.tmd.ac.jp/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM549nnn/GSM549121/GSM549121_chip_array_C80N-H.CEL.gz","54675",""
"GSM549122","patient 082, normal, homogenized [OPG study]","GSM549122","Public on Feb 28 2011","Jun 02 2010","Feb 28 2011","RNA","1","surgically resected material","Homo sapiens","metastasis: none","stage: 2a","tissue: normal, homogenized","Tumor tissue was extracted using laser-capture microdissection.","total RNA","Total RNA was extracted from tissue specimens using RNeasy kit (Qiagen, Hilden, Germany). Integrity of obtained RNA was assessed using Agilent 2100 BioAnalyzer (Agilent Technologies, Palo Alto, CA). All samples had RNA Integrity Number (RIN) greater than 5.0. Contaminant DNA was removed by digestion with RNase-free DNase (Qiagen).","biotin","cRNA was prepared using two-cycle target labeling and control reagents kit (Affymetrix, Santa Clara, CA).","9606","Hybridization and signal detection of HG-U133 Plus 2.0 arrays (Affymetrix) was performed following the manufacturer's instruction using the Affymetrix Fluidics Station 450.","GeneChips were scanned using Affymetrix GeneChip Scanner 3000.","Gene expression profile of surgically resected material","NH082","The data was normalized by robust multichip analysis (RMA) using R/Bioconductor.","GPL570","Kaoru,,Mogushi","mogushi@bioinfo.tmd.ac.jp","+81-3-5803-4758","Information Center for Medical Sciences","Tokyo Medical and Dental University","1-5-45 Yushima","Bunkyo-ku","Tokyo","113-8510","Japan","http://bioinfo.tmd.ac.jp/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM549nnn/GSM549122/GSM549122_chip_array_C82N-H.CEL.gz","54675",""
"GSM549123","patient 088, normal, homogenized [OPG study]","GSM549123","Public on Feb 28 2011","Jun 02 2010","Feb 28 2011","RNA","1","surgically resected material","Homo sapiens","metastasis: metastatic recurrence","stage: 2a","tissue: normal, homogenized","Tumor tissue was extracted using laser-capture microdissection.","total RNA","Total RNA was extracted from tissue specimens using RNeasy kit (Qiagen, Hilden, Germany). Integrity of obtained RNA was assessed using Agilent 2100 BioAnalyzer (Agilent Technologies, Palo Alto, CA). All samples had RNA Integrity Number (RIN) greater than 5.0. Contaminant DNA was removed by digestion with RNase-free DNase (Qiagen).","biotin","cRNA was prepared using two-cycle target labeling and control reagents kit (Affymetrix, Santa Clara, CA).","9606","Hybridization and signal detection of HG-U133 Plus 2.0 arrays (Affymetrix) was performed following the manufacturer's instruction using the Affymetrix Fluidics Station 450.","GeneChips were scanned using Affymetrix GeneChip Scanner 3000.","Gene expression profile of surgically resected material","NH088","The data was normalized by robust multichip analysis (RMA) using R/Bioconductor.","GPL570","Kaoru,,Mogushi","mogushi@bioinfo.tmd.ac.jp","+81-3-5803-4758","Information Center for Medical Sciences","Tokyo Medical and Dental University","1-5-45 Yushima","Bunkyo-ku","Tokyo","113-8510","Japan","http://bioinfo.tmd.ac.jp/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM549nnn/GSM549123/GSM549123_chip_array_C88N-H.CEL.gz","54675",""
"GSM549124","patient 006, cancer, homogenized [OPG study]","GSM549124","Public on Feb 28 2011","Jun 02 2010","Feb 28 2011","RNA","1","surgically resected material","Homo sapiens","metastasis: metastatic recurrence","stage: 2b","tissue: cancer, homogenized","Tumor tissue was extracted using laser-capture microdissection.","total RNA","Total RNA was extracted from tissue specimens using RNeasy kit (Qiagen, Hilden, Germany). Integrity of obtained RNA was assessed using Agilent 2100 BioAnalyzer (Agilent Technologies, Palo Alto, CA). All samples had RNA Integrity Number (RIN) greater than 5.0. Contaminant DNA was removed by digestion with RNase-free DNase (Qiagen).","biotin","cRNA was prepared using two-cycle target labeling and control reagents kit (Affymetrix, Santa Clara, CA).","9606","Hybridization and signal detection of HG-U133 Plus 2.0 arrays (Affymetrix) was performed following the manufacturer's instruction using the Affymetrix Fluidics Station 450.","GeneChips were scanned using Affymetrix GeneChip Scanner 3000.","Gene expression profile of surgically resected material","CH006","The data was normalized by robust multichip analysis (RMA) using R/Bioconductor.","GPL570","Kaoru,,Mogushi","mogushi@bioinfo.tmd.ac.jp","+81-3-5803-4758","Information Center for Medical Sciences","Tokyo Medical and Dental University","1-5-45 Yushima","Bunkyo-ku","Tokyo","113-8510","Japan","http://bioinfo.tmd.ac.jp/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM549nnn/GSM549124/GSM549124_chip_array_C06T-H.CEL.gz","54675",""
"GSM549125","patient 011, cancer, homogenized [OPG study]","GSM549125","Public on Feb 28 2011","Jun 02 2010","Feb 28 2011","RNA","1","surgically resected material","Homo sapiens","metastasis: metastasis","stage: 4","tissue: cancer, homogenized","Tumor tissue was extracted using laser-capture microdissection.","total RNA","Total RNA was extracted from tissue specimens using RNeasy kit (Qiagen, Hilden, Germany). Integrity of obtained RNA was assessed using Agilent 2100 BioAnalyzer (Agilent Technologies, Palo Alto, CA). All samples had RNA Integrity Number (RIN) greater than 5.0. Contaminant DNA was removed by digestion with RNase-free DNase (Qiagen).","biotin","cRNA was prepared using two-cycle target labeling and control reagents kit (Affymetrix, Santa Clara, CA).","9606","Hybridization and signal detection of HG-U133 Plus 2.0 arrays (Affymetrix) was performed following the manufacturer's instruction using the Affymetrix Fluidics Station 450.","GeneChips were scanned using Affymetrix GeneChip Scanner 3000.","Gene expression profile of surgically resected material","CH011","The data was normalized by robust multichip analysis (RMA) using R/Bioconductor.","GPL570","Kaoru,,Mogushi","mogushi@bioinfo.tmd.ac.jp","+81-3-5803-4758","Information Center for Medical Sciences","Tokyo Medical and Dental University","1-5-45 Yushima","Bunkyo-ku","Tokyo","113-8510","Japan","http://bioinfo.tmd.ac.jp/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM549nnn/GSM549125/GSM549125_chip_array_C11T-H.CEL.gz","54675",""
"GSM549126","patient 015, cancer, homogenized [OPG study]","GSM549126","Public on Feb 28 2011","Jun 02 2010","Feb 28 2011","RNA","1","surgically resected material","Homo sapiens","metastasis: metastatic recurrence","stage: 2b","tissue: cancer, homogenized","Tumor tissue was extracted using laser-capture microdissection.","total RNA","Total RNA was extracted from tissue specimens using RNeasy kit (Qiagen, Hilden, Germany). Integrity of obtained RNA was assessed using Agilent 2100 BioAnalyzer (Agilent Technologies, Palo Alto, CA). All samples had RNA Integrity Number (RIN) greater than 5.0. Contaminant DNA was removed by digestion with RNase-free DNase (Qiagen).","biotin","cRNA was prepared using two-cycle target labeling and control reagents kit (Affymetrix, Santa Clara, CA).","9606","Hybridization and signal detection of HG-U133 Plus 2.0 arrays (Affymetrix) was performed following the manufacturer's instruction using the Affymetrix Fluidics Station 450.","GeneChips were scanned using Affymetrix GeneChip Scanner 3000.","Gene expression profile of surgically resected material","CH015","The data was normalized by robust multichip analysis (RMA) using R/Bioconductor.","GPL570","Kaoru,,Mogushi","mogushi@bioinfo.tmd.ac.jp","+81-3-5803-4758","Information Center for Medical Sciences","Tokyo Medical and Dental University","1-5-45 Yushima","Bunkyo-ku","Tokyo","113-8510","Japan","http://bioinfo.tmd.ac.jp/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM549nnn/GSM549126/GSM549126_chip_array_C15T-H.CEL.gz","54675",""
"GSM549127","patient 024, cancer, homogenized [OPG study]","GSM549127","Public on Feb 28 2011","Jun 02 2010","Feb 28 2011","RNA","1","surgically resected material","Homo sapiens","metastasis: metastasis","stage: 4","tissue: cancer, homogenized","Tumor tissue was extracted using laser-capture microdissection.","total RNA","Total RNA was extracted from tissue specimens using RNeasy kit (Qiagen, Hilden, Germany). Integrity of obtained RNA was assessed using Agilent 2100 BioAnalyzer (Agilent Technologies, Palo Alto, CA). All samples had RNA Integrity Number (RIN) greater than 5.0. Contaminant DNA was removed by digestion with RNase-free DNase (Qiagen).","biotin","cRNA was prepared using two-cycle target labeling and control reagents kit (Affymetrix, Santa Clara, CA).","9606","Hybridization and signal detection of HG-U133 Plus 2.0 arrays (Affymetrix) was performed following the manufacturer's instruction using the Affymetrix Fluidics Station 450.","GeneChips were scanned using Affymetrix GeneChip Scanner 3000.","Gene expression profile of surgically resected material","CH024","The data was normalized by robust multichip analysis (RMA) using R/Bioconductor.","GPL570","Kaoru,,Mogushi","mogushi@bioinfo.tmd.ac.jp","+81-3-5803-4758","Information Center for Medical Sciences","Tokyo Medical and Dental University","1-5-45 Yushima","Bunkyo-ku","Tokyo","113-8510","Japan","http://bioinfo.tmd.ac.jp/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM549nnn/GSM549127/GSM549127_chip_array_C24T-H.CEL.gz","54675",""
"GSM549128","patient 025, cancer, homogenized [OPG study]","GSM549128","Public on Feb 28 2011","Jun 02 2010","Feb 28 2011","RNA","1","surgically resected material","Homo sapiens","metastasis: metastatic recurrence","stage: 2b","tissue: cancer, homogenized","Tumor tissue was extracted using laser-capture microdissection.","total RNA","Total RNA was extracted from tissue specimens using RNeasy kit (Qiagen, Hilden, Germany). Integrity of obtained RNA was assessed using Agilent 2100 BioAnalyzer (Agilent Technologies, Palo Alto, CA). All samples had RNA Integrity Number (RIN) greater than 5.0. Contaminant DNA was removed by digestion with RNase-free DNase (Qiagen).","biotin","cRNA was prepared using two-cycle target labeling and control reagents kit (Affymetrix, Santa Clara, CA).","9606","Hybridization and signal detection of HG-U133 Plus 2.0 arrays (Affymetrix) was performed following the manufacturer's instruction using the Affymetrix Fluidics Station 450.","GeneChips were scanned using Affymetrix GeneChip Scanner 3000.","Gene expression profile of surgically resected material","CH025","The data was normalized by robust multichip analysis (RMA) using R/Bioconductor.","GPL570","Kaoru,,Mogushi","mogushi@bioinfo.tmd.ac.jp","+81-3-5803-4758","Information Center for Medical Sciences","Tokyo Medical and Dental University","1-5-45 Yushima","Bunkyo-ku","Tokyo","113-8510","Japan","http://bioinfo.tmd.ac.jp/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM549nnn/GSM549128/GSM549128_chip_array_C25T-H.CEL.gz","54675",""
"GSM549129","patient 027, cancer, homogenized [OPG study]","GSM549129","Public on Feb 28 2011","Jun 02 2010","Feb 28 2011","RNA","1","surgically resected material","Homo sapiens","metastasis: none","stage: 3c","tissue: cancer, homogenized","Tumor tissue was extracted using laser-capture microdissection.","total RNA","Total RNA was extracted from tissue specimens using RNeasy kit (Qiagen, Hilden, Germany). Integrity of obtained RNA was assessed using Agilent 2100 BioAnalyzer (Agilent Technologies, Palo Alto, CA). All samples had RNA Integrity Number (RIN) greater than 5.0. Contaminant DNA was removed by digestion with RNase-free DNase (Qiagen).","biotin","cRNA was prepared using two-cycle target labeling and control reagents kit (Affymetrix, Santa Clara, CA).","9606","Hybridization and signal detection of HG-U133 Plus 2.0 arrays (Affymetrix) was performed following the manufacturer's instruction using the Affymetrix Fluidics Station 450.","GeneChips were scanned using Affymetrix GeneChip Scanner 3000.","Gene expression profile of surgically resected material","CH027","The data was normalized by robust multichip analysis (RMA) using R/Bioconductor.","GPL570","Kaoru,,Mogushi","mogushi@bioinfo.tmd.ac.jp","+81-3-5803-4758","Information Center for Medical Sciences","Tokyo Medical and Dental University","1-5-45 Yushima","Bunkyo-ku","Tokyo","113-8510","Japan","http://bioinfo.tmd.ac.jp/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM549nnn/GSM549129/GSM549129_chip_array_C27T-H.CEL.gz","54675",""
"GSM549130","patient 028, cancer, homogenized [OPG study]","GSM549130","Public on Feb 28 2011","Jun 02 2010","Feb 28 2011","RNA","1","surgically resected material","Homo sapiens","metastasis: metastatic recurrence","stage: 3c","tissue: cancer, homogenized","Tumor tissue was extracted using laser-capture microdissection.","total RNA","Total RNA was extracted from tissue specimens using RNeasy kit (Qiagen, Hilden, Germany). Integrity of obtained RNA was assessed using Agilent 2100 BioAnalyzer (Agilent Technologies, Palo Alto, CA). All samples had RNA Integrity Number (RIN) greater than 5.0. Contaminant DNA was removed by digestion with RNase-free DNase (Qiagen).","biotin","cRNA was prepared using two-cycle target labeling and control reagents kit (Affymetrix, Santa Clara, CA).","9606","Hybridization and signal detection of HG-U133 Plus 2.0 arrays (Affymetrix) was performed following the manufacturer's instruction using the Affymetrix Fluidics Station 450.","GeneChips were scanned using Affymetrix GeneChip Scanner 3000.","Gene expression profile of surgically resected material","CH028","The data was normalized by robust multichip analysis (RMA) using R/Bioconductor.","GPL570","Kaoru,,Mogushi","mogushi@bioinfo.tmd.ac.jp","+81-3-5803-4758","Information Center for Medical Sciences","Tokyo Medical and Dental University","1-5-45 Yushima","Bunkyo-ku","Tokyo","113-8510","Japan","http://bioinfo.tmd.ac.jp/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM549nnn/GSM549130/GSM549130_chip_array_C28T-H.CEL.gz","54675",""
"GSM549131","patient 030, cancer, homogenized [OPG study]","GSM549131","Public on Feb 28 2011","Jun 02 2010","Feb 28 2011","RNA","1","surgically resected material","Homo sapiens","metastasis: none","stage: 3b","tissue: cancer, homogenized","Tumor tissue was extracted using laser-capture microdissection.","total RNA","Total RNA was extracted from tissue specimens using RNeasy kit (Qiagen, Hilden, Germany). Integrity of obtained RNA was assessed using Agilent 2100 BioAnalyzer (Agilent Technologies, Palo Alto, CA). All samples had RNA Integrity Number (RIN) greater than 5.0. Contaminant DNA was removed by digestion with RNase-free DNase (Qiagen).","biotin","cRNA was prepared using two-cycle target labeling and control reagents kit (Affymetrix, Santa Clara, CA).","9606","Hybridization and signal detection of HG-U133 Plus 2.0 arrays (Affymetrix) was performed following the manufacturer's instruction using the Affymetrix Fluidics Station 450.","GeneChips were scanned using Affymetrix GeneChip Scanner 3000.","Gene expression profile of surgically resected material","CH030","The data was normalized by robust multichip analysis (RMA) using R/Bioconductor.","GPL570","Kaoru,,Mogushi","mogushi@bioinfo.tmd.ac.jp","+81-3-5803-4758","Information Center for Medical Sciences","Tokyo Medical and Dental University","1-5-45 Yushima","Bunkyo-ku","Tokyo","113-8510","Japan","http://bioinfo.tmd.ac.jp/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM549nnn/GSM549131/GSM549131_chip_array_C30T-H.CEL.gz","54675",""
"GSM549132","patient 031, cancer, homogenized [OPG study]","GSM549132","Public on Feb 28 2011","Jun 02 2010","Feb 28 2011","RNA","1","surgically resected material","Homo sapiens","metastasis: none","stage: 2b","tissue: cancer, homogenized","Tumor tissue was extracted using laser-capture microdissection.","total RNA","Total RNA was extracted from tissue specimens using RNeasy kit (Qiagen, Hilden, Germany). Integrity of obtained RNA was assessed using Agilent 2100 BioAnalyzer (Agilent Technologies, Palo Alto, CA). All samples had RNA Integrity Number (RIN) greater than 5.0. Contaminant DNA was removed by digestion with RNase-free DNase (Qiagen).","biotin","cRNA was prepared using two-cycle target labeling and control reagents kit (Affymetrix, Santa Clara, CA).","9606","Hybridization and signal detection of HG-U133 Plus 2.0 arrays (Affymetrix) was performed following the manufacturer's instruction using the Affymetrix Fluidics Station 450.","GeneChips were scanned using Affymetrix GeneChip Scanner 3000.","Gene expression profile of surgically resected material","CH031","The data was normalized by robust multichip analysis (RMA) using R/Bioconductor.","GPL570","Kaoru,,Mogushi","mogushi@bioinfo.tmd.ac.jp","+81-3-5803-4758","Information Center for Medical Sciences","Tokyo Medical and Dental University","1-5-45 Yushima","Bunkyo-ku","Tokyo","113-8510","Japan","http://bioinfo.tmd.ac.jp/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM549nnn/GSM549132/GSM549132_chip_array_C31T-H.CEL.gz","54675",""
"GSM549133","patient 032, cancer, homogenized [OPG study]","GSM549133","Public on Feb 28 2011","Jun 02 2010","Feb 28 2011","RNA","1","surgically resected material","Homo sapiens","metastasis: none","stage: 1","tissue: cancer, homogenized","Tumor tissue was extracted using laser-capture microdissection.","total RNA","Total RNA was extracted from tissue specimens using RNeasy kit (Qiagen, Hilden, Germany). Integrity of obtained RNA was assessed using Agilent 2100 BioAnalyzer (Agilent Technologies, Palo Alto, CA). All samples had RNA Integrity Number (RIN) greater than 5.0. Contaminant DNA was removed by digestion with RNase-free DNase (Qiagen).","biotin","cRNA was prepared using two-cycle target labeling and control reagents kit (Affymetrix, Santa Clara, CA).","9606","Hybridization and signal detection of HG-U133 Plus 2.0 arrays (Affymetrix) was performed following the manufacturer's instruction using the Affymetrix Fluidics Station 450.","GeneChips were scanned using Affymetrix GeneChip Scanner 3000.","Gene expression profile of surgically resected material","CH032","The data was normalized by robust multichip analysis (RMA) using R/Bioconductor.","GPL570","Kaoru,,Mogushi","mogushi@bioinfo.tmd.ac.jp","+81-3-5803-4758","Information Center for Medical Sciences","Tokyo Medical and Dental University","1-5-45 Yushima","Bunkyo-ku","Tokyo","113-8510","Japan","http://bioinfo.tmd.ac.jp/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM549nnn/GSM549133/GSM549133_chip_array_C32T-H.CEL.gz","54675",""
"GSM549134","patient 033, cancer, homogenized [OPG study]","GSM549134","Public on Feb 28 2011","Jun 02 2010","Feb 28 2011","RNA","1","surgically resected material","Homo sapiens","metastasis: none","stage: 2a","tissue: cancer, homogenized","Tumor tissue was extracted using laser-capture microdissection.","total RNA","Total RNA was extracted from tissue specimens using RNeasy kit (Qiagen, Hilden, Germany). Integrity of obtained RNA was assessed using Agilent 2100 BioAnalyzer (Agilent Technologies, Palo Alto, CA). All samples had RNA Integrity Number (RIN) greater than 5.0. Contaminant DNA was removed by digestion with RNase-free DNase (Qiagen).","biotin","cRNA was prepared using two-cycle target labeling and control reagents kit (Affymetrix, Santa Clara, CA).","9606","Hybridization and signal detection of HG-U133 Plus 2.0 arrays (Affymetrix) was performed following the manufacturer's instruction using the Affymetrix Fluidics Station 450.","GeneChips were scanned using Affymetrix GeneChip Scanner 3000.","Gene expression profile of surgically resected material","CH033","The data was normalized by robust multichip analysis (RMA) using R/Bioconductor.","GPL570","Kaoru,,Mogushi","mogushi@bioinfo.tmd.ac.jp","+81-3-5803-4758","Information Center for Medical Sciences","Tokyo Medical and Dental University","1-5-45 Yushima","Bunkyo-ku","Tokyo","113-8510","Japan","http://bioinfo.tmd.ac.jp/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM549nnn/GSM549134/GSM549134_chip_array_C33T-H.CEL.gz","54675",""
"GSM549135","patient 035, cancer, homogenized [OPG study]","GSM549135","Public on Feb 28 2011","Jun 02 2010","Feb 28 2011","RNA","1","surgically resected material","Homo sapiens","metastasis: metastasis","stage: 4","tissue: cancer, homogenized","Tumor tissue was extracted using laser-capture microdissection.","total RNA","Total RNA was extracted from tissue specimens using RNeasy kit (Qiagen, Hilden, Germany). Integrity of obtained RNA was assessed using Agilent 2100 BioAnalyzer (Agilent Technologies, Palo Alto, CA). All samples had RNA Integrity Number (RIN) greater than 5.0. Contaminant DNA was removed by digestion with RNase-free DNase (Qiagen).","biotin","cRNA was prepared using two-cycle target labeling and control reagents kit (Affymetrix, Santa Clara, CA).","9606","Hybridization and signal detection of HG-U133 Plus 2.0 arrays (Affymetrix) was performed following the manufacturer's instruction using the Affymetrix Fluidics Station 450.","GeneChips were scanned using Affymetrix GeneChip Scanner 3000.","Gene expression profile of surgically resected material","CH035","The data was normalized by robust multichip analysis (RMA) using R/Bioconductor.","GPL570","Kaoru,,Mogushi","mogushi@bioinfo.tmd.ac.jp","+81-3-5803-4758","Information Center for Medical Sciences","Tokyo Medical and Dental University","1-5-45 Yushima","Bunkyo-ku","Tokyo","113-8510","Japan","http://bioinfo.tmd.ac.jp/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM549nnn/GSM549135/GSM549135_chip_array_C35T-H.CEL.gz","54675",""
"GSM549136","patient 036, cancer, homogenized [OPG study]","GSM549136","Public on Feb 28 2011","Jun 02 2010","Feb 28 2011","RNA","1","surgically resected material","Homo sapiens","metastasis: none","stage: 2a","tissue: cancer, homogenized","Tumor tissue was extracted using laser-capture microdissection.","total RNA","Total RNA was extracted from tissue specimens using RNeasy kit (Qiagen, Hilden, Germany). Integrity of obtained RNA was assessed using Agilent 2100 BioAnalyzer (Agilent Technologies, Palo Alto, CA). All samples had RNA Integrity Number (RIN) greater than 5.0. Contaminant DNA was removed by digestion with RNase-free DNase (Qiagen).","biotin","cRNA was prepared using two-cycle target labeling and control reagents kit (Affymetrix, Santa Clara, CA).","9606","Hybridization and signal detection of HG-U133 Plus 2.0 arrays (Affymetrix) was performed following the manufacturer's instruction using the Affymetrix Fluidics Station 450.","GeneChips were scanned using Affymetrix GeneChip Scanner 3000.","Gene expression profile of surgically resected material","CH036","The data was normalized by robust multichip analysis (RMA) using R/Bioconductor.","GPL570","Kaoru,,Mogushi","mogushi@bioinfo.tmd.ac.jp","+81-3-5803-4758","Information Center for Medical Sciences","Tokyo Medical and Dental University","1-5-45 Yushima","Bunkyo-ku","Tokyo","113-8510","Japan","http://bioinfo.tmd.ac.jp/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM549nnn/GSM549136/GSM549136_chip_array_C36T-H.CEL.gz","54675",""
"GSM549137","patient 038, cancer, homogenized [OPG study]","GSM549137","Public on Feb 28 2011","Jun 02 2010","Feb 28 2011","RNA","1","surgically resected material","Homo sapiens","metastasis: none","stage: 2b","tissue: cancer, homogenized","Tumor tissue was extracted using laser-capture microdissection.","total RNA","Total RNA was extracted from tissue specimens using RNeasy kit (Qiagen, Hilden, Germany). Integrity of obtained RNA was assessed using Agilent 2100 BioAnalyzer (Agilent Technologies, Palo Alto, CA). All samples had RNA Integrity Number (RIN) greater than 5.0. Contaminant DNA was removed by digestion with RNase-free DNase (Qiagen).","biotin","cRNA was prepared using two-cycle target labeling and control reagents kit (Affymetrix, Santa Clara, CA).","9606","Hybridization and signal detection of HG-U133 Plus 2.0 arrays (Affymetrix) was performed following the manufacturer's instruction using the Affymetrix Fluidics Station 450.","GeneChips were scanned using Affymetrix GeneChip Scanner 3000.","Gene expression profile of surgically resected material","CH038","The data was normalized by robust multichip analysis (RMA) using R/Bioconductor.","GPL570","Kaoru,,Mogushi","mogushi@bioinfo.tmd.ac.jp","+81-3-5803-4758","Information Center for Medical Sciences","Tokyo Medical and Dental University","1-5-45 Yushima","Bunkyo-ku","Tokyo","113-8510","Japan","http://bioinfo.tmd.ac.jp/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM549nnn/GSM549137/GSM549137_chip_array_C38T-H.CEL.gz","54675",""
"GSM549138","patient 041, cancer, homogenized [OPG study]","GSM549138","Public on Feb 28 2011","Jun 02 2010","Feb 28 2011","RNA","1","surgically resected material","Homo sapiens","metastasis: metastatic recurrence","stage: 3b","tissue: cancer, homogenized","Tumor tissue was extracted using laser-capture microdissection.","total RNA","Total RNA was extracted from tissue specimens using RNeasy kit (Qiagen, Hilden, Germany). Integrity of obtained RNA was assessed using Agilent 2100 BioAnalyzer (Agilent Technologies, Palo Alto, CA). All samples had RNA Integrity Number (RIN) greater than 5.0. Contaminant DNA was removed by digestion with RNase-free DNase (Qiagen).","biotin","cRNA was prepared using two-cycle target labeling and control reagents kit (Affymetrix, Santa Clara, CA).","9606","Hybridization and signal detection of HG-U133 Plus 2.0 arrays (Affymetrix) was performed following the manufacturer's instruction using the Affymetrix Fluidics Station 450.","GeneChips were scanned using Affymetrix GeneChip Scanner 3000.","Gene expression profile of surgically resected material","CH041","The data was normalized by robust multichip analysis (RMA) using R/Bioconductor.","GPL570","Kaoru,,Mogushi","mogushi@bioinfo.tmd.ac.jp","+81-3-5803-4758","Information Center for Medical Sciences","Tokyo Medical and Dental University","1-5-45 Yushima","Bunkyo-ku","Tokyo","113-8510","Japan","http://bioinfo.tmd.ac.jp/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM549nnn/GSM549138/GSM549138_chip_array_C41T-H.CEL.gz","54675",""
"GSM549139","patient 042, cancer, homogenized [OPG study]","GSM549139","Public on Feb 28 2011","Jun 02 2010","Feb 28 2011","RNA","1","surgically resected material","Homo sapiens","metastasis: none","stage: 1","tissue: cancer, homogenized","Tumor tissue was extracted using laser-capture microdissection.","total RNA","Total RNA was extracted from tissue specimens using RNeasy kit (Qiagen, Hilden, Germany). Integrity of obtained RNA was assessed using Agilent 2100 BioAnalyzer (Agilent Technologies, Palo Alto, CA). All samples had RNA Integrity Number (RIN) greater than 5.0. Contaminant DNA was removed by digestion with RNase-free DNase (Qiagen).","biotin","cRNA was prepared using two-cycle target labeling and control reagents kit (Affymetrix, Santa Clara, CA).","9606","Hybridization and signal detection of HG-U133 Plus 2.0 arrays (Affymetrix) was performed following the manufacturer's instruction using the Affymetrix Fluidics Station 450.","GeneChips were scanned using Affymetrix GeneChip Scanner 3000.","Gene expression profile of surgically resected material","CH042","The data was normalized by robust multichip analysis (RMA) using R/Bioconductor.","GPL570","Kaoru,,Mogushi","mogushi@bioinfo.tmd.ac.jp","+81-3-5803-4758","Information Center for Medical Sciences","Tokyo Medical and Dental University","1-5-45 Yushima","Bunkyo-ku","Tokyo","113-8510","Japan","http://bioinfo.tmd.ac.jp/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM549nnn/GSM549139/GSM549139_chip_array_C42T-H.CEL.gz","54675",""
"GSM549140","patient 044, cancer, homogenized [OPG study]","GSM549140","Public on Feb 28 2011","Jun 02 2010","Feb 28 2011","RNA","1","surgically resected material","Homo sapiens","metastasis: none","stage: 2a","tissue: cancer, homogenized","Tumor tissue was extracted using laser-capture microdissection.","total RNA","Total RNA was extracted from tissue specimens using RNeasy kit (Qiagen, Hilden, Germany). Integrity of obtained RNA was assessed using Agilent 2100 BioAnalyzer (Agilent Technologies, Palo Alto, CA). All samples had RNA Integrity Number (RIN) greater than 5.0. Contaminant DNA was removed by digestion with RNase-free DNase (Qiagen).","biotin","cRNA was prepared using two-cycle target labeling and control reagents kit (Affymetrix, Santa Clara, CA).","9606","Hybridization and signal detection of HG-U133 Plus 2.0 arrays (Affymetrix) was performed following the manufacturer's instruction using the Affymetrix Fluidics Station 450.","GeneChips were scanned using Affymetrix GeneChip Scanner 3000.","Gene expression profile of surgically resected material","CH044","The data was normalized by robust multichip analysis (RMA) using R/Bioconductor.","GPL570","Kaoru,,Mogushi","mogushi@bioinfo.tmd.ac.jp","+81-3-5803-4758","Information Center for Medical Sciences","Tokyo Medical and Dental University","1-5-45 Yushima","Bunkyo-ku","Tokyo","113-8510","Japan","http://bioinfo.tmd.ac.jp/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM549nnn/GSM549140/GSM549140_chip_array_C44T-H.CEL.gz","54675",""
"GSM549141","patient 045, cancer, homogenized [OPG study]","GSM549141","Public on Feb 28 2011","Jun 02 2010","Feb 28 2011","RNA","1","surgically resected material","Homo sapiens","metastasis: metastatic recurrence","stage: 3b","tissue: cancer, homogenized","Tumor tissue was extracted using laser-capture microdissection.","total RNA","Total RNA was extracted from tissue specimens using RNeasy kit (Qiagen, Hilden, Germany). Integrity of obtained RNA was assessed using Agilent 2100 BioAnalyzer (Agilent Technologies, Palo Alto, CA). All samples had RNA Integrity Number (RIN) greater than 5.0. Contaminant DNA was removed by digestion with RNase-free DNase (Qiagen).","biotin","cRNA was prepared using two-cycle target labeling and control reagents kit (Affymetrix, Santa Clara, CA).","9606","Hybridization and signal detection of HG-U133 Plus 2.0 arrays (Affymetrix) was performed following the manufacturer's instruction using the Affymetrix Fluidics Station 450.","GeneChips were scanned using Affymetrix GeneChip Scanner 3000.","Gene expression profile of surgically resected material","CH045","The data was normalized by robust multichip analysis (RMA) using R/Bioconductor.","GPL570","Kaoru,,Mogushi","mogushi@bioinfo.tmd.ac.jp","+81-3-5803-4758","Information Center for Medical Sciences","Tokyo Medical and Dental University","1-5-45 Yushima","Bunkyo-ku","Tokyo","113-8510","Japan","http://bioinfo.tmd.ac.jp/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM549nnn/GSM549141/GSM549141_chip_array_C45T-H.CEL.gz","54675",""
"GSM549142","patient 047, cancer, homogenized [OPG study]","GSM549142","Public on Feb 28 2011","Jun 02 2010","Feb 28 2011","RNA","1","surgically resected material","Homo sapiens","metastasis: none","stage: 2b","tissue: cancer, homogenized","Tumor tissue was extracted using laser-capture microdissection.","total RNA","Total RNA was extracted from tissue specimens using RNeasy kit (Qiagen, Hilden, Germany). Integrity of obtained RNA was assessed using Agilent 2100 BioAnalyzer (Agilent Technologies, Palo Alto, CA). All samples had RNA Integrity Number (RIN) greater than 5.0. Contaminant DNA was removed by digestion with RNase-free DNase (Qiagen).","biotin","cRNA was prepared using two-cycle target labeling and control reagents kit (Affymetrix, Santa Clara, CA).","9606","Hybridization and signal detection of HG-U133 Plus 2.0 arrays (Affymetrix) was performed following the manufacturer's instruction using the Affymetrix Fluidics Station 450.","GeneChips were scanned using Affymetrix GeneChip Scanner 3000.","Gene expression profile of surgically resected material","CH047","The data was normalized by robust multichip analysis (RMA) using R/Bioconductor.","GPL570","Kaoru,,Mogushi","mogushi@bioinfo.tmd.ac.jp","+81-3-5803-4758","Information Center for Medical Sciences","Tokyo Medical and Dental University","1-5-45 Yushima","Bunkyo-ku","Tokyo","113-8510","Japan","http://bioinfo.tmd.ac.jp/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM549nnn/GSM549142/GSM549142_chip_array_C47T-H.CEL.gz","54675",""
